id	sid	tid	token	lemma	pos
ct-9352	1	1	immune	immune	ADJ
ct-9352	1	2	response	response	NOUN
ct-9352	1	3	to	to	ADP
ct-9352	1	4	breeding	breed	VERB
ct-9352	1	5	inflammation	inflammation	NOUN
ct-9352	1	6	and/or	and/or	CCONJ
ct-9352	1	7	infection	infection	NOUN
ct-9352	1	8	of	of	ADP
ct-9352	1	9	the	the	DET
ct-9352	1	10	endometrium	endometrium	NOUN
ct-9352	1	11	is	be	AUX
ct-9352	1	12	the	the	DET
ct-9352	1	13	leading	lead	VERB
ct-9352	1	14	cause	cause	NOUN
ct-9352	1	15	of	of	ADP
ct-9352	1	16	subfertility	subfertility	NOUN
ct-9352	1	17	in	in	ADP
ct-9352	1	18	mares	mare	NOUN
ct-9352	1	19	,	,	PUNCT
ct-9352	1	20	resulting	result	VERB
ct-9352	1	21	in	in	ADP
ct-9352	1	22	persistent	persistent	ADJ
ct-9352	1	23	breeding	breeding	NOUN
ct-9352	1	24	-	-	PUNCT
ct-9352	1	25	induced	induce	VERB
ct-9352	1	26	endometritis	endometritis	NOUN
ct-9352	1	27	(	(	PUNCT
ct-9352	1	28	pbie	pbie	NOUN
ct-9352	1	29	)	)	PUNCT
ct-9352	1	30	,	,	PUNCT
ct-9352	1	31	affecting	affect	VERB
ct-9352	1	32	10	10	NUM
ct-9352	1	33	15	15	NUM
ct-9352	1	34	%	%	NOUN
ct-9352	1	35	of	of	ADP
ct-9352	1	36	the	the	DET
ct-9352	1	37	broodmare	broodmare	NOUN
ct-9352	1	38	population.1	population.1	NOUN
ct-9352	1	39	deposition	deposition	NOUN
ct-9352	1	40	of	of	ADP
ct-9352	1	41	sperm	sperm	NOUN
ct-9352	1	42	,	,	PUNCT
ct-9352	1	43	seminal	seminal	ADJ
ct-9352	1	44	plasma	plasma	NOUN
ct-9352	1	45	,	,	PUNCT
ct-9352	1	46	and/or	and/or	CCONJ
ct-9352	1	47	bacteria	bacteria	NOUN
ct-9352	1	48	in	in	ADP
ct-9352	1	49	the	the	DET
ct-9352	1	50	reproductive	reproductive	ADJ
ct-9352	1	51	tract	tract	NOUN
ct-9352	1	52	elicits	elicit	VERB
ct-9352	1	53	an	an	DET
ct-9352	1	54	inflammatory	inflammatory	ADJ
ct-9352	1	55	response	response	NOUN
ct-9352	1	56	that	that	PRON
ct-9352	1	57	leads	lead	VERB
ct-9352	1	58	to	to	ADP
ct-9352	1	59	activation	activation	NOUN
ct-9352	1	60	of	of	ADP
ct-9352	1	61	the	the	DET
ct-9352	1	62	innate	innate	ADJ
ct-9352	1	63	arm	arm	NOUN
ct-9352	1	64	of	of	ADP
ct-9352	1	65	the	the	DET
ct-9352	1	66	immune	immune	ADJ
ct-9352	1	67	system	system	NOUN
ct-9352	1	68	.	.	PUNCT
ct-9352	2	1	this	this	PRON
ct-9352	2	2	begins	begin	VERB
ct-9352	2	3	with	with	ADP
ct-9352	2	4	the	the	DET
ct-9352	2	5	stimulation	stimulation	NOUN
ct-9352	2	6	of	of	ADP
ct-9352	2	7	pattern	pattern	NOUN
ct-9352	2	8	-	-	PUNCT
ct-9352	2	9	recognition	recognition	NOUN
ct-9352	2	10	receptors,2	receptors,2	NOUN
ct-9352	2	11	induction	induction	NOUN
ct-9352	2	12	of	of	ADP
ct-9352	2	13	the	the	DET
ct-9352	2	14	complement	complement	NOUN
ct-9352	2	15	system,3	system,3	NOUN
ct-9352	2	16	-	-	PUNCT
ct-9352	2	17	5	5	NUM
ct-9352	2	18	increases	increase	NOUN
ct-9352	2	19	in	in	ADP
ct-9352	2	20	proinflammatory	proinflammatory	ADJ
ct-9352	2	21	signaling	signal	VERB
ct-9352	2	22	molecules,6	molecules,6	NOUN
ct-9352	2	23	-	-	PUNCT
ct-9352	2	24	9	9	NUM
ct-9352	2	25	and	and	CCONJ
ct-9352	2	26	recruitment	recruitment	NOUN
ct-9352	2	27	of	of	ADP
ct-9352	2	28	immune	immune	ADJ
ct-9352	2	29	cells	cell	NOUN
ct-9352	2	30	to	to	ADP
ct-9352	2	31	the	the	DET
ct-9352	2	32	site	site	NOUN
ct-9352	2	33	of	of	ADP
ct-9352	2	34	inflammation.5,10	inflammation.5,10	PROPN
ct-9352	2	35	-	-	PUNCT
ct-9352	2	36	12	12	NUM
ct-9352	2	37	release	release	NOUN
ct-9352	2	38	of	of	ADP
ct-9352	2	39	prostaglandin	prostaglandin	NOUN
ct-9352	2	40	f2α	f2α	PROPN
ct-9352	2	41	(	(	PUNCT
ct-9352	2	42	pgf2α	pgf2α	PROPN
ct-9352	2	43	)	)	PUNCT
ct-9352	2	44	from	from	ADP
ct-9352	2	45	an	an	DET
ct-9352	2	46	inflamed	inflame	VERB
ct-9352	2	47	endometrium	endometrium	NOUN
ct-9352	2	48	and	and	CCONJ
ct-9352	2	49	appearance	appearance	NOUN
ct-9352	2	50	of	of	ADP
ct-9352	2	51	activated	activate	VERB
ct-9352	2	52	leukocytes	leukocyte	NOUN
ct-9352	2	53	coincide	coincide	NOUN
ct-9352	2	54	with	with	ADP
ct-9352	2	55	an	an	DET
ct-9352	2	56	increase	increase	NOUN
ct-9352	2	57	in	in	ADP
ct-9352	2	58	myometrial	myometrial	ADJ
ct-9352	2	59	contractility	contractility	NOUN
ct-9352	2	60	,	,	PUNCT
ct-9352	2	61	leading	lead	VERB
ct-9352	2	62	to	to	ADP
ct-9352	2	63	eventual	eventual	ADJ
ct-9352	2	64	expulsion	expulsion	NOUN
ct-9352	2	65	of	of	ADP
ct-9352	2	66	excess	excess	ADJ
ct-9352	2	67	fluid	fluid	NOUN
ct-9352	2	68	and	and	CCONJ
ct-9352	2	69	contaminants.13,14	contaminants.13,14	NOUN
ct-9352	2	70	in	in	ADP
ct-9352	2	71	reproductively	reproductively	ADV
ct-9352	2	72	sound	sound	ADJ
ct-9352	2	73	mares	mare	NOUN
ct-9352	2	74	that	that	PRON
ct-9352	2	75	are	be	AUX
ct-9352	2	76	resistant	resistant	ADJ
ct-9352	2	77	to	to	PART
ct-9352	2	78	pbie	pbie	VERB
ct-9352	2	79	,	,	PUNCT
ct-9352	2	80	this	this	DET
ct-9352	2	81	inflammation	inflammation	NOUN
ct-9352	2	82	is	be	AUX
ct-9352	2	83	resolved	resolve	VERB
ct-9352	2	84	within	within	ADP
ct-9352	2	85	24	24	NUM
ct-9352	2	86	36	36	NUM
ct-9352	2	87	hours	hour	NOUN
ct-9352	2	88	,	,	PUNCT
ct-9352	2	89	whereas	whereas	SCONJ
ct-9352	2	90	a	a	DET
ct-9352	2	91	subset	subset	NOUN
ct-9352	2	92	of	of	ADP
ct-9352	2	93	mares	mare	NOUN
ct-9352	2	94	that	that	PRON
ct-9352	2	95	experience	experience	NOUN
ct-9352	2	96	prolonged	prolong	VERB
ct-9352	2	97	inflammation	inflammation	NOUN
ct-9352	2	98	are	be	AUX
ct-9352	2	99	considered	consider	VERB
ct-9352	2	100	susceptible	susceptible	ADJ
ct-9352	2	101	to	to	ADP
ct-9352	2	102	pbie.9,13	pbie.9,13	NOUN
ct-9352	2	103	this	this	PRON
ct-9352	2	104	leads	lead	VERB
ct-9352	2	105	to	to	ADP
ct-9352	2	106	uterine	uterine	ADJ
ct-9352	2	107	fluid	fluid	ADJ
ct-9352	2	108	accumulation	accumulation	NOUN
ct-9352	2	109	,	,	PUNCT
ct-9352	2	110	extended	extend	VERB
ct-9352	2	111	neutrophilia	neutrophilia	NOUN
ct-9352	2	112	within	within	ADP
ct-9352	2	113	the	the	DET
ct-9352	2	114	uterine	uterine	ADJ
ct-9352	2	115	lumen	luman	NOUN
ct-9352	2	116	,	,	PUNCT
ct-9352	2	117	and	and	CCONJ
ct-9352	2	118	persistent	persistent	ADJ
ct-9352	2	119	inflammation	inflammation	NOUN
ct-9352	2	120	for	for	ADP
ct-9352	2	121	>	>	X
ct-9352	2	122	96	96	NUM
ct-9352	2	123	hours	hour	NOUN
ct-9352	2	124	,	,	PUNCT
ct-9352	2	125	potentially	potentially	ADV
ct-9352	2	126	impeding	impede	VERB
ct-9352	2	127	embryo	embryo	NOUN
ct-9352	2	128	viability	viability	NOUN
ct-9352	2	129	upon	upon	SCONJ
ct-9352	2	130	migration	migration	NOUN
ct-9352	2	131	from	from	ADP
ct-9352	2	132	the	the	DET
ct-9352	2	133	oviduct	oviduct	NOUN
ct-9352	2	134	.	.	PUNCT
ct-9352	3	1	although	although	SCONJ
ct-9352	3	2	both	both	CCONJ
ct-9352	3	3	susceptible	susceptible	ADJ
ct-9352	3	4	and	and	CCONJ
ct-9352	3	5	resistant	resistant	ADJ
ct-9352	3	6	mares	mare	NOUN
ct-9352	3	7	experience	experience	VERB
ct-9352	3	8	this	this	DET
ct-9352	3	9	activation	activation	NOUN
ct-9352	3	10	of	of	ADP
ct-9352	3	11	the	the	DET
ct-9352	3	12	innate	innate	ADJ
ct-9352	3	13	immune	immune	ADJ
ct-9352	3	14	response	response	NOUN
ct-9352	3	15	,	,	PUNCT
ct-9352	3	16	susceptible	susceptible	ADJ
ct-9352	3	17	mares	mare	NOUN
ct-9352	3	18	fail	fail	VERB
ct-9352	3	19	to	to	PART
ct-9352	3	20	mount	mount	VERB
ct-9352	3	21	the	the	DET
ct-9352	3	22	antiinflammatory	antiinflammatory	NOUN
ct-9352	3	23	response	response	NOUN
ct-9352	3	24	required	require	VERB
ct-9352	3	25	to	to	PART
ct-9352	3	26	mitigate	mitigate	VERB
ct-9352	3	27	the	the	DET
ct-9352	3	28	proinflammatory	proinflammatory	ADJ
ct-9352	3	29	signaling	signaling	NOUN
ct-9352	3	30	,	,	PUNCT
ct-9352	3	31	and	and	CCONJ
ct-9352	3	32	this	this	PRON
ct-9352	3	33	is	be	AUX
ct-9352	3	34	speculated	speculate	VERB
ct-9352	3	35	to	to	PART
ct-9352	3	36	be	be	AUX
ct-9352	3	37	the	the	DET
ct-9352	3	38	primary	primary	ADJ
ct-9352	3	39	cause	cause	NOUN
ct-9352	3	40	of	of	ADP
ct-9352	3	41	persistent	persistent	ADJ
ct-9352	3	42	inflammation	inflammation	NOUN
ct-9352	3	43	in	in	ADP
ct-9352	3	44	these	these	DET
ct-9352	3	45	mares	mare	NOUN
ct-9352	3	46	.	.	PUNCT
ct-9352	4	1	the	the	DET
ct-9352	4	2	critical	critical	ADJ
ct-9352	4	3	period	period	NOUN
ct-9352	4	4	for	for	ADP
ct-9352	4	5	the	the	DET
ct-9352	4	6	immune	immune	ADJ
ct-9352	4	7	response	response	NOUN
ct-9352	4	8	is	be	AUX
ct-9352	4	9	within	within	ADP
ct-9352	4	10	6	6	NUM
ct-9352	4	11	hours	hour	NOUN
ct-9352	4	12	after	after	ADP
ct-9352	4	13	insemination.8	insemination.8	NOUN
ct-9352	4	14	in	in	ADP
ct-9352	4	15	this	this	DET
ct-9352	4	16	period	period	NOUN
ct-9352	4	17	,	,	PUNCT
ct-9352	4	18	resistant	resistant	ADJ
ct-9352	4	19	mares	mare	NOUN
ct-9352	4	20	experienced	experience	VERB
ct-9352	4	21	an	an	DET
ct-9352	4	22	upregulation	upregulation	NOUN
ct-9352	4	23	of	of	ADP
ct-9352	4	24	various	various	ADJ
ct-9352	4	25	antiinflammatory	antiinflammatory	NOUN
ct-9352	4	26	and	and	CCONJ
ct-9352	4	27	immunomodulator	immunomodulator	NOUN
ct-9352	4	28	use	use	NOUN
ct-9352	4	29	in	in	ADP
ct-9352	4	30	mares	mare	NOUN
ct-9352	4	31	carleigh	carleigh	PROPN
ct-9352	4	32	fedorka	fedorka	PROPN
ct-9352	4	33	,	,	PUNCT
ct-9352	4	34	mats	mat	VERB
ct-9352	4	35	troedsson	troedsson	PROPN
ct-9352	4	36	department	department	PROPN
ct-9352	4	37	of	of	ADP
ct-9352	4	38	veterinary	veterinary	ADJ
ct-9352	4	39	sciences	sciences	PROPN
ct-9352	4	40	,	,	PUNCT
ct-9352	4	41	university	university	NOUN
ct-9352	4	42	of	of	ADP
ct-9352	4	43	kentucky	kentucky	PROPN
ct-9352	4	44	,	,	PUNCT
ct-9352	4	45	lexington	lexington	PROPN
ct-9352	4	46	,	,	PUNCT
ct-9352	4	47	ky	ky	PROPN
ct-9352	4	48	abstract	abstract	PROPN
ct-9352	4	49	a	a	DET
ct-9352	4	50	delicate	delicate	ADJ
ct-9352	4	51	balance	balance	NOUN
ct-9352	4	52	exists	exist	VERB
ct-9352	4	53	between	between	ADP
ct-9352	4	54	the	the	DET
ct-9352	4	55	immune	immune	ADJ
ct-9352	4	56	system	system	NOUN
ct-9352	4	57	and	and	CCONJ
ct-9352	4	58	the	the	DET
ct-9352	4	59	female	female	ADJ
ct-9352	4	60	reproductive	reproductive	ADJ
ct-9352	4	61	tract	tract	NOUN
ct-9352	4	62	,	,	PUNCT
ct-9352	4	63	modulating	modulate	VERB
ct-9352	4	64	numerous	numerous	ADJ
ct-9352	4	65	aspects	aspect	NOUN
ct-9352	4	66	of	of	ADP
ct-9352	4	67	reproductive	reproductive	ADJ
ct-9352	4	68	health	health	NOUN
ct-9352	4	69	.	.	PUNCT
ct-9352	5	1	this	this	PRON
ct-9352	5	2	includes	include	VERB
ct-9352	5	3	,	,	PUNCT
ct-9352	5	4	but	but	CCONJ
ct-9352	5	5	is	be	AUX
ct-9352	5	6	not	not	PART
ct-9352	5	7	limited	limit	VERB
ct-9352	5	8	to	to	ADP
ct-9352	5	9	,	,	PUNCT
ct-9352	5	10	ovulation	ovulation	NOUN
ct-9352	5	11	,	,	PUNCT
ct-9352	5	12	breeding	breeding	NOUN
ct-9352	5	13	-	-	PUNCT
ct-9352	5	14	induced	induce	VERB
ct-9352	5	15	uterine	uterine	ADJ
ct-9352	5	16	inflammation	inflammation	NOUN
ct-9352	5	17	,	,	PUNCT
ct-9352	5	18	fertilization	fertilization	NOUN
ct-9352	5	19	,	,	PUNCT
ct-9352	5	20	pregnancy	pregnancy	NOUN
ct-9352	5	21	maintenance	maintenance	NOUN
ct-9352	5	22	,	,	PUNCT
ct-9352	5	23	response	response	NOUN
ct-9352	5	24	to	to	ADP
ct-9352	5	25	placental	placental	ADJ
ct-9352	5	26	infection	infection	NOUN
ct-9352	5	27	,	,	PUNCT
ct-9352	5	28	and	and	CCONJ
ct-9352	5	29	postpartum	postpartum	NOUN
ct-9352	5	30	involution	involution	NOUN
ct-9352	5	31	.	.	PUNCT
ct-9352	6	1	additionally	additionally	ADV
ct-9352	6	2	,	,	PUNCT
ct-9352	6	3	stimulation	stimulation	NOUN
ct-9352	6	4	of	of	ADP
ct-9352	6	5	innate	innate	ADJ
ct-9352	6	6	and	and	CCONJ
ct-9352	6	7	adaptive	adaptive	ADJ
ct-9352	6	8	immune	immune	ADJ
ct-9352	6	9	systems	system	NOUN
ct-9352	6	10	can	can	AUX
ct-9352	6	11	assist	assist	VERB
ct-9352	6	12	in	in	ADP
ct-9352	6	13	clearing	clear	VERB
ct-9352	6	14	pathogens	pathogen	NOUN
ct-9352	6	15	from	from	ADP
ct-9352	6	16	the	the	DET
ct-9352	6	17	reproductive	reproductive	ADJ
ct-9352	6	18	tract	tract	NOUN
ct-9352	6	19	,	,	PUNCT
ct-9352	6	20	thereby	thereby	ADV
ct-9352	6	21	diminishing	diminish	VERB
ct-9352	6	22	inflammation	inflammation	NOUN
ct-9352	6	23	and/or	and/or	CCONJ
ct-9352	6	24	infection	infection	NOUN
ct-9352	6	25	that	that	PRON
ct-9352	6	26	may	may	AUX
ct-9352	6	27	inhibit	inhibit	VERB
ct-9352	6	28	reproductive	reproductive	ADJ
ct-9352	6	29	health	health	NOUN
ct-9352	6	30	.	.	PUNCT
ct-9352	7	1	in	in	ADP
ct-9352	7	2	this	this	DET
ct-9352	7	3	review	review	NOUN
ct-9352	7	4	,	,	PUNCT
ct-9352	7	5	the	the	DET
ct-9352	7	6	mechanisms	mechanism	NOUN
ct-9352	7	7	through	through	ADP
ct-9352	7	8	which	which	PRON
ct-9352	7	9	the	the	DET
ct-9352	7	10	immune	immune	ADJ
ct-9352	7	11	system	system	NOUN
ct-9352	7	12	modulates	modulate	VERB
ct-9352	7	13	reproductive	reproductive	ADJ
ct-9352	7	14	tract	tract	NOUN
ct-9352	7	15	will	will	AUX
ct-9352	7	16	be	be	AUX
ct-9352	7	17	elucidated	elucidate	VERB
ct-9352	7	18	and	and	CCONJ
ct-9352	7	19	critically	critically	ADV
ct-9352	7	20	evaluated	evaluate	VERB
ct-9352	7	21	immunomodulators	immunomodulator	NOUN
ct-9352	7	22	will	will	AUX
ct-9352	7	23	be	be	AUX
ct-9352	7	24	discussed	discuss	VERB
ct-9352	7	25	.	.	PUNCT
ct-9352	8	1	keywords	keyword	NOUN
ct-9352	8	2	:	:	PUNCT
ct-9352	8	3	immunomodulators	immunomodulator	NOUN
ct-9352	8	4	,	,	PUNCT
ct-9352	8	5	persistent	persistent	ADJ
ct-9352	8	6	breeding	breeding	NOUN
ct-9352	8	7	-	-	PUNCT
ct-9352	8	8	induced	induce	VERB
ct-9352	8	9	endometritis	endometritis	NOUN
ct-9352	8	10	,	,	PUNCT
ct-9352	8	11	placentitis	placentitis	PROPN
ct-9352	8	12	immunomodulatory	immunomodulatory	ADJ
ct-9352	8	13	cytokines	cytokine	NOUN
ct-9352	8	14	,	,	PUNCT
ct-9352	8	15	including	include	VERB
ct-9352	8	16	interleukin	interleukin	NOUN
ct-9352	8	17	(	(	PUNCT
ct-9352	8	18	il)-1	il)-1	ADP
ct-9352	8	19	receptor	receptor	NOUN
ct-9352	8	20	antagonist	antagonist	NOUN
ct-9352	8	21	,	,	PUNCT
ct-9352	8	22	il-10	il-10	PRON
ct-9352	8	23	,	,	PUNCT
ct-9352	8	24	and	and	CCONJ
ct-9352	8	25	il-6.8	il-6.8	VERB
ct-9352	8	26	in	in	ADP
ct-9352	8	27	contrast	contrast	NOUN
ct-9352	8	28	,	,	PUNCT
ct-9352	8	29	susceptible	susceptible	ADJ
ct-9352	8	30	mares	mare	NOUN
ct-9352	8	31	failed	fail	VERB
ct-9352	8	32	to	to	PART
ct-9352	8	33	upregulate	upregulate	VERB
ct-9352	8	34	these	these	DET
ct-9352	8	35	immunomodulating	immunomodulating	ADJ
ct-9352	8	36	cytokines	cytokine	NOUN
ct-9352	8	37	in	in	ADP
ct-9352	8	38	this	this	DET
ct-9352	8	39	critical	critical	ADJ
ct-9352	8	40	period	period	NOUN
ct-9352	8	41	,	,	PUNCT
ct-9352	8	42	leading	lead	VERB
ct-9352	8	43	to	to	ADP
ct-9352	8	44	prolonged	prolonged	ADJ
ct-9352	8	45	inflammation	inflammation	NOUN
ct-9352	8	46	.	.	PUNCT
ct-9352	9	1	this	this	PRON
ct-9352	9	2	was	be	AUX
ct-9352	9	3	specifically	specifically	ADV
ct-9352	9	4	noted	note	VERB
ct-9352	9	5	in	in	ADP
ct-9352	9	6	increased	increase	VERB
ct-9352	9	7	expression	expression	NOUN
ct-9352	9	8	of	of	ADP
ct-9352	9	9	proinflammatory	proinflammatory	ADJ
ct-9352	9	10	cytokines	cytokine	NOUN
ct-9352	9	11	(	(	PUNCT
ct-9352	9	12	il-1β	il-1β	NOUN
ct-9352	9	13	and	and	CCONJ
ct-9352	9	14	il-8	il-8	NOUN
ct-9352	9	15	)	)	PUNCT
ct-9352	9	16	,	,	PUNCT
ct-9352	9	17	both	both	PRON
ct-9352	9	18	contributing	contribute	VERB
ct-9352	9	19	to	to	ADP
ct-9352	9	20	chemotaxis	chemotaxis	NOUN
ct-9352	9	21	of	of	ADP
ct-9352	9	22	various	various	ADJ
ct-9352	9	23	immune	immune	ADJ
ct-9352	9	24	cells	cell	NOUN
ct-9352	9	25	to	to	ADP
ct-9352	9	26	sites	site	NOUN
ct-9352	9	27	of	of	ADP
ct-9352	9	28	inflammation	inflammation	NOUN
ct-9352	9	29	,	,	PUNCT
ct-9352	9	30	and	and	CCONJ
ct-9352	9	31	specifically	specifically	ADV
ct-9352	9	32	in	in	ADP
ct-9352	9	33	recruitment	recruitment	NOUN
ct-9352	9	34	of	of	ADP
ct-9352	9	35	polymorphonuclear	polymorphonuclear	ADJ
ct-9352	9	36	neutrophils	neutrophil	NOUN
ct-9352	9	37	(	(	PUNCT
ct-9352	9	38	pmn).15	pmn).15	PROPN
ct-9352	9	39	therefore	therefore	ADV
ct-9352	9	40	,	,	PUNCT
ct-9352	9	41	increased	increase	VERB
ct-9352	9	42	expression	expression	NOUN
ct-9352	9	43	of	of	ADP
ct-9352	9	44	these	these	DET
ct-9352	9	45	cytokines	cytokine	NOUN
ct-9352	9	46	coincides	coincide	VERB
ct-9352	9	47	with	with	ADP
ct-9352	9	48	the	the	DET
ct-9352	9	49	pronounced	pronounce	VERB
ct-9352	9	50	neutrophilia	neutrophilia	PROPN
ct-9352	9	51	noted	note	VERB
ct-9352	9	52	in	in	ADP
ct-9352	9	53	susceptible	susceptible	ADJ
ct-9352	9	54	mares	mare	NOUN
ct-9352	9	55	.	.	PUNCT
ct-9352	10	1	additionally	additionally	ADV
ct-9352	10	2	,	,	PUNCT
ct-9352	10	3	susceptible	susceptible	ADJ
ct-9352	10	4	mares	mare	NOUN
ct-9352	10	5	accumulated	accumulate	VERB
ct-9352	10	6	excessive	excessive	ADJ
ct-9352	10	7	nitric	nitric	ADJ
ct-9352	10	8	oxide	oxide	NOUN
ct-9352	10	9	(	(	PUNCT
ct-9352	10	10	no	no	INTJ
ct-9352	10	11	)	)	PUNCT
ct-9352	10	12	in	in	ADP
ct-9352	10	13	the	the	DET
ct-9352	10	14	uterus	uterus	NOUN
ct-9352	10	15	after	after	ADP
ct-9352	10	16	breeding.14	breeding.14	PROPN
ct-9352	10	17	this	this	PRON
ct-9352	10	18	has	have	AUX
ct-9352	10	19	also	also	ADV
ct-9352	10	20	been	be	AUX
ct-9352	10	21	noted	note	VERB
ct-9352	10	22	via	via	ADP
ct-9352	10	23	an	an	DET
ct-9352	10	24	upregulation	upregulation	NOUN
ct-9352	10	25	of	of	ADP
ct-9352	10	26	mrna	mrna	NOUN
ct-9352	10	27	expression	expression	NOUN
ct-9352	10	28	for	for	ADP
ct-9352	10	29	inducible	inducible	ADJ
ct-9352	10	30	nitric	nitric	ADJ
ct-9352	10	31	oxide	oxide	NOUN
ct-9352	10	32	synthase	synthase	NOUN
ct-9352	10	33	(	(	PUNCT
ct-9352	10	34	inos	ino	NOUN
ct-9352	10	35	)	)	PUNCT
ct-9352	10	36	in	in	ADP
ct-9352	10	37	the	the	DET
ct-9352	10	38	endometrium	endometrium	NOUN
ct-9352	10	39	of	of	ADP
ct-9352	10	40	susceptible	susceptible	ADJ
ct-9352	10	41	mares	mare	NOUN
ct-9352	10	42	after	after	SCONJ
ct-9352	10	43	breeding.16	breeding.16	PROPN
ct-9352	10	44	accumulation	accumulation	NOUN
ct-9352	10	45	of	of	ADP
ct-9352	10	46	no	no	PRON
ct-9352	10	47	in	in	ADP
ct-9352	10	48	susceptible	susceptible	ADJ
ct-9352	10	49	mares	mare	NOUN
ct-9352	10	50	is	be	AUX
ct-9352	10	51	believed	believe	VERB
ct-9352	10	52	to	to	PART
ct-9352	10	53	cause	cause	VERB
ct-9352	10	54	impaired	impaired	ADJ
ct-9352	10	55	myometrial	myometrial	ADJ
ct-9352	10	56	contractions	contraction	NOUN
ct-9352	10	57	,	,	PUNCT
ct-9352	10	58	resulting	result	VERB
ct-9352	10	59	in	in	ADP
ct-9352	10	60	delayed	delay	VERB
ct-9352	10	61	uterine	uterine	ADJ
ct-9352	10	62	clearance	clearance	NOUN
ct-9352	10	63	of	of	ADP
ct-9352	10	64	inflammation	inflammation	NOUN
ct-9352	10	65	from	from	ADP
ct-9352	10	66	the	the	DET
ct-9352	10	67	uterus.17,18	uterus.17,18	NOUN
ct-9352	10	68	differences	difference	NOUN
ct-9352	10	69	in	in	ADP
ct-9352	10	70	immune	immune	ADJ
ct-9352	10	71	response	response	NOUN
ct-9352	10	72	between	between	ADP
ct-9352	10	73	susceptible	susceptible	ADJ
ct-9352	10	74	and	and	CCONJ
ct-9352	10	75	resistant	resistant	ADJ
ct-9352	10	76	mares	mare	NOUN
ct-9352	10	77	are	be	AUX
ct-9352	10	78	summarized	summarize	VERB
ct-9352	10	79	(	(	PUNCT
ct-9352	10	80	figure	figure	NOUN
ct-9352	10	81	1	1	NUM
ct-9352	10	82	)	)	PUNCT
ct-9352	10	83	.	.	PUNCT
ct-9352	11	1	several	several	ADJ
ct-9352	11	2	therapeutics	therapeutic	NOUN
ct-9352	11	3	are	be	AUX
ct-9352	11	4	utilized	utilize	VERB
ct-9352	11	5	for	for	ADP
ct-9352	11	6	the	the	DET
ct-9352	11	7	management	management	NOUN
ct-9352	11	8	of	of	ADP
ct-9352	11	9	pbie	pbie	NOUN
ct-9352	11	10	,	,	PUNCT
ct-9352	11	11	with	with	ADP
ct-9352	11	12	many	many	ADJ
ct-9352	11	13	targeting	target	VERB
ct-9352	11	14	the	the	DET
ct-9352	11	15	resolution	resolution	NOUN
ct-9352	11	16	of	of	ADP
ct-9352	11	17	this	this	DET
ct-9352	11	18	persistent	persistent	ADJ
ct-9352	11	19	inflammation	inflammation	NOUN
ct-9352	11	20	.	.	PUNCT
ct-9352	12	1	deemed	deem	VERB
ct-9352	12	2	immunomodulators	immunomodulator	NOUN
ct-9352	12	3	,	,	PUNCT
ct-9352	12	4	these	these	DET
ct-9352	12	5	therapeutics	therapeutic	NOUN
ct-9352	12	6	modify	modify	VERB
ct-9352	12	7	the	the	DET
ct-9352	12	8	immune	immune	ADJ
ct-9352	12	9	response	response	NOUN
ct-9352	12	10	or	or	CCONJ
ct-9352	12	11	the	the	DET
ct-9352	12	12	function	function	NOUN
ct-9352	12	13	of	of	ADP
ct-9352	12	14	the	the	DET
ct-9352	12	15	immune	immune	ADJ
ct-9352	12	16	system	system	NOUN
ct-9352	12	17	through	through	ADP
ct-9352	12	18	a	a	DET
ct-9352	12	19	variety	variety	NOUN
ct-9352	12	20	of	of	ADP
ct-9352	12	21	pathways	pathway	NOUN
ct-9352	12	22	,	,	PUNCT
ct-9352	12	23	including	include	VERB
ct-9352	12	24	stimulation	stimulation	NOUN
ct-9352	12	25	or	or	CCONJ
ct-9352	12	26	suppression	suppression	NOUN
ct-9352	12	27	of	of	ADP
ct-9352	12	28	signaling	signal	VERB
ct-9352	12	29	molecules	molecule	NOUN
ct-9352	12	30	,	,	PUNCT
ct-9352	12	31	recruitment	recruitment	NOUN
ct-9352	12	32	of	of	ADP
ct-9352	12	33	essential	essential	ADJ
ct-9352	12	34	immune	immune	ADJ
ct-9352	12	35	cell	cell	NOUN
ct-9352	12	36	types	type	NOUN
ct-9352	12	37	,	,	PUNCT
ct-9352	12	38	or	or	CCONJ
ct-9352	12	39	activation	activation	NOUN
ct-9352	12	40	of	of	ADP
ct-9352	12	41	other	other	ADJ
ct-9352	12	42	aspects	aspect	NOUN
ct-9352	12	43	of	of	ADP
ct-9352	12	44	immunity	immunity	NOUN
ct-9352	12	45	,	,	PUNCT
ct-9352	12	46	including	include	VERB
ct-9352	12	47	antigen	antigen	ADJ
ct-9352	12	48	recognition	recognition	NOUN
ct-9352	12	49	and	and	CCONJ
ct-9352	12	50	processing	processing	NOUN
ct-9352	12	51	.	.	PUNCT
ct-9352	13	1	critically	critically	ADV
ct-9352	13	2	evaluated	evaluate	VERB
ct-9352	13	3	immunomodulators	immunomodulator	NOUN
ct-9352	13	4	available	available	ADJ
ct-9352	13	5	for	for	ADP
ct-9352	13	6	pbie	pbie	NOUN
ct-9352	13	7	treatment	treatment	NOUN
ct-9352	13	8	are	be	AUX
ct-9352	13	9	reviewed	review	VERB
ct-9352	13	10	.	.	PUNCT
ct-9352	14	1	clinical	clinical	ADJ
ct-9352	14	2	theriogenology	theriogenology	NOUN
ct-9352	14	3	2021	2021	NUM
ct-9352	14	4	;	;	PUNCT
ct-9352	14	5	13	13	NUM
ct-9352	14	6	:	:	SYM
ct-9352	14	7	238	238	NUM
ct-9352	14	8	immunomodulation	immunomodulation	NOUN
ct-9352	14	9	of	of	ADP
ct-9352	14	10	persistent	persistent	ADJ
ct-9352	14	11	endometritis	endometritis	NOUN
ct-9352	14	12	selection	selection	NOUN
ct-9352	14	13	of	of	ADP
ct-9352	14	14	an	an	DET
ct-9352	14	15	immunomodulator	immunomodulator	NOUN
ct-9352	14	16	for	for	ADP
ct-9352	14	17	the	the	DET
ct-9352	14	18	treatment	treatment	NOUN
ct-9352	14	19	of	of	ADP
ct-9352	14	20	pbie	pbie	NOUN
ct-9352	14	21	must	must	AUX
ct-9352	14	22	be	be	AUX
ct-9352	14	23	considered	consider	VERB
ct-9352	14	24	carefully	carefully	ADV
ct-9352	14	25	,	,	PUNCT
ct-9352	14	26	as	as	SCONJ
ct-9352	14	27	proinflammatory	proinflammatory	ADJ
ct-9352	14	28	signaling	signaling	NOUN
ct-9352	14	29	is	be	AUX
ct-9352	14	30	necessary	necessary	ADJ
ct-9352	14	31	for	for	ADP
ct-9352	14	32	the	the	DET
ct-9352	14	33	clearance	clearance	NOUN
ct-9352	14	34	of	of	ADP
ct-9352	14	35	excess	excess	ADJ
ct-9352	14	36	sperm	sperm	NOUN
ct-9352	14	37	,	,	PUNCT
ct-9352	14	38	debris	debris	NOUN
ct-9352	14	39	,	,	PUNCT
ct-9352	14	40	and	and	CCONJ
ct-9352	14	41	pathogen	pathogen	NOUN
ct-9352	14	42	recognition	recognition	NOUN
ct-9352	14	43	,	,	PUNCT
ct-9352	14	44	whereas	whereas	SCONJ
ct-9352	14	45	antiinflammatory	antiinflammatory	NOUN
ct-9352	14	46	signaling	signaling	NOUN
ct-9352	14	47	is	be	AUX
ct-9352	14	48	crucial	crucial	ADJ
ct-9352	14	49	for	for	ADP
ct-9352	14	50	a	a	DET
ct-9352	14	51	timely	timely	ADJ
ct-9352	14	52	resolution	resolution	NOUN
ct-9352	14	53	of	of	ADP
ct-9352	14	54	this	this	DET
ct-9352	14	55	inflammation	inflammation	NOUN
ct-9352	14	56	.	.	PUNCT
ct-9352	15	1	pivotal	pivotal	ADJ
ct-9352	15	2	studies	study	NOUN
ct-9352	15	3	on	on	ADP
ct-9352	15	4	the	the	DET
ct-9352	15	5	immune	immune	ADJ
ct-9352	15	6	response	response	NOUN
ct-9352	15	7	to	to	ADP
ct-9352	15	8	breeding	breeding	NOUN
ct-9352	15	9	indicate	indicate	VERB
ct-9352	15	10	that	that	DET
ct-9352	15	11	activation	activation	NOUN
ct-9352	15	12	of	of	ADP
ct-9352	15	13	proinflammatory	proinflammatory	ADJ
ct-9352	15	14	pathways	pathway	NOUN
ct-9352	15	15	occurs	occur	VERB
ct-9352	15	16	as	as	ADV
ct-9352	15	17	rapidly	rapidly	ADV
ct-9352	15	18	as	as	ADP
ct-9352	15	19	30	30	NUM
ct-9352	15	20	minutes	minute	NOUN
ct-9352	15	21	after	after	ADP
ct-9352	15	22	deposition	deposition	NOUN
ct-9352	15	23	of	of	ADP
ct-9352	15	24	semen	semen	NOUN
ct-9352	15	25	and	and	CCONJ
ct-9352	15	26	is	be	AUX
ct-9352	15	27	necessary	necessary	ADJ
ct-9352	15	28	for	for	ADP
ct-9352	15	29	the	the	DET
ct-9352	15	30	chemotaxis	chemotaxis	NOUN
ct-9352	15	31	of	of	ADP
ct-9352	15	32	pmns	pmn	NOUN
ct-9352	15	33	into	into	ADP
ct-9352	15	34	the	the	DET
ct-9352	15	35	uterine	uterine	ADJ
ct-9352	15	36	lumen	luman	NOUN
ct-9352	15	37	for	for	ADP
ct-9352	15	38	proper	proper	ADJ
ct-9352	15	39	degradation	degradation	NOUN
ct-9352	15	40	of	of	ADP
ct-9352	15	41	nonviable	nonviable	ADJ
ct-9352	15	42	sperm	sperm	NOUN
ct-9352	15	43	and	and	CCONJ
ct-9352	15	44	bacteria.5,8,19	bacteria.5,8,19	PROPN
ct-9352	15	45	therefore	therefore	ADV
ct-9352	15	46	,	,	PUNCT
ct-9352	15	47	antiinflammatory	antiinflammatory	NOUN
ct-9352	15	48	or	or	CCONJ
ct-9352	15	49	immunomodulating	immunomodulate	VERB
ct-9352	15	50	therapeutics	therapeutic	NOUN
ct-9352	15	51	either	either	CCONJ
ct-9352	15	52	prior	prior	ADV
ct-9352	15	53	to	to	ADP
ct-9352	15	54	breeding	breeding	NOUN
ct-9352	15	55	or	or	CCONJ
ct-9352	15	56	immediately	immediately	ADV
ct-9352	15	57	after	after	SCONJ
ct-9352	15	58	breeding	breeding	NOUN
ct-9352	15	59	may	may	AUX
ct-9352	15	60	impede	impede	VERB
ct-9352	15	61	a	a	DET
ct-9352	15	62	mare	mare	NOUN
ct-9352	15	63	’s	’s	PART
ct-9352	15	64	essential	essential	ADJ
ct-9352	15	65	innate	innate	ADJ
ct-9352	15	66	immune	immune	ADJ
ct-9352	15	67	response	response	NOUN
ct-9352	15	68	.	.	PUNCT
ct-9352	16	1	consequently	consequently	ADV
ct-9352	16	2	,	,	PUNCT
ct-9352	16	3	results	result	NOUN
ct-9352	16	4	from	from	ADP
ct-9352	16	5	studies	study	NOUN
ct-9352	16	6	must	must	AUX
ct-9352	16	7	be	be	AUX
ct-9352	16	8	interpreted	interpret	VERB
ct-9352	16	9	critically	critically	ADV
ct-9352	16	10	regarding	regard	VERB
ct-9352	16	11	the	the	DET
ct-9352	16	12	time	time	NOUN
ct-9352	16	13	and	and	CCONJ
ct-9352	16	14	route	route	NOUN
ct-9352	16	15	of	of	ADP
ct-9352	16	16	treatment	treatment	NOUN
ct-9352	16	17	and	and	CCONJ
ct-9352	16	18	observed	observe	VERB
ct-9352	16	19	downstream	downstream	ADJ
ct-9352	16	20	effects	effect	NOUN
ct-9352	16	21	.	.	PUNCT
ct-9352	17	1	nonsteroidal	nonsteroidal	NOUN
ct-9352	17	2	antiinflammatory	antiinflammatory	NOUN
ct-9352	17	3	drugs	drug	NOUN
ct-9352	17	4	nonsteroidal	nonsteroidal	NOUN
ct-9352	17	5	antiinflammatories	antiinflammatorie	NOUN
ct-9352	17	6	(	(	PUNCT
ct-9352	17	7	nsaids	nsaid	NOUN
ct-9352	17	8	)	)	PUNCT
ct-9352	17	9	are	be	AUX
ct-9352	17	10	routinely	routinely	ADV
ct-9352	17	11	used	use	VERB
ct-9352	17	12	with	with	ADP
ct-9352	17	13	the	the	DET
ct-9352	17	14	intent	intent	NOUN
ct-9352	17	15	to	to	PART
ct-9352	17	16	diminish	diminish	VERB
ct-9352	17	17	persistent	persistent	ADJ
ct-9352	17	18	inflammation	inflammation	NOUN
ct-9352	17	19	noted	note	VERB
ct-9352	17	20	in	in	ADP
ct-9352	17	21	susceptible	susceptible	ADJ
ct-9352	17	22	mares	mare	NOUN
ct-9352	17	23	.	.	PUNCT
ct-9352	18	1	most	most	ADJ
ct-9352	18	2	nsaids	nsaid	NOUN
ct-9352	18	3	inhibit	inhibit	VERB
ct-9352	18	4	cyclooxygenases	cyclooxygenase	NOUN
ct-9352	18	5	(	(	PUNCT
ct-9352	18	6	cox-1	cox-1	X
ct-9352	18	7	and	and	CCONJ
ct-9352	18	8	cox-2	cox-2	NUM
ct-9352	18	9	)	)	PUNCT
ct-9352	18	10	,	,	PUNCT
ct-9352	18	11	thereby	thereby	ADV
ct-9352	18	12	decreasing	decrease	VERB
ct-9352	18	13	production	production	NOUN
ct-9352	18	14	of	of	ADP
ct-9352	18	15	prostaglandins	prostaglandin	NOUN
ct-9352	18	16	.	.	PUNCT
ct-9352	19	1	since	since	SCONJ
ct-9352	19	2	the	the	DET
ct-9352	19	3	primary	primary	ADJ
ct-9352	19	4	activity	activity	NOUN
ct-9352	19	5	of	of	ADP
ct-9352	19	6	pgf2α	pgf2α	PROPN
ct-9352	19	7	is	be	AUX
ct-9352	19	8	activation	activation	NOUN
ct-9352	19	9	of	of	ADP
ct-9352	19	10	myometrial	myometrial	ADJ
ct-9352	19	11	contractility	contractility	NOUN
ct-9352	19	12	,	,	PUNCT
ct-9352	19	13	inhibition	inhibition	NOUN
ct-9352	19	14	of	of	ADP
ct-9352	19	15	this	this	DET
ct-9352	19	16	lipid	lipid	NOUN
ct-9352	19	17	can	can	AUX
ct-9352	19	18	lead	lead	VERB
ct-9352	19	19	to	to	ADP
ct-9352	19	20	insufficient	insufficient	ADJ
ct-9352	19	21	uterine	uterine	ADJ
ct-9352	19	22	contractions	contraction	NOUN
ct-9352	19	23	and	and	CCONJ
ct-9352	19	24	luminal	luminal	ADJ
ct-9352	19	25	fluid	fluid	NOUN
ct-9352	19	26	accumulation	accumulation	NOUN
ct-9352	19	27	if	if	SCONJ
ct-9352	19	28	mares	mare	NOUN
ct-9352	19	29	are	be	AUX
ct-9352	19	30	not	not	PART
ct-9352	19	31	concurrently	concurrently	ADV
ct-9352	19	32	treated	treat	VERB
ct-9352	19	33	with	with	ADP
ct-9352	19	34	an	an	DET
ct-9352	19	35	ecbolic	ecbolic	ADJ
ct-9352	19	36	to	to	PART
ct-9352	19	37	stimulate	stimulate	VERB
ct-9352	19	38	uterine	uterine	ADJ
ct-9352	19	39	contractions	contraction	NOUN
ct-9352	19	40	.	.	PUNCT
ct-9352	20	1	intravenous	intravenous	ADJ
ct-9352	20	2	flunixin	flunixin	PROPN
ct-9352	20	3	meglumine	meglumine	NOUN
ct-9352	20	4	(	(	PUNCT
ct-9352	20	5	1.1	1.1	NUM
ct-9352	20	6	mg	mg	PROPN
ct-9352	20	7	/	/	SYM
ct-9352	20	8	kg	kg	PROPN
ct-9352	20	9	,	,	PUNCT
ct-9352	20	10	2	2	NUM
ct-9352	20	11	hours	hour	NOUN
ct-9352	20	12	after	after	ADP
ct-9352	20	13	insemination	insemination	NOUN
ct-9352	20	14	)	)	PUNCT
ct-9352	20	15	treatment	treatment	NOUN
ct-9352	20	16	,	,	PUNCT
ct-9352	20	17	substantially	substantially	ADV
ct-9352	20	18	increased	increase	VERB
ct-9352	20	19	the	the	DET
ct-9352	20	20	number	number	NOUN
ct-9352	20	21	of	of	ADP
ct-9352	20	22	pmns	pmn	NOUN
ct-9352	20	23	in	in	ADP
ct-9352	20	24	the	the	DET
ct-9352	20	25	uterine	uterine	ADJ
ct-9352	20	26	lumen	luman	NOUN
ct-9352	20	27	at	at	ADP
ct-9352	20	28	8	8	NUM
ct-9352	20	29	hours	hour	NOUN
ct-9352	20	30	;	;	PUNCT
ct-9352	20	31	however	however	ADV
ct-9352	20	32	,	,	PUNCT
ct-9352	20	33	they	they	PRON
ct-9352	20	34	were	be	AUX
ct-9352	20	35	decreased	decrease	VERB
ct-9352	20	36	at	at	ADP
ct-9352	20	37	25	25	NUM
ct-9352	20	38	hours	hour	NOUN
ct-9352	20	39	after	after	ADP
ct-9352	20	40	insemination.20	insemination.20	PROPN
ct-9352	20	41	in	in	ADP
ct-9352	20	42	contrast	contrast	NOUN
ct-9352	20	43	,	,	PUNCT
ct-9352	20	44	select	select	VERB
ct-9352	20	45	cox-2	cox-2	ADJ
ct-9352	20	46	inhibitors	inhibitor	NOUN
ct-9352	20	47	(	(	PUNCT
ct-9352	20	48	function	function	VERB
ct-9352	20	49	solely	solely	ADV
ct-9352	20	50	through	through	ADP
ct-9352	20	51	the	the	DET
ct-9352	20	52	inhibition	inhibition	NOUN
ct-9352	20	53	of	of	ADP
ct-9352	20	54	cox-2	cox-2	NOUN
ct-9352	20	55	with	with	ADP
ct-9352	20	56	no	no	DET
ct-9352	20	57	effect	effect	NOUN
ct-9352	20	58	on	on	ADP
ct-9352	20	59	cox-1	cox-1	X
ct-9352	20	60	)	)	PUNCT
ct-9352	20	61	had	have	VERB
ct-9352	20	62	a	a	DET
ct-9352	20	63	positive	positive	ADJ
ct-9352	20	64	effect	effect	NOUN
ct-9352	20	65	on	on	ADP
ct-9352	20	66	uterine	uterine	ADJ
ct-9352	20	67	clearance	clearance	NOUN
ct-9352	20	68	after	after	ADP
ct-9352	20	69	breeding	breed	VERB
ct-9352	20	70	.	.	PUNCT
ct-9352	21	1	when	when	SCONJ
ct-9352	21	2	treated	treat	VERB
ct-9352	21	3	orally	orally	ADV
ct-9352	21	4	once	once	ADV
ct-9352	21	5	in	in	ADP
ct-9352	21	6	the	the	DET
ct-9352	21	7	periovulatory	periovulatory	ADJ
ct-9352	21	8	period	period	NOUN
ct-9352	21	9	,	,	PUNCT
ct-9352	21	10	firocoxib	firocoxib	NOUN
ct-9352	21	11	(	(	PUNCT
ct-9352	21	12	equioxx	equioxx	ADJ
ct-9352	21	13	®	®	NOUN
ct-9352	21	14	,	,	PUNCT
ct-9352	21	15	0.2	0.2	NUM
ct-9352	21	16	mg/	mg/	NOUN
ct-9352	21	17	kg	kg	PROPN
ct-9352	21	18	)	)	PUNCT
ct-9352	21	19	decreased	decrease	VERB
ct-9352	21	20	the	the	DET
ct-9352	21	21	severity	severity	NOUN
ct-9352	21	22	of	of	ADP
ct-9352	21	23	neutrophilia	neutrophilia	PROPN
ct-9352	21	24	.	.	PUNCT
ct-9352	22	1	additionally	additionally	ADV
ct-9352	22	2	,	,	PUNCT
ct-9352	22	3	firocoxib	firocoxib	ADJ
ct-9352	22	4	treatment	treatment	NOUN
ct-9352	22	5	did	do	AUX
ct-9352	22	6	not	not	PART
ct-9352	22	7	impact	impact	VERB
ct-9352	22	8	ovulation	ovulation	NOUN
ct-9352	22	9	,	,	PUNCT
ct-9352	22	10	embryo	embryo	NOUN
ct-9352	22	11	collection	collection	NOUN
ct-9352	22	12	,	,	PUNCT
ct-9352	22	13	or	or	CCONJ
ct-9352	22	14	embryo	embryo	NOUN
ct-9352	22	15	mobility.21,22	mobility.21,22	NOUN
ct-9352	22	16	vedaprofen	vedaprofen	PROPN
ct-9352	22	17	,	,	PUNCT
ct-9352	22	18	an	an	DET
ct-9352	22	19	additional	additional	ADJ
ct-9352	22	20	selective	selective	ADJ
ct-9352	22	21	cox-2	cox-2	ADJ
ct-9352	22	22	inhibitor	inhibitor	NOUN
ct-9352	22	23	,	,	PUNCT
ct-9352	22	24	increased	increase	VERB
ct-9352	22	25	fertility	fertility	NOUN
ct-9352	22	26	in	in	ADP
ct-9352	22	27	pbie	pbie	NOUN
ct-9352	22	28	mares.23	mares.23	NOUN
ct-9352	22	29	oral	oral	ADJ
ct-9352	22	30	vedaprofen	vedaprofen	NOUN
ct-9352	22	31	(	(	PUNCT
ct-9352	22	32	2	2	NUM
ct-9352	22	33	mg	mg	PROPN
ct-9352	22	34	/	/	SYM
ct-9352	22	35	kg	kg	NOUN
ct-9352	22	36	)	)	PUNCT
ct-9352	22	37	administered	administer	VERB
ct-9352	22	38	twice	twice	ADV
ct-9352	22	39	during	during	ADP
ct-9352	22	40	the	the	DET
ct-9352	22	41	periovulatory	periovulatory	ADJ
ct-9352	22	42	period	period	NOUN
ct-9352	22	43	improved	improve	VERB
ct-9352	22	44	pregnancy	pregnancy	NOUN
ct-9352	22	45	rates	rate	NOUN
ct-9352	22	46	;	;	PUNCT
ct-9352	22	47	however	however	ADV
ct-9352	22	48	,	,	PUNCT
ct-9352	22	49	only	only	ADV
ct-9352	22	50	a	a	DET
ct-9352	22	51	limited	limited	ADJ
ct-9352	22	52	number	number	NOUN
ct-9352	22	53	of	of	ADP
ct-9352	22	54	mares	mare	NOUN
ct-9352	22	55	were	be	AUX
ct-9352	22	56	evaluated.23	evaluated.23	PRON
ct-9352	22	57	it	it	PRON
ct-9352	22	58	is	be	AUX
ct-9352	22	59	emphasized	emphasize	VERB
ct-9352	22	60	that	that	SCONJ
ct-9352	22	61	all	all	DET
ct-9352	22	62	nsaid	nsaid	PROPN
ct-9352	22	63	treatments	treatment	NOUN
ct-9352	22	64	of	of	ADP
ct-9352	22	65	pbie	pbie	NOUN
ct-9352	22	66	should	should	AUX
ct-9352	22	67	be	be	AUX
ct-9352	22	68	accompanied	accompany	VERB
ct-9352	22	69	by	by	ADP
ct-9352	22	70	ecbolic	ecbolic	ADJ
ct-9352	22	71	treatment	treatment	NOUN
ct-9352	22	72	to	to	PART
ct-9352	22	73	stimulate	stimulate	VERB
ct-9352	22	74	uterine	uterine	ADJ
ct-9352	22	75	contractions	contraction	NOUN
ct-9352	22	76	glucocorticoids	glucocorticoid	NOUN
ct-9352	22	77	glucocorticoids	glucocorticoid	NOUN
ct-9352	22	78	are	be	AUX
ct-9352	22	79	a	a	DET
ct-9352	22	80	class	class	NOUN
ct-9352	22	81	of	of	ADP
ct-9352	22	82	corticosteroids	corticosteroid	NOUN
ct-9352	22	83	that	that	PRON
ct-9352	22	84	modulate	modulate	VERB
ct-9352	22	85	the	the	DET
ct-9352	22	86	immune	immune	ADJ
ct-9352	22	87	system	system	NOUN
ct-9352	22	88	by	by	ADP
ct-9352	22	89	activating	activate	VERB
ct-9352	22	90	downstream	downstream	ADJ
ct-9352	22	91	functions	function	NOUN
ct-9352	22	92	of	of	ADP
ct-9352	22	93	the	the	DET
ct-9352	22	94	glucocorticoid	glucocorticoid	ADJ
ct-9352	22	95	receptor	receptor	NOUN
ct-9352	22	96	.	.	PUNCT
ct-9352	23	1	although	although	SCONJ
ct-9352	23	2	various	various	ADJ
ct-9352	23	3	glucocorticoids	glucocorticoid	NOUN
ct-9352	23	4	figure	figure	VERB
ct-9352	23	5	1	1	NUM
ct-9352	23	6	.	.	NOUN
ct-9352	23	7	immune	immune	ADJ
ct-9352	23	8	response	response	NOUN
ct-9352	23	9	to	to	ADP
ct-9352	23	10	breeding	breed	VERB
ct-9352	23	11	in	in	ADP
ct-9352	23	12	resistant	resistant	ADJ
ct-9352	23	13	and	and	CCONJ
ct-9352	23	14	susceptible	susceptible	ADJ
ct-9352	23	15	mares	mare	NOUN
ct-9352	23	16	to	to	ADP
ct-9352	23	17	persistent	persistent	ADJ
ct-9352	23	18	breeding	breeding	NOUN
ct-9352	23	19	-	-	PUNCT
ct-9352	23	20	induced	induce	VERB
ct-9352	23	21	endometritis	endometritis	PROPN
ct-9352	23	22	clinical	clinical	ADJ
ct-9352	23	23	theriogenology	theriogenology	NOUN
ct-9352	23	24	2021	2021	NUM
ct-9352	23	25	;	;	PUNCT
ct-9352	23	26	13	13	NUM
ct-9352	23	27	:	:	SYM
ct-9352	23	28	239	239	NUM
ct-9352	23	29	are	be	AUX
ct-9352	23	30	available	available	ADJ
ct-9352	23	31	to	to	ADP
ct-9352	23	32	the	the	DET
ct-9352	23	33	practitioner	practitioner	NOUN
ct-9352	23	34	,	,	PUNCT
ct-9352	23	35	only	only	ADV
ct-9352	23	36	a	a	DET
ct-9352	23	37	few	few	ADJ
ct-9352	23	38	have	have	AUX
ct-9352	23	39	been	be	AUX
ct-9352	23	40	critically	critically	ADV
ct-9352	23	41	evaluated	evaluate	VERB
ct-9352	23	42	for	for	ADP
ct-9352	23	43	their	their	PRON
ct-9352	23	44	efficacy	efficacy	NOUN
ct-9352	23	45	in	in	ADP
ct-9352	23	46	treating	treat	VERB
ct-9352	23	47	pbie	pbie	NOUN
ct-9352	23	48	.	.	PUNCT
ct-9352	24	1	dexamethasone	dexamethasone	NOUN
ct-9352	24	2	functioned	function	VERB
ct-9352	24	3	as	as	ADP
ct-9352	24	4	an	an	DET
ct-9352	24	5	antiinflammatory	antiinflammatory	NOUN
ct-9352	24	6	agent	agent	NOUN
ct-9352	24	7	to	to	ADP
ct-9352	24	8	both	both	DET
ct-9352	24	9	sperm	sperm	NOUN
ct-9352	24	10	and	and	CCONJ
ct-9352	24	11	bacterial	bacterial	ADJ
ct-9352	24	12	challenges.24,25	challenges.24,25	NOUN
ct-9352	24	13	additionally	additionally	ADV
ct-9352	24	14	,	,	PUNCT
ct-9352	24	15	dexamethasone	dexamethasone	NOUN
ct-9352	24	16	decreased	decrease	VERB
ct-9352	24	17	endometrial	endometrial	ADJ
ct-9352	24	18	expression	expression	NOUN
ct-9352	24	19	of	of	ADP
ct-9352	24	20	positive	positive	ADJ
ct-9352	24	21	acute	acute	NOUN
ct-9352	24	22	phase	phase	NOUN
ct-9352	24	23	protein	protein	NOUN
ct-9352	24	24	,	,	PUNCT
ct-9352	24	25	serum	serum	NOUN
ct-9352	24	26	amyloid	amyloid	NOUN
ct-9352	24	27	a	a	DET
ct-9352	24	28	(	(	PUNCT
ct-9352	24	29	saa),26	saa),26	NOUN
ct-9352	24	30	and	and	CCONJ
ct-9352	24	31	similarly	similarly	ADV
ct-9352	24	32	prednisolone	prednisolone	PROPN
ct-9352	24	33	treatment	treatment	NOUN
ct-9352	24	34	decreased	decrease	VERB
ct-9352	24	35	expression	expression	NOUN
ct-9352	24	36	of	of	ADP
ct-9352	24	37	this	this	DET
ct-9352	24	38	protein.27	protein.27	PROPN
ct-9352	24	39	clinically	clinically	ADV
ct-9352	24	40	,	,	PUNCT
ct-9352	24	41	a	a	DET
ct-9352	24	42	single	single	ADJ
ct-9352	24	43	intramuscular	intramuscular	ADJ
ct-9352	24	44	treatment	treatment	NOUN
ct-9352	24	45	of	of	ADP
ct-9352	24	46	50	50	NUM
ct-9352	24	47	mg	mg	NOUN
ct-9352	24	48	dexamethasone	dexamethasone	NOUN
ct-9352	24	49	at	at	ADP
ct-9352	24	50	breeding	breed	VERB
ct-9352	24	51	improved	improve	VERB
ct-9352	24	52	pregnancy	pregnancy	NOUN
ct-9352	24	53	rates	rate	NOUN
ct-9352	24	54	in	in	ADP
ct-9352	24	55	mares	mare	NOUN
ct-9352	24	56	with	with	ADP
ct-9352	24	57	>	>	SYM
ct-9352	24	58	3	3	NUM
ct-9352	24	59	risk	risk	NOUN
ct-9352	24	60	factors	factor	NOUN
ct-9352	24	61	associated	associate	VERB
ct-9352	24	62	with	with	ADP
ct-9352	24	63	susceptibility	susceptibility	NOUN
ct-9352	24	64	to	to	ADP
ct-9352	24	65	pbie.28	pbie.28	NOUN
ct-9352	24	66	although	although	SCONJ
ct-9352	24	67	limited	limited	ADJ
ct-9352	24	68	research	research	NOUN
ct-9352	24	69	has	have	AUX
ct-9352	24	70	been	be	AUX
ct-9352	24	71	conducted	conduct	VERB
ct-9352	24	72	on	on	ADP
ct-9352	24	73	the	the	DET
ct-9352	24	74	antiinflammatory	antiinflammatory	NOUN
ct-9352	24	75	functions	function	NOUN
ct-9352	24	76	of	of	ADP
ct-9352	24	77	corticosteroids	corticosteroid	NOUN
ct-9352	24	78	,	,	PUNCT
ct-9352	24	79	a	a	DET
ct-9352	24	80	subset	subset	NOUN
ct-9352	24	81	was	be	AUX
ct-9352	24	82	evaluated	evaluate	VERB
ct-9352	24	83	clinically	clinically	ADV
ct-9352	24	84	.	.	PUNCT
ct-9352	25	1	treatment	treatment	NOUN
ct-9352	25	2	with	with	ADP
ct-9352	25	3	acetate-9	acetate-9	PROPN
ct-9352	25	4	-	-	PUNCT
ct-9352	25	5	α	α	NOUN
ct-9352	25	6	-	-	PUNCT
ct-9352	25	7	prednisolone	prednisolone	PROPN
ct-9352	25	8	(	(	PUNCT
ct-9352	25	9	0.1	0.1	NUM
ct-9352	25	10	mg/	mg/	NOUN
ct-9352	25	11	kg	kg	PROPN
ct-9352	25	12	)	)	PUNCT
ct-9352	25	13	twice	twice	ADV
ct-9352	25	14	daily	daily	ADV
ct-9352	25	15	also	also	ADV
ct-9352	25	16	had	have	VERB
ct-9352	25	17	a	a	DET
ct-9352	25	18	positive	positive	ADJ
ct-9352	25	19	effect	effect	NOUN
ct-9352	25	20	on	on	ADP
ct-9352	25	21	pregnancy	pregnancy	NOUN
ct-9352	25	22	rates	rate	NOUN
ct-9352	25	23	in	in	ADP
ct-9352	25	24	mares	mare	NOUN
ct-9352	25	25	with	with	ADP
ct-9352	25	26	excessive	excessive	ADJ
ct-9352	25	27	inflammation.29	inflammation.29	NOUN
ct-9352	25	28	twice	twice	ADV
ct-9352	25	29	daily	daily	ADV
ct-9352	25	30	intramuscular	intramuscular	ADJ
ct-9352	25	31	treatment	treatment	NOUN
ct-9352	25	32	with	with	ADP
ct-9352	25	33	isoflupredone	isoflupredone	NOUN
ct-9352	25	34	acetate	acetate	NOUN
ct-9352	25	35	(	(	PUNCT
ct-9352	25	36	predef	predef	PROPN
ct-9352	25	37	®	®	NOUN
ct-9352	25	38	2x	2x	NUM
ct-9352	25	39	,	,	PUNCT
ct-9352	25	40	10	10	NUM
ct-9352	25	41	20	20	NUM
ct-9352	25	42	mg	mg	NOUN
ct-9352	25	43	)	)	PUNCT
ct-9352	25	44	24	24	NUM
ct-9352	25	45	hours	hour	NOUN
ct-9352	25	46	prior	prior	ADV
ct-9352	25	47	to	to	ADP
ct-9352	25	48	bacterial	bacterial	ADJ
ct-9352	25	49	challenge	challenge	NOUN
ct-9352	25	50	in	in	ADP
ct-9352	25	51	susceptible	susceptible	ADJ
ct-9352	25	52	mares	mare	NOUN
ct-9352	25	53	altered	alter	VERB
ct-9352	25	54	the	the	DET
ct-9352	25	55	immune	immune	ADJ
ct-9352	25	56	response.27	response.27	PROPN
ct-9352	25	57	responses	response	NOUN
ct-9352	25	58	included	include	VERB
ct-9352	25	59	reduction	reduction	NOUN
ct-9352	25	60	in	in	ADP
ct-9352	25	61	immunoglobulin	immunoglobulin	NOUN
ct-9352	25	62	g	g	PROPN
ct-9352	25	63	(	(	PUNCT
ct-9352	25	64	igg	igg	PROPN
ct-9352	25	65	)	)	PUNCT
ct-9352	25	66	and	and	CCONJ
ct-9352	25	67	increases	increase	NOUN
ct-9352	25	68	in	in	ADP
ct-9352	25	69	positive	positive	ADJ
ct-9352	25	70	acute	acute	NOUN
ct-9352	25	71	phase	phase	NOUN
ct-9352	25	72	proteins	protein	NOUN
ct-9352	25	73	’	'	PUNCT
ct-9352	25	74	(	(	PUNCT
ct-9352	25	75	e.g.	e.g.	ADV
ct-9352	25	76	haptoglobin	haptoglobin	NOUN
ct-9352	25	77	)	)	PUNCT
ct-9352	25	78	concentrations	concentration	NOUN
ct-9352	25	79	.	.	PUNCT
ct-9352	26	1	it	it	PRON
ct-9352	26	2	is	be	AUX
ct-9352	26	3	noteworthy	noteworthy	ADJ
ct-9352	26	4	that	that	SCONJ
ct-9352	26	5	various	various	ADJ
ct-9352	26	6	glucocorticoids	glucocorticoid	NOUN
ct-9352	26	7	altered	alter	VERB
ct-9352	26	8	secretion	secretion	NOUN
ct-9352	26	9	of	of	ADP
ct-9352	26	10	gnrh	gnrh	NOUN
ct-9352	26	11	and	and	CCONJ
ct-9352	26	12	lh	lh	PROPN
ct-9352	26	13	,	,	PUNCT
ct-9352	26	14	in	in	ADP
ct-9352	26	15	addition	addition	NOUN
ct-9352	26	16	to	to	ADP
ct-9352	26	17	altering	alter	VERB
ct-9352	26	18	the	the	DET
ct-9352	26	19	function	function	NOUN
ct-9352	26	20	of	of	ADP
ct-9352	26	21	hypothalamic	hypothalamic	ADJ
ct-9352	26	22	-	-	PUNCT
ct-9352	26	23	pituitary	pituitary	ADJ
ct-9352	26	24	-	-	PUNCT
ct-9352	26	25	gonadal	gonadal	NOUN
ct-9352	26	26	axis.30	axis.30	NOUN
ct-9352	26	27	additionally	additionally	ADV
ct-9352	26	28	,	,	PUNCT
ct-9352	26	29	prolonged	prolong	VERB
ct-9352	26	30	dexamethasone	dexamethasone	NOUN
ct-9352	26	31	treatment	treatment	NOUN
ct-9352	26	32	has	have	AUX
ct-9352	26	33	been	be	AUX
ct-9352	26	34	associated	associate	VERB
ct-9352	26	35	with	with	ADP
ct-9352	26	36	ovulation	ovulation	NOUN
ct-9352	26	37	failure.31	failure.31	NOUN
ct-9352	26	38	therefore	therefore	ADV
ct-9352	26	39	,	,	PUNCT
ct-9352	26	40	treatment	treatment	NOUN
ct-9352	26	41	of	of	ADP
ct-9352	26	42	pbie	pbie	NOUN
ct-9352	26	43	should	should	AUX
ct-9352	26	44	be	be	AUX
ct-9352	26	45	limited	limit	VERB
ct-9352	26	46	to	to	ADP
ct-9352	26	47	a	a	DET
ct-9352	26	48	single	single	ADJ
ct-9352	26	49	dose	dose	NOUN
ct-9352	26	50	of	of	ADP
ct-9352	26	51	glucocorticoid	glucocorticoid	NOUN
ct-9352	26	52	.	.	PUNCT
ct-9352	27	1	bacterial	bacterial	ADJ
ct-9352	27	2	extracts	extract	NOUN
ct-9352	27	3	extracts	extract	NOUN
ct-9352	27	4	from	from	ADP
ct-9352	27	5	nonpathogenic	nonpathogenic	ADJ
ct-9352	27	6	bacteria	bacteria	NOUN
ct-9352	27	7	are	be	AUX
ct-9352	27	8	utilized	utilize	VERB
ct-9352	27	9	for	for	ADP
ct-9352	27	10	their	their	PRON
ct-9352	27	11	antiinflammatory	antiinflammatory	NOUN
ct-9352	27	12	,	,	PUNCT
ct-9352	27	13	antimicrobial	antimicrobial	ADJ
ct-9352	27	14	,	,	PUNCT
ct-9352	27	15	and	and	CCONJ
ct-9352	27	16	anticancer	anticancer	NOUN
ct-9352	27	17	functions	function	NOUN
ct-9352	27	18	in	in	ADP
ct-9352	27	19	a	a	DET
ct-9352	27	20	variety	variety	NOUN
ct-9352	27	21	of	of	ADP
ct-9352	27	22	diseases	disease	NOUN
ct-9352	27	23	and	and	CCONJ
ct-9352	27	24	disorders	disorder	NOUN
ct-9352	27	25	.	.	PUNCT
ct-9352	28	1	of	of	ADP
ct-9352	28	2	these	these	DET
ct-9352	28	3	bacterial	bacterial	ADJ
ct-9352	28	4	extracts	extract	NOUN
ct-9352	28	5	,	,	PUNCT
ct-9352	28	6	only	only	ADV
ct-9352	28	7	2	2	NUM
ct-9352	28	8	have	have	AUX
ct-9352	28	9	been	be	AUX
ct-9352	28	10	evaluated	evaluate	VERB
ct-9352	28	11	for	for	ADP
ct-9352	28	12	their	their	PRON
ct-9352	28	13	efficacy	efficacy	NOUN
ct-9352	28	14	in	in	ADP
ct-9352	28	15	the	the	DET
ct-9352	28	16	treatment	treatment	NOUN
ct-9352	28	17	of	of	ADP
ct-9352	28	18	equine	equine	NOUN
ct-9352	28	19	pbie	pbie	NOUN
ct-9352	28	20	:	:	PUNCT
ct-9352	28	21	mycobacterium	mycobacterium	NOUN
ct-9352	28	22	cell	cell	NOUN
ct-9352	28	23	wall	wall	PROPN
ct-9352	28	24	fraction	fraction	PROPN
ct-9352	28	25	(	(	PUNCT
ct-9352	28	26	mcwf	mcwf	ADV
ct-9352	28	27	;	;	PUNCT
ct-9352	28	28	settle	settle	NOUN
ct-9352	28	29	®	®	NOUN
ct-9352	28	30	,	,	PUNCT
ct-9352	28	31	novavive	novavive	PROPN
ct-9352	28	32	;	;	PUNCT
ct-9352	28	33	canada	canada	PROPN
ct-9352	28	34	)	)	PUNCT
ct-9352	28	35	and	and	CCONJ
ct-9352	28	36	propionibacterium	propionibacterium	NOUN
ct-9352	28	37	acnes	acne	NOUN
ct-9352	28	38	(	(	PUNCT
ct-9352	28	39	eqstim	eqstim	PROPN
ct-9352	28	40	®	®	NOUN
ct-9352	28	41	,	,	PUNCT
ct-9352	28	42	neogen	neogen	NOUN
ct-9352	28	43	;	;	PUNCT
ct-9352	28	44	us	we	PRON
ct-9352	28	45	)	)	PUNCT
ct-9352	28	46	.	.	PUNCT
ct-9352	29	1	in	in	ADP
ct-9352	29	2	the	the	DET
ct-9352	29	3	research	research	NOUN
ct-9352	29	4	setting	setting	NOUN
ct-9352	29	5	,	,	PUNCT
ct-9352	29	6	settle	settle	NOUN
ct-9352	29	7	®	®	NOUN
ct-9352	29	8	has	have	AUX
ct-9352	29	9	shown	show	VERB
ct-9352	29	10	both	both	CCONJ
ct-9352	29	11	antimicrobial	antimicrobial	ADJ
ct-9352	29	12	and	and	CCONJ
ct-9352	29	13	antiinflammatory	antiinflammatory	NOUN
ct-9352	29	14	actions	action	NOUN
ct-9352	29	15	in	in	ADP
ct-9352	29	16	susceptible	susceptible	ADJ
ct-9352	29	17	mares	mare	NOUN
ct-9352	29	18	.	.	PUNCT
ct-9352	30	1	settle	settle	NOUN
ct-9352	30	2	®	®	NOUN
ct-9352	30	3	decreased	decrease	VERB
ct-9352	30	4	endometrial	endometrial	ADJ
ct-9352	30	5	expressions	expression	NOUN
ct-9352	30	6	of	of	ADP
ct-9352	30	7	il-1β	il-1β	PROPN
ct-9352	30	8	,	,	PUNCT
ct-9352	30	9	a	a	DET
ct-9352	30	10	proinflammatory	proinflammatory	ADJ
ct-9352	30	11	cytokine	cytokine	NOUN
ct-9352	30	12	and	and	CCONJ
ct-9352	30	13	increased	increase	VERB
ct-9352	30	14	cytokine	cytokine	NOUN
ct-9352	30	15	il-10	il-10	PRON
ct-9352	30	16	,	,	PUNCT
ct-9352	30	17	an	an	DET
ct-9352	30	18	antiinflammatory	antiinflammatory	NOUN
ct-9352	30	19	cytokine	cytokine	NOUN
ct-9352	30	20	,	,	PUNCT
ct-9352	30	21	after	after	ADP
ct-9352	30	22	a	a	DET
ct-9352	30	23	bacterial	bacterial	ADJ
ct-9352	30	24	challenge	challenge	NOUN
ct-9352	30	25	with	with	ADP
ct-9352	30	26	gram	gram	NOUN
ct-9352	30	27	positive	positive	ADJ
ct-9352	30	28	streptococcus	streptococcus	NOUN
ct-9352	30	29	equi.32	equi.32	NOUN
ct-9352	30	30	additionally	additionally	ADV
ct-9352	30	31	,	,	PUNCT
ct-9352	30	32	settle	settle	VERB
ct-9352	30	33	®	®	NOUN
ct-9352	30	34	substantially	substantially	ADV
ct-9352	30	35	reduced	reduce	VERB
ct-9352	30	36	inflammation	inflammation	NOUN
ct-9352	30	37	in	in	ADP
ct-9352	30	38	several	several	ADJ
ct-9352	30	39	mares	mare	NOUN
ct-9352	30	40	that	that	PRON
ct-9352	30	41	cultured	culture	VERB
ct-9352	30	42	positive	positive	ADJ
ct-9352	30	43	for	for	ADP
ct-9352	30	44	bacteria	bacteria	NOUN
ct-9352	30	45	.	.	PUNCT
ct-9352	31	1	these	these	DET
ct-9352	31	2	antiinflammatory	antiinflammatory	NOUN
ct-9352	31	3	effects	effect	NOUN
ct-9352	31	4	were	be	AUX
ct-9352	31	5	also	also	ADV
ct-9352	31	6	noted	note	VERB
ct-9352	31	7	after	after	ADP
ct-9352	31	8	a	a	DET
ct-9352	31	9	challenge	challenge	NOUN
ct-9352	31	10	with	with	ADP
ct-9352	31	11	gram	gram	NOUN
ct-9352	31	12	negative	negative	ADJ
ct-9352	31	13	escherichia	escherichia	NOUN
ct-9352	31	14	coli	coli	NOUN
ct-9352	31	15	,	,	PUNCT
ct-9352	31	16	wherein	wherein	SCONJ
ct-9352	31	17	settle	settle	NOUN
ct-9352	31	18	®	®	NOUN
ct-9352	31	19	substantially	substantially	ADV
ct-9352	31	20	decreased	decrease	VERB
ct-9352	31	21	the	the	DET
ct-9352	31	22	endometrial	endometrial	ADJ
ct-9352	31	23	expression	expression	NOUN
ct-9352	31	24	of	of	ADP
ct-9352	31	25	the	the	DET
ct-9352	31	26	positive	positive	ADJ
ct-9352	31	27	acute	acute	NOUN
ct-9352	31	28	phase	phase	NOUN
ct-9352	31	29	protein	protein	NOUN
ct-9352	31	30	saa	saa	PROPN
ct-9352	31	31	,	,	PUNCT
ct-9352	31	32	decreased	decrease	VERB
ct-9352	31	33	intrauterine	intrauterine	ADJ
ct-9352	31	34	fluid	fluid	NOUN
ct-9352	31	35	,	,	PUNCT
ct-9352	31	36	and	and	CCONJ
ct-9352	31	37	also	also	ADV
ct-9352	31	38	decreased	decrease	VERB
ct-9352	31	39	the	the	DET
ct-9352	31	40	number	number	NOUN
ct-9352	31	41	of	of	ADP
ct-9352	31	42	mares	mare	NOUN
ct-9352	31	43	that	that	PRON
ct-9352	31	44	cultured	culture	VERB
ct-9352	31	45	positive	positive	ADJ
ct-9352	31	46	for	for	ADP
ct-9352	31	47	intrauterine	intrauterine	ADJ
ct-9352	31	48	bacterial	bacterial	ADJ
ct-9352	31	49	growth.24	growth.24	NOUN
ct-9352	31	50	after	after	ADP
ct-9352	31	51	a	a	DET
ct-9352	31	52	challenge	challenge	NOUN
ct-9352	31	53	with	with	ADP
ct-9352	31	54	freeze	freeze	NOUN
ct-9352	31	55	-	-	PUNCT
ct-9352	31	56	killed	kill	VERB
ct-9352	31	57	sperm	sperm	NOUN
ct-9352	31	58	in	in	ADP
ct-9352	31	59	susceptible	susceptible	ADJ
ct-9352	31	60	mares	mare	NOUN
ct-9352	31	61	,	,	PUNCT
ct-9352	31	62	settle	settle	VERB
ct-9352	31	63	®	®	NOUN
ct-9352	31	64	substantially	substantially	ADV
ct-9352	31	65	reduced	reduce	VERB
ct-9352	31	66	the	the	DET
ct-9352	31	67	endometrial	endometrial	ADJ
ct-9352	31	68	expression	expression	NOUN
ct-9352	31	69	of	of	ADP
ct-9352	31	70	proinflammatory	proinflammatory	ADJ
ct-9352	31	71	cytokines	cytokine	NOUN
ct-9352	31	72	il-1β	il-1β	ADJ
ct-9352	31	73	and	and	CCONJ
ct-9352	31	74	ifnγ.25	ifnγ.25	ADJ
ct-9352	31	75	settle	settle	NOUN
ct-9352	31	76	®	®	NOUN
ct-9352	31	77	was	be	AUX
ct-9352	31	78	effective	effective	ADJ
ct-9352	31	79	at	at	ADP
ct-9352	31	80	1.5	1.5	NUM
ct-9352	31	81	mg	mg	NOUN
ct-9352	31	82	dose	dose	PROPN
ct-9352	31	83	,	,	PUNCT
ct-9352	31	84	either	either	CCONJ
ct-9352	31	85	given	give	VERB
ct-9352	31	86	intravenously	intravenously	ADV
ct-9352	31	87	or	or	CCONJ
ct-9352	31	88	infused	infuse	VERB
ct-9352	31	89	into	into	ADP
ct-9352	31	90	the	the	DET
ct-9352	31	91	uterine	uterine	ADJ
ct-9352	31	92	lumen.33	lumen.33	NOUN
ct-9352	31	93	eqstim	eqstim	NOUN
ct-9352	31	94	®	®	NOUN
ct-9352	31	95	treatment	treatment	NOUN
ct-9352	31	96	of	of	ADP
ct-9352	31	97	endometritis	endometritis	NOUN
ct-9352	31	98	along	along	ADP
ct-9352	31	99	with	with	ADP
ct-9352	31	100	other	other	ADJ
ct-9352	31	101	conventional	conventional	ADJ
ct-9352	31	102	therapies	therapy	NOUN
ct-9352	31	103	improved	improve	VERB
ct-9352	31	104	pregnancy	pregnancy	NOUN
ct-9352	31	105	rates	rate	NOUN
ct-9352	31	106	in	in	ADP
ct-9352	31	107	mares	mare	NOUN
ct-9352	31	108	with	with	ADP
ct-9352	31	109	clinical	clinical	ADJ
ct-9352	31	110	endometritis.1	endometritis.1	PROPN
ct-9352	31	111	however	however	ADV
ct-9352	31	112	,	,	PUNCT
ct-9352	31	113	effects	effect	NOUN
ct-9352	31	114	of	of	ADP
ct-9352	31	115	this	this	DET
ct-9352	31	116	therapeutic	therapeutic	ADJ
ct-9352	31	117	as	as	ADP
ct-9352	31	118	a	a	DET
ct-9352	31	119	sole	sole	ADJ
ct-9352	31	120	modality	modality	NOUN
ct-9352	31	121	are	be	AUX
ct-9352	31	122	unknown	unknown	ADJ
ct-9352	31	123	.	.	PUNCT
ct-9352	32	1	biologics	biologic	NOUN
ct-9352	32	2	during	during	ADP
ct-9352	32	3	the	the	DET
ct-9352	32	4	1970s	1970	NOUN
ct-9352	32	5	,	,	PUNCT
ct-9352	32	6	naturally	naturally	ADV
ct-9352	32	7	sourced	source	VERB
ct-9352	32	8	biologics	biologic	NOUN
ct-9352	32	9	,	,	PUNCT
ct-9352	32	10	were	be	AUX
ct-9352	32	11	evaluated	evaluate	VERB
ct-9352	32	12	for	for	ADP
ct-9352	32	13	the	the	DET
ct-9352	32	14	treatment	treatment	NOUN
ct-9352	32	15	of	of	ADP
ct-9352	32	16	inflammation	inflammation	NOUN
ct-9352	32	17	/	/	SYM
ct-9352	32	18	infection	infection	NOUN
ct-9352	32	19	of	of	ADP
ct-9352	32	20	uterus	uterus	NOUN
ct-9352	32	21	.	.	PUNCT
ct-9352	33	1	intrauterine	intrauterine	ADJ
ct-9352	33	2	infusion	infusion	NOUN
ct-9352	33	3	of	of	ADP
ct-9352	33	4	equine	equine	NOUN
ct-9352	33	5	colostrum	colostrum	NOUN
ct-9352	33	6	was	be	AUX
ct-9352	33	7	the	the	DET
ct-9352	33	8	first	first	ADJ
ct-9352	33	9	agent	agent	NOUN
ct-9352	33	10	tested.34	tested.34	NOUN
ct-9352	33	11	due	due	ADP
ct-9352	33	12	to	to	ADP
ct-9352	33	13	its	its	PRON
ct-9352	33	14	high	high	ADJ
ct-9352	33	15	immunoglobulin	immunoglobulin	NOUN
ct-9352	33	16	content	content	NOUN
ct-9352	33	17	and	and	CCONJ
ct-9352	33	18	potential	potential	ADJ
ct-9352	33	19	antimicrobial	antimicrobial	ADJ
ct-9352	33	20	action	action	NOUN
ct-9352	33	21	,	,	PUNCT
ct-9352	33	22	colostrum	colostrum	PROPN
ct-9352	33	23	was	be	AUX
ct-9352	33	24	collected	collect	VERB
ct-9352	33	25	from	from	ADP
ct-9352	33	26	mares	mare	NOUN
ct-9352	33	27	immediately	immediately	ADV
ct-9352	33	28	after	after	ADP
ct-9352	33	29	parturition	parturition	NOUN
ct-9352	33	30	and	and	CCONJ
ct-9352	33	31	120	120	NUM
ct-9352	33	32	ml	ml	NOUN
ct-9352	33	33	infused	infuse	VERB
ct-9352	33	34	into	into	ADP
ct-9352	33	35	the	the	DET
ct-9352	33	36	uterus	uterus	NOUN
ct-9352	33	37	of	of	ADP
ct-9352	33	38	subfertile	subfertile	ADJ
ct-9352	33	39	mares	mare	NOUN
ct-9352	33	40	.	.	PUNCT
ct-9352	34	1	mares	mare	NOUN
ct-9352	34	2	returned	return	VERB
ct-9352	34	3	to	to	ADP
ct-9352	34	4	normal	normal	ADJ
ct-9352	34	5	cyclicity	cyclicity	NOUN
ct-9352	34	6	and	and	CCONJ
ct-9352	34	7	uterine	uterine	ADJ
ct-9352	34	8	lumen	luman	NOUN
ct-9352	34	9	had	have	VERB
ct-9352	34	10	various	various	ADJ
ct-9352	34	11	immunoglobulins	immunoglobulin	NOUN
ct-9352	34	12	(	(	PUNCT
ct-9352	34	13	igg	igg	PROPN
ct-9352	34	14	,	,	PUNCT
ct-9352	34	15	igm	igm	PROPN
ct-9352	34	16	,	,	PUNCT
ct-9352	34	17	and	and	CCONJ
ct-9352	34	18	ige	ige	PROPN
ct-9352	34	19	)	)	PUNCT
ct-9352	34	20	.	.	PUNCT
ct-9352	35	1	however	however	ADV
ct-9352	35	2	,	,	PUNCT
ct-9352	35	3	intrauterine	intrauterine	ADJ
ct-9352	35	4	deficiency	deficiency	NOUN
ct-9352	35	5	in	in	ADP
ct-9352	35	6	igg	igg	PROPN
ct-9352	35	7	and	and	CCONJ
ct-9352	35	8	iga	iga	PROPN
ct-9352	35	9	in	in	ADP
ct-9352	35	10	susceptible	susceptible	ADJ
ct-9352	35	11	mares	mare	NOUN
ct-9352	35	12	was	be	AUX
ct-9352	35	13	not	not	PART
ct-9352	35	14	likely	likely	ADJ
ct-9352	35	15	the	the	DET
ct-9352	35	16	cause	cause	NOUN
ct-9352	35	17	of	of	ADP
ct-9352	35	18	susceptibility	susceptibility	NOUN
ct-9352	35	19	to	to	ADP
ct-9352	35	20	persistent	persistent	NOUN
ct-9352	35	21	endometritis.4	endometritis.4	PROPN
ct-9352	35	22	a	a	DET
ct-9352	35	23	key	key	ADJ
ct-9352	35	24	factor	factor	NOUN
ct-9352	35	25	believed	believe	VERB
ct-9352	35	26	to	to	PART
ct-9352	35	27	distinguish	distinguish	VERB
ct-9352	35	28	resistant	resistant	ADJ
ct-9352	35	29	from	from	ADP
ct-9352	35	30	susceptible	susceptible	ADJ
ct-9352	35	31	mares	mare	NOUN
ct-9352	35	32	is	be	AUX
ct-9352	35	33	the	the	DET
ct-9352	35	34	innate	innate	ADJ
ct-9352	35	35	immune	immune	ADJ
ct-9352	35	36	system	system	NOUN
ct-9352	35	37	’s	’s	PART
ct-9352	35	38	ability	ability	NOUN
ct-9352	35	39	to	to	PART
ct-9352	35	40	degrade	degrade	VERB
ct-9352	35	41	and	and	CCONJ
ct-9352	35	42	digest	digest	VERB
ct-9352	35	43	bacteria	bacteria	NOUN
ct-9352	35	44	and	and	CCONJ
ct-9352	35	45	excess	excess	ADJ
ct-9352	35	46	sperm	sperm	NOUN
ct-9352	35	47	from	from	ADP
ct-9352	35	48	the	the	DET
ct-9352	35	49	uterine	uterine	ADJ
ct-9352	35	50	lumen	luman	NOUN
ct-9352	35	51	.	.	PUNCT
ct-9352	36	1	the	the	DET
ct-9352	36	2	addition	addition	NOUN
ct-9352	36	3	of	of	ADP
ct-9352	36	4	blood	blood	NOUN
ct-9352	36	5	serum	serum	NOUN
ct-9352	36	6	substantially	substantially	ADV
ct-9352	36	7	increased	increase	VERB
ct-9352	36	8	opsonization	opsonization	NOUN
ct-9352	36	9	potential	potential	NOUN
ct-9352	36	10	in	in	ADP
ct-9352	36	11	both	both	CCONJ
ct-9352	36	12	resistant	resistant	ADJ
ct-9352	36	13	and	and	CCONJ
ct-9352	36	14	susceptible	susceptible	ADJ
ct-9352	36	15	mares	mare	NOUN
ct-9352	36	16	,	,	PUNCT
ct-9352	36	17	indicating	indicate	VERB
ct-9352	36	18	an	an	DET
ct-9352	36	19	antimicrobial	antimicrobial	ADJ
ct-9352	36	20	effect	effect	NOUN
ct-9352	36	21	of	of	ADP
ct-9352	36	22	blood	blood	NOUN
ct-9352	36	23	plasma	plasma	NOUN
ct-9352	36	24	.	.	PUNCT
ct-9352	37	1	uterine	uterine	ADJ
ct-9352	37	2	-	-	PUNCT
ct-9352	37	3	derived	derive	VERB
ct-9352	37	4	pmns	pmn	NOUN
ct-9352	37	5	from	from	ADP
ct-9352	37	6	susceptible	susceptible	ADJ
ct-9352	37	7	mares	mare	NOUN
ct-9352	37	8	were	be	AUX
ct-9352	37	9	able	able	ADJ
ct-9352	37	10	to	to	PART
ct-9352	37	11	migrate	migrate	VERB
ct-9352	37	12	toward	toward	ADP
ct-9352	37	13	a	a	DET
ct-9352	37	14	chemical	chemical	NOUN
ct-9352	37	15	gradient	gradient	NOUN
ct-9352	37	16	and	and	CCONJ
ct-9352	37	17	phagocytosis	phagocytosis	NOUN
ct-9352	37	18	was	be	AUX
ct-9352	37	19	fully	fully	ADV
ct-9352	37	20	functional	functional	ADJ
ct-9352	37	21	if	if	SCONJ
ct-9352	37	22	a	a	DET
ct-9352	37	23	healthy	healthy	ADJ
ct-9352	37	24	environment	environment	NOUN
ct-9352	37	25	was	be	AUX
ct-9352	37	26	provided.35	provided.35	NOUN
ct-9352	37	27	however	however	ADV
ct-9352	37	28	,	,	PUNCT
ct-9352	37	29	phagocytosis	phagocytosis	NOUN
ct-9352	37	30	was	be	AUX
ct-9352	37	31	impaired	impair	VERB
ct-9352	37	32	in	in	ADP
ct-9352	37	33	uterine	uterine	ADJ
ct-9352	37	34	secretions	secretion	NOUN
ct-9352	37	35	from	from	ADP
ct-9352	37	36	susceptible	susceptible	ADJ
ct-9352	37	37	mares	mare	NOUN
ct-9352	37	38	.	.	PUNCT
ct-9352	38	1	it	it	PRON
ct-9352	38	2	was	be	AUX
ct-9352	38	3	concluded	conclude	VERB
ct-9352	38	4	that	that	SCONJ
ct-9352	38	5	dysfunctions	dysfunction	NOUN
ct-9352	38	6	of	of	ADP
ct-9352	38	7	pmns	pmn	NOUN
ct-9352	38	8	from	from	ADP
ct-9352	38	9	susceptible	susceptible	ADJ
ct-9352	38	10	mares	mare	NOUN
ct-9352	38	11	were	be	AUX
ct-9352	38	12	due	due	ADJ
ct-9352	38	13	to	to	ADP
ct-9352	38	14	a	a	DET
ct-9352	38	15	poor	poor	ADJ
ct-9352	38	16	environment	environment	NOUN
ct-9352	38	17	rather	rather	ADV
ct-9352	38	18	than	than	ADP
ct-9352	38	19	the	the	DET
ct-9352	38	20	pmns	pmn	NOUN
ct-9352	38	21	of	of	ADP
ct-9352	38	22	susceptible	susceptible	ADJ
ct-9352	38	23	mares	mare	NOUN
ct-9352	38	24	.	.	PUNCT
ct-9352	39	1	nevertheless	nevertheless	ADV
ct-9352	39	2	,	,	PUNCT
ct-9352	39	3	it	it	PRON
ct-9352	39	4	was	be	AUX
ct-9352	39	5	suggested	suggest	VERB
ct-9352	39	6	that	that	SCONJ
ct-9352	39	7	addition	addition	NOUN
ct-9352	39	8	of	of	ADP
ct-9352	39	9	fresh	fresh	ADJ
ct-9352	39	10	blood	blood	NOUN
ct-9352	39	11	-	-	PUNCT
ct-9352	39	12	derived	derive	VERB
ct-9352	39	13	leucocytes	leucocyte	NOUN
ct-9352	39	14	to	to	ADP
ct-9352	39	15	autologous	autologous	ADJ
ct-9352	39	16	plasma	plasma	NOUN
ct-9352	39	17	prior	prior	ADV
ct-9352	39	18	to	to	ADP
ct-9352	39	19	post	post	ADJ
ct-9352	39	20	-	-	ADJ
ct-9352	39	21	breeding	breeding	ADJ
ct-9352	39	22	intrauterine	intrauterine	ADJ
ct-9352	39	23	infusions	infusion	NOUN
ct-9352	39	24	can	can	AUX
ct-9352	39	25	improve	improve	VERB
ct-9352	39	26	pregnancy	pregnancy	NOUN
ct-9352	39	27	rates	rate	NOUN
ct-9352	39	28	in	in	ADP
ct-9352	39	29	barren	barren	ADJ
ct-9352	39	30	mares.36	mares.36	NOUN
ct-9352	39	31	there	there	PRON
ct-9352	39	32	was	be	VERB
ct-9352	39	33	clinical	clinical	ADJ
ct-9352	39	34	improvement	improvement	NOUN
ct-9352	39	35	(	(	PUNCT
ct-9352	39	36	24/29	24/29	NUM
ct-9352	39	37	mares	mare	NOUN
ct-9352	39	38	)	)	PUNCT
ct-9352	39	39	and	and	CCONJ
ct-9352	39	40	pregnancy	pregnancy	NOUN
ct-9352	39	41	rate	rate	NOUN
ct-9352	39	42	(	(	PUNCT
ct-9352	39	43	15/29	15/29	NUM
ct-9352	39	44	mares	mare	NOUN
ct-9352	39	45	)	)	PUNCT
ct-9352	39	46	in	in	ADP
ct-9352	39	47	mares	mare	NOUN
ct-9352	39	48	experiencing	experience	VERB
ct-9352	39	49	uterine	uterine	ADJ
ct-9352	39	50	inflammation	inflammation	NOUN
ct-9352	39	51	after	after	ADP
ct-9352	39	52	intrauterine	intrauterine	ADJ
ct-9352	39	53	infusion	infusion	NOUN
ct-9352	39	54	of	of	ADP
ct-9352	39	55	plasma.37	plasma.37	NOUN
ct-9352	39	56	however	however	ADV
ct-9352	39	57	,	,	PUNCT
ct-9352	39	58	it	it	PRON
ct-9352	39	59	was	be	AUX
ct-9352	39	60	ineffective	ineffective	ADJ
ct-9352	39	61	in	in	ADP
ct-9352	39	62	the	the	DET
ct-9352	39	63	treatment	treatment	NOUN
ct-9352	39	64	of	of	ADP
ct-9352	39	65	either	either	CCONJ
ct-9352	39	66	lymphocytic	lymphocytic	ADJ
ct-9352	39	67	or	or	CCONJ
ct-9352	39	68	infectious	infectious	ADJ
ct-9352	39	69	endometritis.38	endometritis.38	NOUN
ct-9352	39	70	these	these	DET
ct-9352	39	71	findings	finding	NOUN
ct-9352	39	72	were	be	AUX
ct-9352	39	73	further	far	ADV
ct-9352	39	74	supported	support	VERB
ct-9352	39	75	by	by	ADP
ct-9352	39	76	the	the	DET
ct-9352	39	77	observation	observation	NOUN
ct-9352	39	78	that	that	SCONJ
ct-9352	39	79	intrauterine	intrauterine	ADJ
ct-9352	39	80	treatment	treatment	NOUN
ct-9352	39	81	with	with	ADP
ct-9352	39	82	autologous	autologous	ADJ
ct-9352	39	83	blood	blood	NOUN
ct-9352	39	84	plasma	plasma	NOUN
ct-9352	39	85	in	in	ADP
ct-9352	39	86	susceptible	susceptible	ADJ
ct-9352	39	87	mares	mare	NOUN
ct-9352	39	88	was	be	AUX
ct-9352	39	89	less	less	ADV
ct-9352	39	90	effective	effective	ADJ
ct-9352	39	91	than	than	ADP
ct-9352	39	92	antibiotics	antibiotic	NOUN
ct-9352	39	93	,	,	PUNCT
ct-9352	39	94	ecbolics	ecbolic	NOUN
ct-9352	39	95	,	,	PUNCT
ct-9352	39	96	or	or	CCONJ
ct-9352	39	97	uterine	uterine	ADJ
ct-9352	39	98	lavage	lavage	NOUN
ct-9352	39	99	in	in	ADP
ct-9352	39	100	mares	mare	NOUN
ct-9352	39	101	with	with	ADP
ct-9352	39	102	acute	acute	ADJ
ct-9352	39	103	infectious	infectious	ADJ
ct-9352	39	104	endometritis.39	endometritis.39	NOUN
ct-9352	39	105	it	it	PRON
ct-9352	39	106	is	be	AUX
ct-9352	39	107	noteworthy	noteworthy	ADJ
ct-9352	39	108	that	that	SCONJ
ct-9352	39	109	there	there	PRON
ct-9352	39	110	was	be	VERB
ct-9352	39	111	a	a	DET
ct-9352	39	112	subgroup	subgroup	NOUN
ct-9352	39	113	of	of	ADP
ct-9352	39	114	individual	individual	ADJ
ct-9352	39	115	susceptible	susceptible	ADJ
ct-9352	39	116	mares	mare	NOUN
ct-9352	39	117	that	that	PRON
ct-9352	39	118	responded	respond	VERB
ct-9352	39	119	adequately	adequately	ADV
ct-9352	39	120	to	to	ADP
ct-9352	39	121	autologous	autologous	ADJ
ct-9352	39	122	plasma	plasma	NOUN
ct-9352	39	123	treatment	treatment	NOUN
ct-9352	39	124	.	.	PUNCT
ct-9352	40	1	decades	decade	NOUN
ct-9352	40	2	later	later	ADV
ct-9352	40	3	,	,	PUNCT
ct-9352	40	4	plasma	plasma	NOUN
ct-9352	40	5	treatment	treatment	NOUN
ct-9352	40	6	protocols	protocol	NOUN
ct-9352	40	7	were	be	AUX
ct-9352	40	8	modified	modify	VERB
ct-9352	40	9	with	with	ADP
ct-9352	40	10	intrauterine	intrauterine	ADJ
ct-9352	40	11	treatment	treatment	NOUN
ct-9352	40	12	of	of	ADP
ct-9352	40	13	platelet	platelet	ADJ
ct-9352	40	14	-	-	PUNCT
ct-9352	40	15	rich	rich	ADJ
ct-9352	40	16	plasma	plasma	NOUN
ct-9352	40	17	(	(	PUNCT
ct-9352	40	18	prp	prp	PROPN
ct-9352	40	19	)	)	PUNCT
ct-9352	40	20	.	.	PUNCT
ct-9352	41	1	a	a	DET
ct-9352	41	2	concentrate	concentrate	NOUN
ct-9352	41	3	of	of	ADP
ct-9352	41	4	prp	prp	NOUN
ct-9352	41	5	protein	protein	NOUN
ct-9352	41	6	derived	derive	VERB
ct-9352	41	7	from	from	ADP
ct-9352	41	8	whole	whole	ADJ
ct-9352	41	9	blood	blood	NOUN
ct-9352	41	10	,	,	PUNCT
ct-9352	41	11	contained	contain	VERB
ct-9352	41	12	several	several	ADJ
ct-9352	41	13	growth	growth	NOUN
ct-9352	41	14	factors	factor	NOUN
ct-9352	41	15	and	and	CCONJ
ct-9352	41	16	cytokines	cytokine	NOUN
ct-9352	41	17	released	release	VERB
ct-9352	41	18	from	from	ADP
ct-9352	41	19	the	the	DET
ct-9352	41	20	intracytoplasmic	intracytoplasmic	ADJ
ct-9352	41	21	granules	granule	NOUN
ct-9352	41	22	when	when	SCONJ
ct-9352	41	23	cells	cell	NOUN
ct-9352	41	24	are	be	AUX
ct-9352	41	25	activated.40	activated.40	PROPN
ct-9352	41	26	prp	prp	PROPN
ct-9352	41	27	is	be	AUX
ct-9352	41	28	utilized	utilize	VERB
ct-9352	41	29	in	in	ADP
ct-9352	41	30	several	several	ADJ
ct-9352	41	31	tissues	tissue	NOUN
ct-9352	41	32	and	and	CCONJ
ct-9352	41	33	disorders	disorder	NOUN
ct-9352	41	34	for	for	ADP
ct-9352	41	35	its	its	PRON
ct-9352	41	36	antiinflammatory	antiinflammatory	NOUN
ct-9352	41	37	,	,	PUNCT
ct-9352	41	38	antimicrobial	antimicrobial	ADJ
ct-9352	41	39	,	,	PUNCT
ct-9352	41	40	and	and	CCONJ
ct-9352	41	41	angiogenic	angiogenic	ADJ
ct-9352	41	42	properties	property	NOUN
ct-9352	41	43	,	,	PUNCT
ct-9352	41	44	including	include	VERB
ct-9352	41	45	joint	joint	ADJ
ct-9352	41	46	disease	disease	NOUN
ct-9352	41	47	,	,	PUNCT
ct-9352	41	48	soft	soft	ADJ
ct-9352	41	49	tissue	tissue	NOUN
ct-9352	41	50	injury	injury	NOUN
ct-9352	41	51	,	,	PUNCT
ct-9352	41	52	and	and	CCONJ
ct-9352	41	53	skin	skin	NOUN
ct-9352	41	54	wounds.41	wounds.41	NOUN
ct-9352	41	55	-	-	PUNCT
ct-9352	41	56	43	43	NUM
ct-9352	41	57	prp	prp	NOUN
ct-9352	41	58	functioned	function	VERB
ct-9352	41	59	as	as	ADP
ct-9352	41	60	an	an	DET
ct-9352	41	61	antiinflammatory	antiinflammatory	NOUN
ct-9352	41	62	agent	agent	NOUN
ct-9352	41	63	when	when	SCONJ
ct-9352	41	64	infused	infuse	VERB
ct-9352	41	65	within	within	ADP
ct-9352	41	66	the	the	DET
ct-9352	41	67	uterine	uterine	ADJ
ct-9352	41	68	lumen	luman	NOUN
ct-9352	41	69	by	by	ADP
ct-9352	41	70	decreasing	decrease	VERB
ct-9352	41	71	the	the	DET
ct-9352	41	72	expression	expression	NOUN
ct-9352	41	73	of	of	ADP
ct-9352	41	74	proinflammatory	proinflammatory	ADJ
ct-9352	41	75	cytokines	cytokine	NOUN
ct-9352	41	76	(	(	PUNCT
ct-9352	41	77	cox-2	cox-2	NOUN
ct-9352	41	78	,	,	PUNCT
ct-9352	41	79	il-1β	il-1β	PROPN
ct-9352	41	80	,	,	PUNCT
ct-9352	41	81	and	and	CCONJ
ct-9352	41	82	tnf).44	tnf).44	NOUN
ct-9352	41	83	-	-	PUNCT
ct-9352	41	84	45	45	NUM
ct-9352	41	85	although	although	SCONJ
ct-9352	41	86	a	a	DET
ct-9352	41	87	small	small	ADJ
ct-9352	41	88	number	number	NOUN
ct-9352	41	89	of	of	ADP
ct-9352	41	90	mares	mare	NOUN
ct-9352	41	91	were	be	AUX
ct-9352	41	92	investigated	investigate	VERB
ct-9352	41	93	,	,	PUNCT
ct-9352	41	94	this	this	DET
ct-9352	41	95	study	study	NOUN
ct-9352	41	96	demonstrated	demonstrate	VERB
ct-9352	41	97	an	an	DET
ct-9352	41	98	increase	increase	NOUN
ct-9352	41	99	in	in	ADP
ct-9352	41	100	fertility	fertility	NOUN
ct-9352	41	101	rates	rate	NOUN
ct-9352	41	102	in	in	ADP
ct-9352	41	103	susceptible	susceptible	ADJ
ct-9352	41	104	mares	mare	NOUN
ct-9352	41	105	receiving	receive	VERB
ct-9352	41	106	prp	prp	NOUN
ct-9352	41	107	,	,	PUNCT
ct-9352	41	108	without	without	ADP
ct-9352	41	109	a	a	DET
ct-9352	41	110	detected	detect	VERB
ct-9352	41	111	change	change	NOUN
ct-9352	41	112	in	in	ADP
ct-9352	41	113	intrauterine	intrauterine	ADJ
ct-9352	41	114	clinical	clinical	ADJ
ct-9352	41	115	theriogenology	theriogenology	NOUN
ct-9352	41	116	2021	2021	NUM
ct-9352	41	117	;	;	PUNCT
ct-9352	41	118	13	13	NUM
ct-9352	41	119	:	:	SYM
ct-9352	41	120	240	240	NUM
ct-9352	41	121	fluid	fluid	NOUN
ct-9352	41	122	.	.	PUNCT
ct-9352	42	1	furthermore	furthermore	ADV
ct-9352	42	2	,	,	PUNCT
ct-9352	42	3	time	time	NOUN
ct-9352	42	4	of	of	ADP
ct-9352	42	5	treatment	treatment	NOUN
ct-9352	42	6	(	(	PUNCT
ct-9352	42	7	24	24	NUM
ct-9352	42	8	hours	hour	NOUN
ct-9352	42	9	preinsemination	preinsemination	NOUN
ct-9352	42	10	or	or	CCONJ
ct-9352	42	11	4	4	NUM
ct-9352	42	12	hours	hour	NOUN
ct-9352	42	13	postinsemination	postinsemination	NOUN
ct-9352	42	14	)	)	PUNCT
ct-9352	42	15	had	have	VERB
ct-9352	42	16	similar	similar	ADJ
ct-9352	42	17	effects	effect	NOUN
ct-9352	42	18	.	.	PUNCT
ct-9352	43	1	although	although	SCONJ
ct-9352	43	2	prp	prp	PROPN
ct-9352	43	3	did	do	AUX
ct-9352	43	4	not	not	PART
ct-9352	43	5	increase	increase	VERB
ct-9352	43	6	antiinflammatory	antiinflammatory	NOUN
ct-9352	43	7	cytokine	cytokine	NOUN
ct-9352	43	8	expression	expression	NOUN
ct-9352	43	9	,	,	PUNCT
ct-9352	43	10	it	it	PRON
ct-9352	43	11	decreased	decrease	VERB
ct-9352	43	12	mrna	mrna	NOUN
ct-9352	43	13	expression	expression	NOUN
ct-9352	43	14	of	of	ADP
ct-9352	43	15	proinflammatory	proinflammatory	ADJ
ct-9352	43	16	cytokines.46	cytokines.46	NOUN
ct-9352	43	17	clinically	clinically	ADV
ct-9352	43	18	,	,	PUNCT
ct-9352	43	19	intrauterine	intrauterine	ADJ
ct-9352	43	20	prp	prp	NOUN
ct-9352	43	21	treatment	treatment	NOUN
ct-9352	43	22	at	at	ADP
ct-9352	43	23	insemination	insemination	NOUN
ct-9352	43	24	decreased	decrease	VERB
ct-9352	43	25	the	the	DET
ct-9352	43	26	amount	amount	NOUN
ct-9352	43	27	of	of	ADP
ct-9352	43	28	intrauterine	intrauterine	ADJ
ct-9352	43	29	fluid	fluid	NOUN
ct-9352	43	30	and	and	CCONJ
ct-9352	43	31	improved	improve	VERB
ct-9352	43	32	pregnancy	pregnancy	NOUN
ct-9352	43	33	rates	rate	NOUN
ct-9352	43	34	,	,	PUNCT
ct-9352	43	35	indicating	indicate	VERB
ct-9352	43	36	that	that	SCONJ
ct-9352	43	37	time	time	NOUN
ct-9352	43	38	of	of	ADP
ct-9352	43	39	treatment	treatment	NOUN
ct-9352	43	40	may	may	AUX
ct-9352	43	41	cause	cause	VERB
ct-9352	43	42	variable	variable	ADJ
ct-9352	43	43	outcomes.47	outcomes.47	PRON
ct-9352	43	44	intrauterine	intrauterine	ADJ
ct-9352	43	45	infusion	infusion	NOUN
ct-9352	43	46	of	of	ADP
ct-9352	43	47	lactoferrin	lactoferrin	NOUN
ct-9352	43	48	,	,	PUNCT
ct-9352	43	49	expanded	expand	VERB
ct-9352	43	50	our	our	PRON
ct-9352	43	51	understanding	understanding	NOUN
ct-9352	43	52	of	of	ADP
ct-9352	43	53	its	its	PRON
ct-9352	43	54	immunomodulation	immunomodulation	NOUN
ct-9352	43	55	.	.	PUNCT
ct-9352	44	1	lactoferrin	lactoferrin	PROPN
ct-9352	44	2	,	,	PUNCT
ct-9352	44	3	present	present	ADJ
ct-9352	44	4	in	in	ADP
ct-9352	44	5	high	high	ADJ
ct-9352	44	6	concentrations	concentration	NOUN
ct-9352	44	7	in	in	ADP
ct-9352	44	8	both	both	CCONJ
ct-9352	44	9	milk	milk	NOUN
ct-9352	44	10	and	and	CCONJ
ct-9352	44	11	seminal	seminal	ADJ
ct-9352	44	12	plasma	plasma	NOUN
ct-9352	44	13	,	,	PUNCT
ct-9352	44	14	has	have	AUX
ct-9352	44	15	been	be	AUX
ct-9352	44	16	described	describe	VERB
ct-9352	44	17	as	as	ADP
ct-9352	44	18	both	both	DET
ct-9352	44	19	antiinflammatory	antiinflammatory	NOUN
ct-9352	44	20	and	and	CCONJ
ct-9352	44	21	antimicrobial	antimicrobial	ADJ
ct-9352	44	22	in	in	ADP
ct-9352	44	23	a	a	DET
ct-9352	44	24	variety	variety	NOUN
ct-9352	44	25	of	of	ADP
ct-9352	44	26	species.48	species.48	PROPN
ct-9352	44	27	-	-	PUNCT
ct-9352	44	28	52	52	NUM
ct-9352	44	29	however	however	ADV
ct-9352	44	30	,	,	PUNCT
ct-9352	44	31	its	its	PRON
ct-9352	44	32	bactericidal	bactericidal	ADJ
ct-9352	44	33	properties	property	NOUN
ct-9352	44	34	have	have	AUX
ct-9352	44	35	not	not	PART
ct-9352	44	36	been	be	AUX
ct-9352	44	37	elucidated	elucidate	VERB
ct-9352	44	38	in	in	ADP
ct-9352	44	39	the	the	DET
ct-9352	44	40	horse	horse	NOUN
ct-9352	44	41	.	.	PUNCT
ct-9352	45	1	in	in	ADP
ct-9352	45	2	a	a	DET
ct-9352	45	3	periovulatory	periovulatory	ADJ
ct-9352	45	4	susceptible	susceptible	ADJ
ct-9352	45	5	mare	mare	NOUN
ct-9352	45	6	,	,	PUNCT
ct-9352	45	7	150	150	NUM
ct-9352	45	8	µg	µg	NOUN
ct-9352	45	9	/	/	SYM
ct-9352	45	10	ml	ml	NOUN
ct-9352	45	11	human	human	ADJ
ct-9352	45	12	recombinant	recombinant	ADJ
ct-9352	45	13	lactoferrin	lactoferrin	NOUN
ct-9352	45	14	(	(	PUNCT
ct-9352	45	15	re	re	NOUN
ct-9352	45	16	-	-	NOUN
ct-9352	45	17	lf	lf	ADJ
ct-9352	45	18	)	)	PUNCT
ct-9352	45	19	treatment	treatment	NOUN
ct-9352	45	20	,	,	PUNCT
ct-9352	45	21	suppressed	suppress	VERB
ct-9352	45	22	endometrial	endometrial	ADJ
ct-9352	45	23	expression	expression	NOUN
ct-9352	45	24	of	of	ADP
ct-9352	45	25	pleiotropic	pleiotropic	NOUN
ct-9352	45	26	tnf.52	tnf.52	NOUN
ct-9352	45	27	lactoferrin	lactoferrin	NOUN
ct-9352	45	28	treatment	treatment	NOUN
ct-9352	45	29	along	along	ADP
ct-9352	45	30	with	with	ADP
ct-9352	45	31	artificial	artificial	ADJ
ct-9352	45	32	insemination	insemination	NOUN
ct-9352	45	33	in	in	ADP
ct-9352	45	34	healthy	healthy	ADJ
ct-9352	45	35	resistant	resistant	ADJ
ct-9352	45	36	mares	mare	NOUN
ct-9352	45	37	also	also	ADV
ct-9352	45	38	substantially	substantially	ADV
ct-9352	45	39	decreased	decrease	VERB
ct-9352	45	40	expression	expression	NOUN
ct-9352	45	41	of	of	ADP
ct-9352	45	42	various	various	ADJ
ct-9352	45	43	proinflammatory	proinflammatory	ADJ
ct-9352	45	44	cytokines	cytokine	NOUN
ct-9352	45	45	(	(	PUNCT
ct-9352	45	46	including	include	VERB
ct-9352	45	47	il-1β	il-1β	PROPN
ct-9352	45	48	and	and	CCONJ
ct-9352	45	49	il-8).53	il-8).53	NOUN
ct-9352	45	50	in	in	ADP
ct-9352	45	51	susceptible	susceptible	ADJ
ct-9352	45	52	mares	mare	NOUN
ct-9352	45	53	,	,	PUNCT
ct-9352	45	54	re	re	VERB
ct-9352	45	55	-	-	NOUN
ct-9352	45	56	lf	lf	ADP
ct-9352	45	57	treatment	treatment	NOUN
ct-9352	45	58	,	,	PUNCT
ct-9352	45	59	6	6	NUM
ct-9352	45	60	hours	hour	NOUN
ct-9352	45	61	after	after	ADP
ct-9352	45	62	insemination	insemination	NOUN
ct-9352	45	63	,	,	PUNCT
ct-9352	45	64	decreased	decrease	VERB
ct-9352	45	65	endometrial	endometrial	ADJ
ct-9352	45	66	expression	expression	NOUN
ct-9352	45	67	of	of	ADP
ct-9352	45	68	proinflammatory	proinflammatory	ADJ
ct-9352	45	69	ifnγ	ifnγ	NOUN
ct-9352	45	70	and	and	CCONJ
ct-9352	45	71	simultaneously	simultaneously	ADV
ct-9352	45	72	increased	increase	VERB
ct-9352	45	73	expression	expression	NOUN
ct-9352	45	74	of	of	ADP
ct-9352	45	75	antiinflammatory	antiinflammatory	NOUN
ct-9352	45	76	il-1rn.51	il-1rn.51	ADV
ct-9352	45	77	additionally	additionally	ADV
ct-9352	45	78	,	,	PUNCT
ct-9352	45	79	re	re	VERB
ct-9352	45	80	-	-	VERB
ct-9352	45	81	lf	lf	PRON
ct-9352	45	82	substantially	substantially	ADV
ct-9352	45	83	decreased	decrease	VERB
ct-9352	45	84	the	the	DET
ct-9352	45	85	number	number	NOUN
ct-9352	45	86	of	of	ADP
ct-9352	45	87	neutrophils	neutrophil	NOUN
ct-9352	45	88	in	in	ADP
ct-9352	45	89	the	the	DET
ct-9352	45	90	uterine	uterine	ADJ
ct-9352	45	91	lumen	luman	NOUN
ct-9352	45	92	.	.	PUNCT
ct-9352	46	1	further	further	ADJ
ct-9352	46	2	work	work	NOUN
ct-9352	46	3	is	be	AUX
ct-9352	46	4	necessary	necessary	ADJ
ct-9352	46	5	to	to	PART
ct-9352	46	6	assess	assess	VERB
ct-9352	46	7	bactericidal	bactericidal	ADJ
ct-9352	46	8	properties	property	NOUN
ct-9352	46	9	of	of	ADP
ct-9352	46	10	re	re	NOUN
ct-9352	46	11	-	-	NOUN
ct-9352	46	12	lf	lf	ADP
ct-9352	46	13	and	and	CCONJ
ct-9352	46	14	its	its	PRON
ct-9352	46	15	efficacy	efficacy	NOUN
ct-9352	46	16	in	in	ADP
ct-9352	46	17	treatment	treatment	NOUN
ct-9352	46	18	of	of	ADP
ct-9352	46	19	infectious	infectious	ADJ
ct-9352	46	20	endometritis	endometritis	NOUN
ct-9352	46	21	.	.	PUNCT
ct-9352	47	1	mesenchymal	mesenchymal	ADJ
ct-9352	47	2	stem	stem	NOUN
ct-9352	47	3	cells	cell	NOUN
ct-9352	47	4	(	(	PUNCT
ct-9352	47	5	mscs	msc	NOUN
ct-9352	47	6	)	)	PUNCT
ct-9352	47	7	have	have	AUX
ct-9352	47	8	also	also	ADV
ct-9352	47	9	been	be	AUX
ct-9352	47	10	investigated	investigate	VERB
ct-9352	47	11	for	for	ADP
ct-9352	47	12	their	their	PRON
ct-9352	47	13	antiinflammatory	antiinflammatory	NOUN
ct-9352	47	14	and	and	CCONJ
ct-9352	47	15	regenerative	regenerative	ADJ
ct-9352	47	16	effects.54	effects.54	NOUN
ct-9352	47	17	for	for	ADP
ct-9352	47	18	the	the	DET
ct-9352	47	19	past	past	ADJ
ct-9352	47	20	2	2	NUM
ct-9352	47	21	decades	decade	NOUN
ct-9352	47	22	,	,	PUNCT
ct-9352	47	23	mscs	msc	NOUN
ct-9352	47	24	have	have	AUX
ct-9352	47	25	been	be	AUX
ct-9352	47	26	utilized	utilize	VERB
ct-9352	47	27	in	in	ADP
ct-9352	47	28	a	a	DET
ct-9352	47	29	variety	variety	NOUN
ct-9352	47	30	of	of	ADP
ct-9352	47	31	diseases/	diseases/	NUM
ct-9352	47	32	disorders	disorder	NOUN
ct-9352	47	33	in	in	ADP
ct-9352	47	34	humans	human	NOUN
ct-9352	47	35	;	;	PUNCT
ct-9352	47	36	however	however	ADV
ct-9352	47	37	,	,	PUNCT
ct-9352	47	38	research	research	NOUN
ct-9352	47	39	in	in	ADP
ct-9352	47	40	their	their	PRON
ct-9352	47	41	capabilities	capability	NOUN
ct-9352	47	42	for	for	ADP
ct-9352	47	43	horses	horse	NOUN
ct-9352	47	44	is	be	AUX
ct-9352	47	45	more	more	ADV
ct-9352	47	46	limited	limited	ADJ
ct-9352	47	47	.	.	PUNCT
ct-9352	48	1	intrauterine	intrauterine	ADJ
ct-9352	48	2	infusion	infusion	NOUN
ct-9352	48	3	of	of	ADP
ct-9352	48	4	bone	bone	NOUN
ct-9352	48	5	marrow	marrow	NOUN
ct-9352	48	6	-	-	PUNCT
ct-9352	48	7	derived	derive	VERB
ct-9352	48	8	mscs	msc	NOUN
ct-9352	48	9	at	at	ADP
ct-9352	48	10	24	24	NUM
ct-9352	48	11	hours	hour	NOUN
ct-9352	48	12	pre	pre	NOUN
ct-9352	48	13	-	-	NOUN
ct-9352	48	14	insemination	insemination	NOUN
ct-9352	48	15	in	in	ADP
ct-9352	48	16	normal	normal	ADJ
ct-9352	48	17	mares	mare	NOUN
ct-9352	48	18	decreased	decrease	VERB
ct-9352	48	19	the	the	DET
ct-9352	48	20	number	number	NOUN
ct-9352	48	21	of	of	ADP
ct-9352	48	22	neutrophils	neutrophil	NOUN
ct-9352	48	23	in	in	ADP
ct-9352	48	24	the	the	DET
ct-9352	48	25	uterine	uterine	ADJ
ct-9352	48	26	lumen	luman	NOUN
ct-9352	48	27	in	in	ADP
ct-9352	48	28	addition	addition	NOUN
ct-9352	48	29	to	to	ADP
ct-9352	48	30	increasing	increase	VERB
ct-9352	48	31	the	the	DET
ct-9352	48	32	expression	expression	NOUN
ct-9352	48	33	of	of	ADP
ct-9352	48	34	antiinflammatory	antiinflammatory	NOUN
ct-9352	48	35	il-1rn.55	il-1rn.55	NOUN
ct-9352	48	36	antiinflammatory	antiinflammatory	NOUN
ct-9352	48	37	effects	effect	NOUN
ct-9352	48	38	of	of	ADP
ct-9352	48	39	mscs	msc	NOUN
ct-9352	48	40	in	in	ADP
ct-9352	48	41	the	the	DET
ct-9352	48	42	treatment	treatment	NOUN
ct-9352	48	43	of	of	ADP
ct-9352	48	44	endometritis	endometritis	NOUN
ct-9352	48	45	were	be	AUX
ct-9352	48	46	compared	compare	VERB
ct-9352	48	47	between	between	ADP
ct-9352	48	48	adipose	adipose	ADJ
ct-9352	48	49	tissue	tissue	NOUN
ct-9352	48	50	and	and	CCONJ
ct-9352	48	51	endometrium.56	endometrium.56	VERB
ct-9352	48	52	both	both	CCONJ
ct-9352	48	53	adipose	adipose	ADJ
ct-9352	48	54	tissue	tissue	NOUN
ct-9352	48	55	and	and	CCONJ
ct-9352	48	56	endometrial	endometrial	ADJ
ct-9352	48	57	-	-	PUNCT
ct-9352	48	58	derived	derive	VERB
ct-9352	48	59	mscs	msc	NOUN
ct-9352	48	60	decreased	decrease	VERB
ct-9352	48	61	concentrations	concentration	NOUN
ct-9352	48	62	of	of	ADP
ct-9352	48	63	pleiotropic	pleiotropic	NOUN
ct-9352	48	64	il-6	il-6	NOUN
ct-9352	48	65	and	and	CCONJ
ct-9352	48	66	tnf	tnf	PROPN
ct-9352	48	67	in	in	ADP
ct-9352	48	68	the	the	DET
ct-9352	48	69	luminal	luminal	ADJ
ct-9352	48	70	fluid	fluid	NOUN
ct-9352	48	71	.	.	PUNCT
ct-9352	49	1	within	within	ADP
ct-9352	49	2	the	the	DET
ct-9352	49	3	endometrium	endometrium	NOUN
ct-9352	49	4	,	,	PUNCT
ct-9352	49	5	adipose	adipose	NOUN
ct-9352	49	6	-	-	PUNCT
ct-9352	49	7	derived	derive	VERB
ct-9352	49	8	mscs	msc	NOUN
ct-9352	49	9	significantly	significantly	ADV
ct-9352	49	10	decreased	decrease	VERB
ct-9352	49	11	expression	expression	NOUN
ct-9352	49	12	of	of	ADP
ct-9352	49	13	proinflammatory	proinflammatory	ADJ
ct-9352	49	14	il-1a	il-1a	NOUN
ct-9352	49	15	and	and	CCONJ
ct-9352	49	16	il-8	il-8	NOUN
ct-9352	49	17	in	in	ADP
ct-9352	49	18	addition	addition	NOUN
ct-9352	49	19	to	to	ADP
ct-9352	49	20	il-6	il-6	NOUN
ct-9352	49	21	and	and	CCONJ
ct-9352	49	22	tnf	tnf	PROPN
ct-9352	49	23	.	.	PUNCT
ct-9352	50	1	in	in	ADP
ct-9352	50	2	contrast	contrast	NOUN
ct-9352	50	3	,	,	PUNCT
ct-9352	50	4	endometrial	endometrial	ADJ
ct-9352	50	5	-	-	PUNCT
ct-9352	50	6	derived	derive	VERB
ct-9352	50	7	mscs	msc	NOUN
ct-9352	50	8	significantly	significantly	ADV
ct-9352	50	9	decreased	decrease	VERB
ct-9352	50	10	proinflammatory	proinflammatory	ADJ
ct-9352	50	11	il-8	il-8	NOUN
ct-9352	50	12	and	and	CCONJ
ct-9352	50	13	simultaneously	simultaneously	ADV
ct-9352	50	14	increased	increase	VERB
ct-9352	50	15	endometrial	endometrial	ADJ
ct-9352	50	16	expression	expression	NOUN
ct-9352	50	17	of	of	ADP
ct-9352	50	18	antiinflammatory	antiinflammatory	NOUN
ct-9352	50	19	il-10	il-10	NOUN
ct-9352	50	20	.	.	PUNCT
ct-9352	51	1	no	no	DET
ct-9352	51	2	cellular	cellular	ADJ
ct-9352	51	3	infiltration	infiltration	NOUN
ct-9352	51	4	within	within	ADP
ct-9352	51	5	the	the	DET
ct-9352	51	6	endometrium	endometrium	NOUN
ct-9352	51	7	was	be	AUX
ct-9352	51	8	noted	note	VERB
ct-9352	51	9	24	24	NUM
ct-9352	51	10	hours	hour	NOUN
ct-9352	51	11	following	follow	VERB
ct-9352	51	12	infusion	infusion	NOUN
ct-9352	51	13	of	of	ADP
ct-9352	51	14	mscs	msc	NOUN
ct-9352	51	15	had	have	VERB
ct-9352	51	16	no	no	DET
ct-9352	51	17	cellular	cellular	ADJ
ct-9352	51	18	infiltration	infiltration	NOUN
ct-9352	51	19	,	,	PUNCT
ct-9352	51	20	although	although	SCONJ
ct-9352	51	21	there	there	PRON
ct-9352	51	22	was	be	VERB
ct-9352	51	23	a	a	DET
ct-9352	51	24	substantial	substantial	ADJ
ct-9352	51	25	decrease	decrease	NOUN
ct-9352	51	26	in	in	ADP
ct-9352	51	27	luminal	luminal	ADJ
ct-9352	51	28	neutrophilia.57	neutrophilia.57	PROPN
ct-9352	52	1	this	this	DET
ct-9352	52	2	study	study	NOUN
ct-9352	52	3	concluded	conclude	VERB
ct-9352	52	4	that	that	SCONJ
ct-9352	52	5	mscs	msc	NOUN
ct-9352	52	6	are	be	AUX
ct-9352	52	7	a	a	DET
ct-9352	52	8	safe	safe	ADJ
ct-9352	52	9	and	and	CCONJ
ct-9352	52	10	effective	effective	ADJ
ct-9352	52	11	antiinflammatory	antiinflammatory	NOUN
ct-9352	52	12	option	option	NOUN
ct-9352	52	13	for	for	ADP
ct-9352	52	14	the	the	DET
ct-9352	52	15	uterine	uterine	ADJ
ct-9352	52	16	lumen	luman	NOUN
ct-9352	52	17	without	without	ADP
ct-9352	52	18	invading	invade	VERB
ct-9352	52	19	or	or	CCONJ
ct-9352	52	20	implanting	implant	VERB
ct-9352	52	21	within	within	ADP
ct-9352	52	22	the	the	DET
ct-9352	52	23	endometrium	endometrium	NOUN
ct-9352	52	24	.	.	PUNCT
ct-9352	53	1	immune	immune	ADJ
ct-9352	53	2	response	response	NOUN
ct-9352	53	3	to	to	ADP
ct-9352	53	4	pregnancy	pregnancy	NOUN
ct-9352	53	5	the	the	DET
ct-9352	53	6	immune	immune	ADJ
ct-9352	53	7	system	system	NOUN
ct-9352	53	8	of	of	ADP
ct-9352	53	9	pregnant	pregnant	ADJ
ct-9352	53	10	females	female	NOUN
ct-9352	53	11	exists	exist	VERB
ct-9352	53	12	in	in	ADP
ct-9352	53	13	a	a	DET
ct-9352	53	14	delicate	delicate	ADJ
ct-9352	53	15	balance	balance	NOUN
ct-9352	53	16	between	between	ADP
ct-9352	53	17	protection	protection	NOUN
ct-9352	53	18	and	and	CCONJ
ct-9352	53	19	recognition	recognition	NOUN
ct-9352	53	20	,	,	PUNCT
ct-9352	53	21	as	as	SCONJ
ct-9352	53	22	it	it	PRON
ct-9352	53	23	must	must	AUX
ct-9352	53	24	both	both	PRON
ct-9352	53	25	tolerate	tolerate	VERB
ct-9352	53	26	the	the	DET
ct-9352	53	27	semi	semi	ADJ
ct-9352	53	28	-	-	ADJ
ct-9352	53	29	allogeneic	allogeneic	ADJ
ct-9352	53	30	fetus	fetus	NOUN
ct-9352	53	31	while	while	SCONJ
ct-9352	53	32	still	still	ADV
ct-9352	53	33	defending	defend	VERB
ct-9352	53	34	the	the	DET
ct-9352	53	35	body	body	NOUN
ct-9352	53	36	from	from	ADP
ct-9352	53	37	pathogens	pathogen	NOUN
ct-9352	53	38	that	that	PRON
ct-9352	53	39	can	can	AUX
ct-9352	53	40	impede	impede	VERB
ct-9352	53	41	the	the	DET
ct-9352	53	42	health	health	NOUN
ct-9352	53	43	of	of	ADP
ct-9352	53	44	both	both	DET
ct-9352	53	45	mother	mother	NOUN
ct-9352	53	46	and	and	CCONJ
ct-9352	53	47	fetus	fetus	NOUN
ct-9352	53	48	.	.	PUNCT
ct-9352	54	1	it	it	PRON
ct-9352	54	2	is	be	AUX
ct-9352	54	3	now	now	ADV
ct-9352	54	4	understood	understand	VERB
ct-9352	54	5	that	that	SCONJ
ct-9352	54	6	this	this	DET
ct-9352	54	7	phenomenon	phenomenon	NOUN
ct-9352	54	8	is	be	AUX
ct-9352	54	9	due	due	ADJ
ct-9352	54	10	to	to	ADP
ct-9352	54	11	fluctuating	fluctuate	VERB
ct-9352	54	12	adaptive	adaptive	ADJ
ct-9352	54	13	immune	immune	ADJ
ct-9352	54	14	system	system	NOUN
ct-9352	54	15	,	,	PUNCT
ct-9352	54	16	specifically	specifically	ADV
ct-9352	54	17	effector	effector	NOUN
ct-9352	54	18	and	and	CCONJ
ct-9352	54	19	regulatory	regulatory	ADJ
ct-9352	54	20	t	t	NOUN
ct-9352	54	21	lymphocytes.58	lymphocytes.58	VERB
ct-9352	54	22	these	these	DET
ct-9352	54	23	immune	immune	ADJ
ct-9352	54	24	cells	cell	NOUN
ct-9352	54	25	are	be	AUX
ct-9352	54	26	both	both	PRON
ct-9352	54	27	crucial	crucial	ADJ
ct-9352	54	28	for	for	ADP
ct-9352	54	29	pregnancy	pregnancy	NOUN
ct-9352	54	30	maintenance	maintenance	NOUN
ct-9352	54	31	and	and	CCONJ
ct-9352	54	32	proper	proper	ADJ
ct-9352	54	33	embryo	embryo	NOUN
ct-9352	54	34	development	development	NOUN
ct-9352	54	35	,	,	PUNCT
ct-9352	54	36	and	and	CCONJ
ct-9352	54	37	also	also	ADV
ct-9352	54	38	essential	essential	ADJ
ct-9352	54	39	for	for	ADP
ct-9352	54	40	responses	response	NOUN
ct-9352	54	41	to	to	PART
ct-9352	54	42	pathogen	pathogen	VERB
ct-9352	54	43	detection.59	detection.59	PROPN
ct-9352	54	44	-	-	PUNCT
ct-9352	54	45	61	61	NUM
ct-9352	54	46	however	however	ADV
ct-9352	54	47	,	,	PUNCT
ct-9352	54	48	many	many	ADJ
ct-9352	54	49	of	of	ADP
ct-9352	54	50	the	the	DET
ct-9352	54	51	signals	signal	NOUN
ct-9352	54	52	necessary	necessary	ADJ
ct-9352	54	53	for	for	ADP
ct-9352	54	54	pathogen	pathogen	NOUN
ct-9352	54	55	recognition	recognition	NOUN
ct-9352	54	56	and	and	CCONJ
ct-9352	54	57	elimination	elimination	NOUN
ct-9352	54	58	are	be	AUX
ct-9352	54	59	similar	similar	ADJ
ct-9352	54	60	to	to	ADP
ct-9352	54	61	the	the	DET
ct-9352	54	62	proinflammatory	proinflammatory	ADJ
ct-9352	54	63	mechanisms	mechanism	NOUN
ct-9352	54	64	preceding	precede	VERB
ct-9352	54	65	parturition	parturition	NOUN
ct-9352	54	66	,	,	PUNCT
ct-9352	54	67	leading	lead	VERB
ct-9352	54	68	to	to	ADP
ct-9352	54	69	an	an	DET
ct-9352	54	70	increased	increase	VERB
ct-9352	54	71	risk	risk	NOUN
ct-9352	54	72	of	of	ADP
ct-9352	54	73	preterm	preterm	ADJ
ct-9352	54	74	labor	labor	NOUN
ct-9352	54	75	or	or	CCONJ
ct-9352	54	76	abortion	abortion	NOUN
ct-9352	54	77	after	after	ADP
ct-9352	54	78	detection	detection	NOUN
ct-9352	54	79	of	of	ADP
ct-9352	54	80	microbes	microbe	NOUN
ct-9352	54	81	in	in	ADP
ct-9352	54	82	the	the	DET
ct-9352	54	83	reproductive	reproductive	ADJ
ct-9352	54	84	tract	tract	NOUN
ct-9352	54	85	during	during	ADP
ct-9352	54	86	pregnancy	pregnancy	NOUN
ct-9352	54	87	.	.	PUNCT
ct-9352	55	1	involvement	involvement	NOUN
ct-9352	55	2	of	of	ADP
ct-9352	55	3	regulatory	regulatory	ADJ
ct-9352	55	4	t	t	NOUN
ct-9352	55	5	cell	cell	NOUN
ct-9352	55	6	(	(	PUNCT
ct-9352	55	7	treg	treg	PROPN
ct-9352	55	8	)	)	PUNCT
ct-9352	55	9	in	in	ADP
ct-9352	55	10	pregnancy	pregnancy	NOUN
ct-9352	55	11	maintenance	maintenance	NOUN
ct-9352	55	12	is	be	AUX
ct-9352	55	13	a	a	DET
ct-9352	55	14	topic	topic	NOUN
ct-9352	55	15	of	of	ADP
ct-9352	55	16	interest	interest	NOUN
ct-9352	55	17	in	in	ADP
ct-9352	55	18	the	the	DET
ct-9352	55	19	development	development	NOUN
ct-9352	55	20	of	of	ADP
ct-9352	55	21	therapeutic	therapeutic	ADJ
ct-9352	55	22	options	option	NOUN
ct-9352	55	23	within	within	ADP
ct-9352	55	24	this	this	DET
ct-9352	55	25	field	field	NOUN
ct-9352	55	26	.	.	PUNCT
ct-9352	56	1	in	in	ADP
ct-9352	56	2	human	human	ADJ
ct-9352	56	3	medicine	medicine	NOUN
ct-9352	56	4	,	,	PUNCT
ct-9352	56	5	several	several	ADJ
ct-9352	56	6	immunomodulators	immunomodulator	NOUN
ct-9352	56	7	that	that	PRON
ct-9352	56	8	heighten	heighten	VERB
ct-9352	56	9	or	or	CCONJ
ct-9352	56	10	mimic	mimic	ADJ
ct-9352	56	11	treg	treg	PROPN
ct-9352	56	12	function	function	PROPN
ct-9352	56	13	are	be	AUX
ct-9352	56	14	currently	currently	ADV
ct-9352	56	15	investigated	investigate	VERB
ct-9352	56	16	for	for	ADP
ct-9352	56	17	their	their	PRON
ct-9352	56	18	ability	ability	NOUN
ct-9352	56	19	to	to	PART
ct-9352	56	20	support	support	VERB
ct-9352	56	21	pregnancy	pregnancy	NOUN
ct-9352	56	22	in	in	ADP
ct-9352	56	23	addition	addition	NOUN
ct-9352	56	24	to	to	ADP
ct-9352	56	25	preventing	prevent	VERB
ct-9352	56	26	placental	placental	ADJ
ct-9352	56	27	infection	infection	NOUN
ct-9352	56	28	and/or	and/or	CCONJ
ct-9352	56	29	preterm	preterm	ADJ
ct-9352	56	30	labor	labor	NOUN
ct-9352	56	31	.	.	PUNCT
ct-9352	57	1	tregs	treg	NOUN
ct-9352	57	2	are	be	AUX
ct-9352	57	3	both	both	PRON
ct-9352	57	4	antiinflammatory	antiinflammatory	NOUN
ct-9352	57	5	and	and	CCONJ
ct-9352	57	6	antiapoptotic	antiapoptotic	ADJ
ct-9352	57	7	,	,	PUNCT
ct-9352	57	8	and	and	CCONJ
ct-9352	57	9	therefore	therefore	ADV
ct-9352	57	10	critical	critical	ADJ
ct-9352	57	11	in	in	ADP
ct-9352	57	12	the	the	DET
ct-9352	57	13	prevention	prevention	NOUN
ct-9352	57	14	of	of	ADP
ct-9352	57	15	effector	effector	NOUN
ct-9352	57	16	-	-	PUNCT
ct-9352	57	17	type	type	NOUN
ct-9352	57	18	immune	immune	ADJ
ct-9352	57	19	responses	response	NOUN
ct-9352	57	20	to	to	ADP
ct-9352	57	21	paternal	paternal	ADJ
ct-9352	57	22	antigens	antigen	NOUN
ct-9352	57	23	present	present	ADJ
ct-9352	57	24	in	in	ADP
ct-9352	57	25	feto	feto	VERB
ct-9352	57	26	-	-	PUNCT
ct-9352	57	27	placental	placental	ADJ
ct-9352	57	28	tissues	tissue	NOUN
ct-9352	57	29	.	.	PUNCT
ct-9352	58	1	limited	limited	ADJ
ct-9352	58	2	research	research	NOUN
ct-9352	58	3	has	have	AUX
ct-9352	58	4	been	be	AUX
ct-9352	58	5	done	do	VERB
ct-9352	58	6	in	in	ADP
ct-9352	58	7	this	this	DET
ct-9352	58	8	field	field	NOUN
ct-9352	58	9	in	in	ADP
ct-9352	58	10	equine	equine	NOUN
ct-9352	58	11	reproduction	reproduction	NOUN
ct-9352	58	12	,	,	PUNCT
ct-9352	58	13	but	but	CCONJ
ct-9352	58	14	it	it	PRON
ct-9352	58	15	is	be	AUX
ct-9352	58	16	a	a	DET
ct-9352	58	17	topic	topic	NOUN
ct-9352	58	18	of	of	ADP
ct-9352	58	19	interest	interest	NOUN
ct-9352	58	20	for	for	ADP
ct-9352	58	21	future	future	ADJ
ct-9352	58	22	research	research	NOUN
ct-9352	58	23	.	.	PUNCT
ct-9352	59	1	we	we	PRON
ct-9352	59	2	review	review	VERB
ct-9352	59	3	the	the	DET
ct-9352	59	4	therapeutic	therapeutic	ADJ
ct-9352	59	5	options	option	NOUN
ct-9352	59	6	currently	currently	ADV
ct-9352	59	7	available	available	ADJ
ct-9352	59	8	for	for	ADP
ct-9352	59	9	equine	equine	NOUN
ct-9352	59	10	practitioners	practitioner	NOUN
ct-9352	59	11	and	and	CCONJ
ct-9352	59	12	identify	identify	VERB
ct-9352	59	13	potential	potential	ADJ
ct-9352	59	14	future	future	ADJ
ct-9352	59	15	targets	target	NOUN
ct-9352	59	16	.	.	PUNCT
ct-9352	60	1	immunomodulators	immunomodulator	NOUN
ct-9352	60	2	for	for	ADP
ct-9352	60	3	pregnancy	pregnancy	NOUN
ct-9352	60	4	maintenance	maintenance	NOUN
ct-9352	60	5	immunomodulation	immunomodulation	NOUN
ct-9352	60	6	for	for	ADP
ct-9352	60	7	improvement	improvement	NOUN
ct-9352	60	8	of	of	ADP
ct-9352	60	9	pregnancy	pregnancy	NOUN
ct-9352	60	10	maintenance	maintenance	NOUN
ct-9352	60	11	has	have	AUX
ct-9352	60	12	been	be	AUX
ct-9352	60	13	attempted	attempt	VERB
ct-9352	60	14	through	through	ADP
ct-9352	60	15	a	a	DET
ct-9352	60	16	variety	variety	NOUN
ct-9352	60	17	of	of	ADP
ct-9352	60	18	avenues	avenue	NOUN
ct-9352	60	19	,	,	PUNCT
ct-9352	60	20	including	include	VERB
ct-9352	60	21	transplanting	transplant	VERB
ct-9352	60	22	lymphocytes	lymphocyte	NOUN
ct-9352	60	23	from	from	ADP
ct-9352	60	24	donor	donor	NOUN
ct-9352	60	25	stallions	stallion	NOUN
ct-9352	60	26	,	,	PUNCT
ct-9352	60	27	in	in	ADP
ct-9352	60	28	addition	addition	NOUN
ct-9352	60	29	to	to	ADP
ct-9352	60	30	stimulation	stimulation	NOUN
ct-9352	60	31	of	of	ADP
ct-9352	60	32	naïve	naïve	ADJ
ct-9352	60	33	lymphocytes	lymphocyte	NOUN
ct-9352	60	34	towards	towards	ADP
ct-9352	60	35	treg	treg	PROPN
ct-9352	60	36	development	development	PROPN
ct-9352	60	37	through	through	ADP
ct-9352	60	38	various	various	ADJ
ct-9352	60	39	cytokines	cytokine	NOUN
ct-9352	60	40	and	and	CCONJ
ct-9352	60	41	biologics	biologic	NOUN
ct-9352	60	42	treatment.62	treatment.62	VERB
ct-9352	60	43	many	many	ADJ
ct-9352	60	44	of	of	ADP
ct-9352	60	45	these	these	DET
ct-9352	60	46	immunomodulators	immunomodulator	NOUN
ct-9352	60	47	(	(	PUNCT
ct-9352	60	48	e.g.	e.g.	ADV
ct-9352	60	49	recombinant	recombinant	ADJ
ct-9352	60	50	granulocyte	granulocyte	ADJ
ct-9352	60	51	-	-	PUNCT
ct-9352	60	52	macrophage	macrophage	ADJ
ct-9352	60	53	colony	colony	NOUN
ct-9352	60	54	-	-	PUNCT
ct-9352	60	55	stimulating	stimulate	VERB
ct-9352	60	56	factor	factor	NOUN
ct-9352	60	57	[	[	X
ct-9352	60	58	filgrastim	filgrastim	NOUN
ct-9352	60	59	]	]	X
ct-9352	60	60	)	)	PUNCT
ct-9352	60	61	or	or	CCONJ
ct-9352	60	62	intravenous	intravenous	ADJ
ct-9352	60	63	immunoglobulin	immunoglobulin	NOUN
ct-9352	60	64	(	(	PUNCT
ct-9352	60	65	plasma	plasma	NOUN
ct-9352	60	66	)	)	PUNCT
ct-9352	60	67	improved	improve	VERB
ct-9352	60	68	success	success	NOUN
ct-9352	60	69	of	of	ADP
ct-9352	60	70	pregnancy	pregnancy	NOUN
ct-9352	60	71	in	in	ADP
ct-9352	60	72	the	the	DET
ct-9352	60	73	human.62	human.62	NOUN
ct-9352	60	74	-	-	PUNCT
ct-9352	60	75	67however	67however	NUM
ct-9352	60	76	,	,	PUNCT
ct-9352	60	77	the	the	DET
ct-9352	60	78	authors	author	NOUN
ct-9352	60	79	are	be	AUX
ct-9352	60	80	not	not	PART
ct-9352	60	81	aware	aware	ADJ
ct-9352	60	82	of	of	ADP
ct-9352	60	83	similar	similar	ADJ
ct-9352	60	84	studies	study	NOUN
ct-9352	60	85	in	in	ADP
ct-9352	60	86	the	the	DET
ct-9352	60	87	horse	horse	NOUN
ct-9352	60	88	.	.	PUNCT
ct-9352	61	1	in	in	ADP
ct-9352	61	2	contrast	contrast	NOUN
ct-9352	61	3	,	,	PUNCT
ct-9352	61	4	some	some	DET
ct-9352	61	5	effort	effort	NOUN
ct-9352	61	6	has	have	AUX
ct-9352	61	7	been	be	AUX
ct-9352	61	8	made	make	VERB
ct-9352	61	9	to	to	PART
ct-9352	61	10	determine	determine	VERB
ct-9352	61	11	the	the	DET
ct-9352	61	12	use	use	NOUN
ct-9352	61	13	of	of	ADP
ct-9352	61	14	lymphocyte	lymphocyte	ADJ
ct-9352	61	15	donation	donation	NOUN
ct-9352	61	16	to	to	PART
ct-9352	61	17	improve	improve	VERB
ct-9352	61	18	pregnancy	pregnancy	NOUN
ct-9352	61	19	maintenance	maintenance	NOUN
ct-9352	61	20	in	in	ADP
ct-9352	61	21	women	woman	NOUN
ct-9352	61	22	and	and	CCONJ
ct-9352	61	23	mares	mare	NOUN
ct-9352	61	24	.	.	PUNCT
ct-9352	62	1	women	woman	NOUN
ct-9352	62	2	experiencing	experience	VERB
ct-9352	62	3	repeated	repeat	VERB
ct-9352	62	4	spontaneous	spontaneous	ADJ
ct-9352	62	5	abortion	abortion	NOUN
ct-9352	62	6	during	during	ADP
ct-9352	62	7	early	early	ADJ
ct-9352	62	8	pregnancy	pregnancy	NOUN
ct-9352	62	9	had	have	AUX
ct-9352	62	10	improved	improve	VERB
ct-9352	62	11	pregnancy	pregnancy	NOUN
ct-9352	62	12	success	success	NOUN
ct-9352	62	13	after	after	ADP
ct-9352	62	14	receiving	receive	VERB
ct-9352	62	15	lymphocyte	lymphocyte	ADJ
ct-9352	62	16	donation	donation	NOUN
ct-9352	62	17	from	from	ADP
ct-9352	62	18	either	either	CCONJ
ct-9352	62	19	the	the	DET
ct-9352	62	20	sperm	sperm	NOUN
ct-9352	62	21	donor	donor	NOUN
ct-9352	62	22	or	or	CCONJ
ct-9352	62	23	a	a	DET
ct-9352	62	24	third	third	ADJ
ct-9352	62	25	-	-	PUNCT
ct-9352	62	26	party	party	NOUN
ct-9352	62	27	donor.68	donor.68	NOUN
ct-9352	62	28	in	in	ADP
ct-9352	62	29	1	1	NUM
ct-9352	62	30	meta	meta	ADJ
ct-9352	62	31	-	-	PUNCT
ct-9352	62	32	analysis	analysis	NOUN
ct-9352	62	33	,	,	PUNCT
ct-9352	62	34	women	woman	NOUN
ct-9352	62	35	receiving	receive	VERB
ct-9352	62	36	lymphocytes	lymphocyte	NOUN
ct-9352	62	37	from	from	ADP
ct-9352	62	38	the	the	DET
ct-9352	62	39	sperm	sperm	NOUN
ct-9352	62	40	donor	donor	NOUN
ct-9352	62	41	had	have	AUX
ct-9352	62	42	improved	improve	VERB
ct-9352	62	43	pregnancy	pregnancy	NOUN
ct-9352	62	44	success	success	NOUN
ct-9352	62	45	by	by	ADP
ct-9352	62	46	68	68	NUM
ct-9352	62	47	%	%	NOUN
ct-9352	62	48	,	,	PUNCT
ct-9352	62	49	whereas	whereas	SCONJ
ct-9352	62	50	women	woman	NOUN
ct-9352	62	51	that	that	PRON
ct-9352	62	52	received	receive	VERB
ct-9352	62	53	lymphocytes	lymphocyte	NOUN
ct-9352	62	54	from	from	ADP
ct-9352	62	55	a	a	DET
ct-9352	62	56	third	third	ADJ
ct-9352	62	57	-	-	PUNCT
ct-9352	62	58	party	party	NOUN
ct-9352	62	59	donor	donor	NOUN
ct-9352	62	60	improved	improve	VERB
ct-9352	62	61	pregnancy	pregnancy	NOUN
ct-9352	62	62	success	success	NOUN
ct-9352	62	63	by	by	ADP
ct-9352	62	64	36	36	NUM
ct-9352	62	65	%	%	NOUN
ct-9352	62	66	.	.	PUNCT
ct-9352	63	1	lymphocyte	lymphocyte	ADJ
ct-9352	63	2	donation	donation	NOUN
ct-9352	63	3	has	have	AUX
ct-9352	63	4	been	be	AUX
ct-9352	63	5	attempted	attempt	VERB
ct-9352	63	6	in	in	ADP
ct-9352	63	7	mares.69	mares.69	ADJ
ct-9352	63	8	autologous	autologous	ADJ
ct-9352	63	9	lymphocyte	lymphocyte	ADJ
ct-9352	63	10	treatment	treatment	NOUN
ct-9352	63	11	improved	improve	VERB
ct-9352	63	12	pregnancy	pregnancy	NOUN
ct-9352	63	13	rates	rate	NOUN
ct-9352	63	14	in	in	ADP
ct-9352	63	15	thoroughbred	thoroughbred	ADJ
ct-9352	63	16	mares	mare	NOUN
ct-9352	63	17	that	that	PRON
ct-9352	63	18	had	have	AUX
ct-9352	63	19	previously	previously	ADV
ct-9352	63	20	experienced	experience	VERB
ct-9352	63	21	early	early	ADJ
ct-9352	63	22	embryonic	embryonic	ADJ
ct-9352	63	23	loss.69	loss.69	NOUN
ct-9352	63	24	in	in	ADP
ct-9352	63	25	a	a	DET
ct-9352	63	26	second	second	ADJ
ct-9352	63	27	study	study	NOUN
ct-9352	63	28	,	,	PUNCT
ct-9352	63	29	lymphocytes	lymphocyte	NOUN
ct-9352	63	30	had	have	VERB
ct-9352	63	31	no	no	DET
ct-9352	63	32	effect	effect	NOUN
ct-9352	63	33	on	on	ADP
ct-9352	63	34	pregnancy	pregnancy	NOUN
ct-9352	63	35	outcome	outcome	NOUN
ct-9352	63	36	.	.	PUNCT
ct-9352	64	1	however	however	ADV
ct-9352	64	2	,	,	PUNCT
ct-9352	64	3	neither	neither	DET
ct-9352	64	4	study	study	NOUN
ct-9352	64	5	had	have	VERB
ct-9352	64	6	a	a	DET
ct-9352	64	7	control	control	NOUN
ct-9352	64	8	group	group	NOUN
ct-9352	64	9	,	,	PUNCT
ct-9352	64	10	so	so	SCONJ
ct-9352	64	11	the	the	DET
ct-9352	64	12	results	result	NOUN
ct-9352	64	13	should	should	AUX
ct-9352	64	14	be	be	AUX
ct-9352	64	15	interpreted	interpret	VERB
ct-9352	64	16	carefully	carefully	ADV
ct-9352	64	17	.	.	PUNCT
ct-9352	65	1	additionally	additionally	ADV
ct-9352	65	2	,	,	PUNCT
ct-9352	65	3	it	it	PRON
ct-9352	65	4	is	be	AUX
ct-9352	65	5	unknown	unknown	ADJ
ct-9352	65	6	what	what	DET
ct-9352	65	7	proportion	proportion	NOUN
ct-9352	65	8	of	of	ADP
ct-9352	65	9	this	this	DET
ct-9352	65	10	lymphocyte	lymphocyte	ADJ
ct-9352	65	11	population	population	NOUN
ct-9352	65	12	clinical	clinical	ADJ
ct-9352	65	13	theriogenology	theriogenology	NOUN
ct-9352	65	14	2021	2021	NUM
ct-9352	65	15	;	;	PUNCT
ct-9352	65	16	13	13	NUM
ct-9352	65	17	:	:	SYM
ct-9352	65	18	241	241	NUM
ct-9352	65	19	were	be	AUX
ct-9352	65	20	effector	effector	NOUN
ct-9352	65	21	or	or	CCONJ
ct-9352	65	22	regulatory	regulatory	ADJ
ct-9352	65	23	lymphocytes	lymphocyte	NOUN
ct-9352	65	24	,	,	PUNCT
ct-9352	65	25	and	and	CCONJ
ct-9352	65	26	the	the	DET
ct-9352	65	27	responses	response	NOUN
ct-9352	65	28	noted	note	VERB
ct-9352	65	29	could	could	AUX
ct-9352	65	30	be	be	AUX
ct-9352	65	31	mitigated	mitigate	VERB
ct-9352	65	32	or	or	CCONJ
ct-9352	65	33	enhanced	enhance	VERB
ct-9352	65	34	if	if	SCONJ
ct-9352	65	35	these	these	DET
ct-9352	65	36	populations	population	NOUN
ct-9352	65	37	were	be	AUX
ct-9352	65	38	altered	alter	VERB
ct-9352	65	39	.	.	PUNCT
ct-9352	66	1	lower	low	ADJ
ct-9352	66	2	percentage	percentage	NOUN
ct-9352	66	3	of	of	ADP
ct-9352	66	4	tregs	treg	NOUN
ct-9352	66	5	during	during	ADP
ct-9352	66	6	estrus	estrus	NOUN
ct-9352	66	7	strongly	strongly	ADV
ct-9352	66	8	correlated	correlate	VERB
ct-9352	66	9	with	with	ADP
ct-9352	66	10	an	an	DET
ct-9352	66	11	increased	increase	VERB
ct-9352	66	12	risk	risk	NOUN
ct-9352	66	13	of	of	ADP
ct-9352	66	14	early	early	ADJ
ct-9352	66	15	embryonic	embryonic	ADJ
ct-9352	66	16	loss,70	loss,70	NOUN
ct-9352	66	17	further	far	ADV
ct-9352	66	18	indicating	indicate	VERB
ct-9352	66	19	the	the	DET
ct-9352	66	20	crucial	crucial	ADJ
ct-9352	66	21	role	role	NOUN
ct-9352	66	22	of	of	ADP
ct-9352	66	23	these	these	DET
ct-9352	66	24	cells	cell	NOUN
ct-9352	66	25	on	on	ADP
ct-9352	66	26	pregnancy	pregnancy	NOUN
ct-9352	66	27	maintenance	maintenance	NOUN
ct-9352	66	28	.	.	PUNCT
ct-9352	67	1	immune	immune	ADJ
ct-9352	67	2	response	response	NOUN
ct-9352	67	3	to	to	ADP
ct-9352	67	4	pregnancy	pregnancy	NOUN
ct-9352	67	5	-	-	PUNCT
ct-9352	67	6	related	relate	VERB
ct-9352	67	7	complications	complication	NOUN
ct-9352	67	8	in	in	ADP
ct-9352	67	9	women	woman	NOUN
ct-9352	67	10	,	,	PUNCT
ct-9352	67	11	the	the	DET
ct-9352	67	12	balance	balance	NOUN
ct-9352	67	13	between	between	ADP
ct-9352	67	14	recognition	recognition	NOUN
ct-9352	67	15	of	of	ADP
ct-9352	67	16	self	self	NOUN
ct-9352	67	17	and	and	CCONJ
ct-9352	67	18	detection	detection	NOUN
ct-9352	67	19	of	of	ADP
ct-9352	67	20	pathogen	pathogen	NOUN
ct-9352	67	21	becomes	become	VERB
ct-9352	67	22	skewed	skewed	ADJ
ct-9352	67	23	preceding	precede	VERB
ct-9352	67	24	numerous	numerous	ADJ
ct-9352	67	25	pregnancy	pregnancy	NOUN
ct-9352	67	26	-	-	PUNCT
ct-9352	67	27	related	relate	VERB
ct-9352	67	28	complications	complication	NOUN
ct-9352	67	29	.	.	PUNCT
ct-9352	68	1	this	this	DET
ct-9352	68	2	alteration	alteration	NOUN
ct-9352	68	3	in	in	ADP
ct-9352	68	4	the	the	DET
ct-9352	68	5	adaptive	adaptive	ADJ
ct-9352	68	6	immune	immune	ADJ
ct-9352	68	7	response	response	NOUN
ct-9352	68	8	is	be	AUX
ct-9352	68	9	most	most	ADV
ct-9352	68	10	noted	note	VERB
ct-9352	68	11	as	as	ADP
ct-9352	68	12	an	an	DET
ct-9352	68	13	increase	increase	NOUN
ct-9352	68	14	in	in	ADP
ct-9352	68	15	activation	activation	NOUN
ct-9352	68	16	/	/	SYM
ct-9352	68	17	recruitment	recruitment	NOUN
ct-9352	68	18	of	of	ADP
ct-9352	68	19	the	the	DET
ct-9352	68	20	proinflammatory	proinflammatory	ADJ
ct-9352	68	21	th17	th17	PROPN
ct-9352	68	22	cells	cell	NOUN
ct-9352	68	23	alongside	alongside	ADP
ct-9352	68	24	a	a	DET
ct-9352	68	25	diminished	diminished	ADJ
ct-9352	68	26	treg	treg	PROPN
ct-9352	68	27	response	response	NOUN
ct-9352	68	28	,	,	PUNCT
ct-9352	68	29	leading	lead	VERB
ct-9352	68	30	to	to	ADP
ct-9352	68	31	rejection	rejection	NOUN
ct-9352	68	32	of	of	ADP
ct-9352	68	33	the	the	DET
ct-9352	68	34	semi	semi	ADJ
ct-9352	68	35	-	-	ADJ
ct-9352	68	36	allogeneic	allogeneic	ADJ
ct-9352	68	37	tissue	tissue	NOUN
ct-9352	68	38	and	and	CCONJ
ct-9352	68	39	eventual	eventual	ADJ
ct-9352	68	40	abortion.59,71	abortion.59,71	NOUN
ct-9352	68	41	-	-	PUNCT
ct-9352	68	42	74	74	NUM
ct-9352	68	43	in	in	ADP
ct-9352	68	44	mares	mare	NOUN
ct-9352	68	45	,	,	PUNCT
ct-9352	68	46	the	the	DET
ct-9352	68	47	leading	lead	VERB
ct-9352	68	48	cause	cause	NOUN
ct-9352	68	49	of	of	ADP
ct-9352	68	50	infectious	infectious	ADJ
ct-9352	68	51	abortion	abortion	NOUN
ct-9352	68	52	is	be	AUX
ct-9352	68	53	placental	placental	ADJ
ct-9352	68	54	infection	infection	NOUN
ct-9352	68	55	,	,	PUNCT
ct-9352	68	56	and	and	CCONJ
ct-9352	68	57	this	this	PRON
ct-9352	68	58	contributes	contribute	VERB
ct-9352	68	59	to	to	ADP
ct-9352	68	60	19	19	NUM
ct-9352	68	61	%	%	NOUN
ct-9352	68	62	of	of	ADP
ct-9352	68	63	all	all	DET
ct-9352	68	64	abortions	abortion	NOUN
ct-9352	68	65	in	in	ADP
ct-9352	68	66	north	north	PROPN
ct-9352	68	67	america.75,76	america.75,76	NOUN
ct-9352	68	68	we	we	PRON
ct-9352	68	69	recently	recently	ADV
ct-9352	68	70	reported77	reported77	VERB
ct-9352	68	71	a	a	DET
ct-9352	68	72	comparable	comparable	ADJ
ct-9352	68	73	adaptive	adaptive	ADJ
ct-9352	68	74	immune	immune	ADJ
ct-9352	68	75	response	response	NOUN
ct-9352	68	76	to	to	ADP
ct-9352	68	77	the	the	DET
ct-9352	68	78	experimental	experimental	ADJ
ct-9352	68	79	induction	induction	NOUN
ct-9352	68	80	of	of	ADP
ct-9352	68	81	ascending	ascend	VERB
ct-9352	68	82	placentitis	placentitis	PROPN
ct-9352	68	83	to	to	ADP
ct-9352	68	84	what	what	PRON
ct-9352	68	85	has	have	AUX
ct-9352	68	86	been	be	AUX
ct-9352	68	87	reported	report	VERB
ct-9352	68	88	in	in	ADP
ct-9352	68	89	women	woman	NOUN
ct-9352	68	90	,	,	PUNCT
ct-9352	68	91	with	with	ADP
ct-9352	68	92	activation	activation	NOUN
ct-9352	68	93	of	of	ADP
ct-9352	68	94	effector	effector	NOUN
ct-9352	68	95	functions	function	NOUN
ct-9352	68	96	of	of	ADP
ct-9352	68	97	the	the	DET
ct-9352	68	98	adaptive	adaptive	ADJ
ct-9352	68	99	immune	immune	ADJ
ct-9352	68	100	system	system	NOUN
ct-9352	68	101	and	and	CCONJ
ct-9352	68	102	suppression	suppression	NOUN
ct-9352	68	103	of	of	ADP
ct-9352	68	104	the	the	DET
ct-9352	68	105	regulatory	regulatory	ADJ
ct-9352	68	106	arm	arm	NOUN
ct-9352	68	107	(	(	PUNCT
ct-9352	68	108	figure	figure	NOUN
ct-9352	68	109	2	2	NUM
ct-9352	68	110	)	)	PUNCT
ct-9352	68	111	.	.	PUNCT
ct-9352	69	1	this	this	PRON
ct-9352	69	2	was	be	AUX
ct-9352	69	3	observed	observe	VERB
ct-9352	69	4	both	both	CCONJ
ct-9352	69	5	locally	locally	ADV
ct-9352	69	6	to	to	ADP
ct-9352	69	7	the	the	DET
ct-9352	69	8	feto	feto	VERB
ct-9352	69	9	-	-	PUNCT
ct-9352	69	10	placental	placental	ADJ
ct-9352	69	11	unit	unit	NOUN
ct-9352	69	12	with	with	ADP
ct-9352	69	13	an	an	DET
ct-9352	69	14	increase	increase	NOUN
ct-9352	69	15	in	in	ADP
ct-9352	69	16	th17related	th17relate	VERB
ct-9352	69	17	transcripts	transcript	NOUN
ct-9352	69	18	,	,	PUNCT
ct-9352	69	19	alongside	alongside	ADP
ct-9352	69	20	dysregulation	dysregulation	NOUN
ct-9352	69	21	of	of	ADP
ct-9352	69	22	treg	treg	PROPN
ct-9352	69	23	-	-	PUNCT
ct-9352	69	24	related	relate	VERB
ct-9352	69	25	transcripts	transcript	NOUN
ct-9352	69	26	.	.	PUNCT
ct-9352	70	1	additionally	additionally	ADV
ct-9352	70	2	,	,	PUNCT
ct-9352	70	3	induction	induction	NOUN
ct-9352	70	4	of	of	ADP
ct-9352	70	5	ascending	ascend	VERB
ct-9352	70	6	placentitis	placentitis	PROPN
ct-9352	70	7	led	lead	VERB
ct-9352	70	8	to	to	ADP
ct-9352	70	9	immune	immune	ADJ
ct-9352	70	10	alterations	alteration	NOUN
ct-9352	70	11	in	in	ADP
ct-9352	70	12	circulation	circulation	NOUN
ct-9352	70	13	,	,	PUNCT
ct-9352	70	14	including	include	VERB
ct-9352	70	15	an	an	DET
ct-9352	70	16	increase	increase	NOUN
ct-9352	70	17	in	in	ADP
ct-9352	70	18	various	various	ADJ
ct-9352	70	19	proinflammatory	proinflammatory	NOUN
ct-9352	70	20	(	(	PUNCT
ct-9352	70	21	il-2	il-2	NUM
ct-9352	70	22	,	,	PUNCT
ct-9352	70	23	ifnγ	ifnγ	NOUN
ct-9352	70	24	)	)	PUNCT
ct-9352	70	25	,	,	PUNCT
ct-9352	70	26	antiinflammatory	antiinflammatory	NOUN
ct-9352	70	27	(	(	PUNCT
ct-9352	70	28	il-5	il-5	NOUN
ct-9352	70	29	,	,	PUNCT
ct-9352	70	30	il-10	il-10	PRON
ct-9352	70	31	)	)	PUNCT
ct-9352	70	32	and	and	CCONJ
ct-9352	70	33	pleiotropic	pleiotropic	ADJ
ct-9352	70	34	cytokines	cytokine	NOUN
ct-9352	70	35	(	(	PUNCT
ct-9352	70	36	il-6	il-6	NUM
ct-9352	70	37	,	,	PUNCT
ct-9352	70	38	tnf	tnf	PROPN
ct-9352	70	39	)	)	PUNCT
ct-9352	70	40	,	,	PUNCT
ct-9352	70	41	with	with	ADP
ct-9352	70	42	il-6	il-6	PRON
ct-9352	70	43	having	have	VERB
ct-9352	70	44	the	the	DET
ct-9352	70	45	highest	high	ADJ
ct-9352	70	46	fold	fold	ADJ
ct-9352	70	47	change	change	NOUN
ct-9352	70	48	of	of	ADP
ct-9352	70	49	among	among	ADP
ct-9352	70	50	the	the	DET
ct-9352	70	51	cytokines	cytokine	NOUN
ct-9352	70	52	investigated.78	investigated.78	VERB
ct-9352	70	53	further	further	ADJ
ct-9352	70	54	research	research	NOUN
ct-9352	70	55	conducted	conduct	VERB
ct-9352	70	56	in	in	ADP
ct-9352	70	57	our	our	PRON
ct-9352	70	58	laboratory	laboratory	NOUN
ct-9352	70	59	suggested	suggest	VERB
ct-9352	70	60	that	that	SCONJ
ct-9352	70	61	the	the	DET
ct-9352	70	62	fetus	fetus	NOUN
ct-9352	70	63	also	also	ADV
ct-9352	70	64	had	have	VERB
ct-9352	70	65	an	an	DET
ct-9352	70	66	active	active	ADJ
ct-9352	70	67	immune	immune	ADJ
ct-9352	70	68	response	response	NOUN
ct-9352	70	69	to	to	ADP
ct-9352	70	70	placentitis	placentitis	PROPN
ct-9352	70	71	and	and	CCONJ
ct-9352	70	72	it	it	PRON
ct-9352	70	73	was	be	AUX
ct-9352	70	74	primarily	primarily	ADV
ct-9352	70	75	characterized	characterize	VERB
ct-9352	70	76	by	by	ADP
ct-9352	70	77	expression	expression	NOUN
ct-9352	70	78	,	,	PUNCT
ct-9352	70	79	production	production	NOUN
ct-9352	70	80	,	,	PUNCT
ct-9352	70	81	and	and	CCONJ
ct-9352	70	82	secretion	secretion	NOUN
ct-9352	70	83	of	of	ADP
ct-9352	70	84	both	both	DET
ct-9352	70	85	antiinflammatory	antiinflammatory	NOUN
ct-9352	70	86	(	(	PUNCT
ct-9352	70	87	il-10	il-10	NUM
ct-9352	70	88	)	)	PUNCT
ct-9352	70	89	and	and	CCONJ
ct-9352	70	90	pleiotropic	pleiotropic	NOUN
ct-9352	70	91	(	(	PUNCT
ct-9352	70	92	il-6	il-6	NUM
ct-9352	70	93	)	)	PUNCT
ct-9352	70	94	cytokines.79	cytokines.79	PROPN
ct-9352	70	95	pleiotropic	pleiotropic	NOUN
ct-9352	70	96	il-6	il-6	PRON
ct-9352	70	97	was	be	AUX
ct-9352	70	98	recently	recently	ADV
ct-9352	70	99	observed	observe	VERB
ct-9352	70	100	to	to	PART
ct-9352	70	101	function	function	VERB
ct-9352	70	102	through	through	ADP
ct-9352	70	103	the	the	DET
ct-9352	70	104	classical	classical	ADJ
ct-9352	70	105	il-6r	il-6r	ADJ
ct-9352	70	106	signaling	signal	VERB
ct-9352	70	107	pathway	pathway	NOUN
ct-9352	70	108	during	during	ADP
ct-9352	70	109	the	the	DET
ct-9352	70	110	pathophysiology	pathophysiology	NOUN
ct-9352	70	111	of	of	ADP
ct-9352	70	112	ascending	ascend	VERB
ct-9352	70	113	placentitis	placentitis	PROPN
ct-9352	70	114	,	,	PUNCT
ct-9352	70	115	leading	lead	VERB
ct-9352	70	116	to	to	ADP
ct-9352	70	117	various	various	ADJ
ct-9352	70	118	downstream	downstream	ADJ
ct-9352	70	119	antiinflammatory	antiinflammatory	NOUN
ct-9352	70	120	effects	effect	NOUN
ct-9352	70	121	,	,	PUNCT
ct-9352	70	122	including	include	VERB
ct-9352	70	123	inhibition	inhibition	NOUN
ct-9352	70	124	of	of	ADP
ct-9352	70	125	apoptosis	apoptosis	NOUN
ct-9352	70	126	and	and	CCONJ
ct-9352	70	127	proliferation	proliferation	NOUN
ct-9352	70	128	of	of	ADP
ct-9352	70	129	epithelial	epithelial	ADJ
ct-9352	70	130	cells.80	cells.80	PROPN
ct-9352	70	131	further	further	ADJ
ct-9352	70	132	work	work	NOUN
ct-9352	70	133	in	in	ADP
ct-9352	70	134	our	our	PRON
ct-9352	70	135	laboratory	laboratory	NOUN
ct-9352	70	136	had	have	VERB
ct-9352	70	137	similar	similar	ADJ
ct-9352	70	138	cytokines	cytokine	NOUN
ct-9352	70	139	increase	increase	NOUN
ct-9352	70	140	during	during	ADP
ct-9352	70	141	both	both	CCONJ
ct-9352	70	142	ascending	ascend	VERB
ct-9352	70	143	and	and	CCONJ
ct-9352	70	144	focal	focal	ADJ
ct-9352	70	145	mucoid	mucoid	ADJ
ct-9352	70	146	placentitis	placentitis	PROPN
ct-9352	70	147	(	(	PUNCT
ct-9352	70	148	the	the	DET
ct-9352	70	149	etiology	etiology	NOUN
ct-9352	70	150	included	include	VERB
ct-9352	70	151	nocardioform	nocardioform	NOUN
ct-9352	70	152	placentitis.81	placentitis.81	PROPN
ct-9352	70	153	)	)	PUNCT
ct-9352	70	154	since	since	SCONJ
ct-9352	70	155	all	all	DET
ct-9352	70	156	mares	mare	NOUN
ct-9352	70	157	investigated	investigate	VERB
ct-9352	70	158	within	within	ADP
ct-9352	70	159	this	this	DET
ct-9352	70	160	study	study	NOUN
ct-9352	70	161	produced	produce	VERB
ct-9352	70	162	a	a	DET
ct-9352	70	163	viable	viable	ADJ
ct-9352	70	164	neonate	neonate	NOUN
ct-9352	70	165	,	,	PUNCT
ct-9352	70	166	additional	additional	ADJ
ct-9352	70	167	research	research	NOUN
ct-9352	70	168	is	be	AUX
ct-9352	70	169	necessary	necessary	ADJ
ct-9352	70	170	to	to	PART
ct-9352	70	171	determine	determine	VERB
ct-9352	70	172	the	the	DET
ct-9352	70	173	profile	profile	NOUN
ct-9352	70	174	of	of	ADP
ct-9352	70	175	these	these	DET
ct-9352	70	176	cytokines	cytokine	NOUN
ct-9352	70	177	preceding	precede	VERB
ct-9352	70	178	abortion	abortion	NOUN
ct-9352	70	179	.	.	PUNCT
ct-9352	71	1	immunomodulation	immunomodulation	NOUN
ct-9352	71	2	of	of	ADP
ct-9352	71	3	pregnancy	pregnancy	NOUN
ct-9352	71	4	-	-	PUNCT
ct-9352	71	5	related	relate	VERB
ct-9352	71	6	complications	complication	NOUN
ct-9352	71	7	a	a	DET
ct-9352	71	8	few	few	ADJ
ct-9352	71	9	experimental	experimental	ADJ
ct-9352	71	10	models	model	NOUN
ct-9352	71	11	exist	exist	VERB
ct-9352	71	12	for	for	ADP
ct-9352	71	13	induction	induction	NOUN
ct-9352	71	14	of	of	ADP
ct-9352	71	15	pregnancy	pregnancy	NOUN
ct-9352	71	16	-	-	PUNCT
ct-9352	71	17	related	relate	VERB
ct-9352	71	18	complications	complication	NOUN
ct-9352	71	19	,	,	PUNCT
ct-9352	71	20	forcing	force	VERB
ct-9352	71	21	inferences	inference	NOUN
ct-9352	71	22	made	make	VERB
ct-9352	71	23	from	from	ADP
ct-9352	71	24	the	the	DET
ct-9352	71	25	experimental	experimental	ADJ
ct-9352	71	26	induction	induction	NOUN
ct-9352	71	27	of	of	ADP
ct-9352	71	28	ascending	ascend	VERB
ct-9352	71	29	placentitis	placentitis	PROPN
ct-9352	71	30	towards	towards	ADP
ct-9352	71	31	various	various	ADJ
ct-9352	71	32	etiologies	etiology	NOUN
ct-9352	71	33	in	in	ADP
ct-9352	71	34	equine	equine	NOUN
ct-9352	71	35	reproduction	reproduction	NOUN
ct-9352	71	36	.	.	PUNCT
ct-9352	72	1	for	for	ADP
ct-9352	72	2	ascending	ascend	VERB
ct-9352	72	3	placentitis	placentitis	PROPN
ct-9352	72	4	,	,	PUNCT
ct-9352	72	5	treatment	treatment	NOUN
ct-9352	72	6	commonly	commonly	ADV
ct-9352	72	7	includes	include	VERB
ct-9352	72	8	an	an	DET
ct-9352	72	9	antimicrobial	antimicrobial	ADJ
ct-9352	72	10	,	,	PUNCT
ct-9352	72	11	progestin	progestin	NOUN
ct-9352	72	12	(	(	PUNCT
ct-9352	72	13	altrenogest	altrenogest	ADV
ct-9352	72	14	;	;	PUNCT
ct-9352	72	15	regu	regu	NOUN
ct-9352	72	16	-	-	PUNCT
ct-9352	72	17	mate	mate	NOUN
ct-9352	72	18	®	®	NOUN
ct-9352	72	19	)	)	PUNCT
ct-9352	72	20	,	,	PUNCT
ct-9352	72	21	and	and	CCONJ
ct-9352	72	22	antiinflammatory	antiinflammatory	NOUN
ct-9352	72	23	(	(	PUNCT
ct-9352	72	24	pentoxifylline	pentoxifylline	NOUN
ct-9352	72	25	and/or	and/or	CCONJ
ct-9352	72	26	nsaid	nsaid	PROPN
ct-9352	72	27	)	)	PUNCT
ct-9352	72	28	agents.82	agents.82	PROPN
ct-9352	72	29	pentoxifylline	pentoxifylline	NOUN
ct-9352	72	30	is	be	AUX
ct-9352	72	31	considered	consider	VERB
ct-9352	72	32	both	both	DET
ct-9352	72	33	antiinflammatory	antiinflammatory	NOUN
ct-9352	72	34	and	and	CCONJ
ct-9352	72	35	anticytokine	anticytokine	NOUN
ct-9352	72	36	,	,	PUNCT
ct-9352	72	37	due	due	ADP
ct-9352	72	38	to	to	ADP
ct-9352	72	39	its	its	PRON
ct-9352	72	40	dual	dual	ADJ
ct-9352	72	41	ability	ability	NOUN
ct-9352	72	42	to	to	PART
ct-9352	72	43	inhibit	inhibit	VERB
ct-9352	72	44	the	the	DET
ct-9352	72	45	nfkβ	nfkβ	NOUN
ct-9352	72	46	pathway	pathway	NOUN
ct-9352	72	47	while	while	SCONJ
ct-9352	72	48	simultaneously	simultaneously	ADV
ct-9352	72	49	acting	act	VERB
ct-9352	72	50	as	as	SCONJ
ct-9352	72	51	both	both	PRON
ct-9352	72	52	antitnf	antitnf	PROPN
ct-9352	72	53	and	and	CCONJ
ct-9352	72	54	antiil-6	antiil-6	PROPN
ct-9352	72	55	,	,	PUNCT
ct-9352	72	56	both	both	PRON
ct-9352	72	57	of	of	ADP
ct-9352	72	58	which	which	PRON
ct-9352	72	59	have	have	AUX
ct-9352	72	60	been	be	AUX
ct-9352	72	61	found	find	VERB
ct-9352	72	62	to	to	PART
ct-9352	72	63	elevate	elevate	VERB
ct-9352	72	64	during	during	ADP
ct-9352	72	65	the	the	DET
ct-9352	72	66	pathophysiology	pathophysiology	NOUN
ct-9352	72	67	of	of	ADP
ct-9352	72	68	ascending	ascend	VERB
ct-9352	72	69	placentitis.83	placentitis.83	PROPN
ct-9352	72	70	however	however	ADV
ct-9352	72	71	,	,	PUNCT
ct-9352	72	72	no	no	DET
ct-9352	72	73	studies	study	NOUN
ct-9352	72	74	have	have	AUX
ct-9352	72	75	investigated	investigate	VERB
ct-9352	72	76	the	the	DET
ct-9352	72	77	role	role	NOUN
ct-9352	72	78	of	of	ADP
ct-9352	72	79	pentoxifylline	pentoxifylline	NOUN
ct-9352	72	80	on	on	ADP
ct-9352	72	81	the	the	DET
ct-9352	72	82	immune	immune	ADJ
ct-9352	72	83	response	response	NOUN
ct-9352	72	84	of	of	ADP
ct-9352	72	85	the	the	DET
ct-9352	72	86	horse	horse	NOUN
ct-9352	72	87	.	.	PUNCT
ct-9352	73	1	additionally	additionally	ADV
ct-9352	73	2	,	,	PUNCT
ct-9352	73	3	although	although	SCONJ
ct-9352	73	4	the	the	DET
ct-9352	73	5	oral	oral	ADJ
ct-9352	73	6	dosage	dosage	NOUN
ct-9352	73	7	utilized	utilize	VERB
ct-9352	73	8	in	in	ADP
ct-9352	73	9	the	the	DET
ct-9352	73	10	present	present	ADJ
ct-9352	73	11	study	study	NOUN
ct-9352	73	12	was	be	AUX
ct-9352	73	13	8.8	8.8	NUM
ct-9352	73	14	mg	mg	PROPN
ct-9352	73	15	/	/	SYM
ct-9352	73	16	kg,84,85	kg,84,85	PROPN
ct-9352	73	17	no	no	DET
ct-9352	73	18	study	study	NOUN
ct-9352	73	19	has	have	AUX
ct-9352	73	20	assessed	assess	VERB
ct-9352	73	21	the	the	DET
ct-9352	73	22	appropriate	appropriate	ADJ
ct-9352	73	23	dose	dose	NOUN
ct-9352	73	24	to	to	PART
ct-9352	73	25	use	use	VERB
ct-9352	73	26	in	in	ADP
ct-9352	73	27	the	the	DET
ct-9352	73	28	horse	horse	NOUN
ct-9352	73	29	,	,	PUNCT
ct-9352	73	30	with	with	ADP
ct-9352	73	31	figure	figure	NOUN
ct-9352	73	32	2	2	NUM
ct-9352	73	33	.	.	NOUN
ct-9352	73	34	overview	overview	NOUN
ct-9352	73	35	of	of	ADP
ct-9352	73	36	dysregulation	dysregulation	NOUN
ct-9352	73	37	th17	th17	PROPN
ct-9352	73	38	/	/	SYM
ct-9352	73	39	treg	treg	PROPN
ct-9352	73	40	response	response	NOUN
ct-9352	73	41	after	after	ADP
ct-9352	73	42	equine	equine	NOUN
ct-9352	73	43	placental	placental	ADJ
ct-9352	73	44	infection	infection	NOUN
ct-9352	73	45	.	.	PUNCT
ct-9352	74	1	equine	equine	NOUN
ct-9352	74	2	ascending	ascend	VERB
ct-9352	74	3	placentitis	placentitis	PROPN
ct-9352	74	4	begins	begin	VERB
ct-9352	74	5	by	by	ADP
ct-9352	74	6	detection	detection	NOUN
ct-9352	74	7	of	of	ADP
ct-9352	74	8	extracellular	extracellular	ADJ
ct-9352	74	9	s.	s.	PROPN
ct-9352	74	10	zooepidemicus	zooepidemicus	PROPN
ct-9352	74	11	that	that	PRON
ct-9352	74	12	is	be	AUX
ct-9352	74	13	recognized	recognize	VERB
ct-9352	74	14	by	by	ADP
ct-9352	74	15	an	an	DET
ct-9352	74	16	antigen	antigen	NOUN
ct-9352	74	17	presenting	present	VERB
ct-9352	74	18	cell	cell	NOUN
ct-9352	74	19	.	.	PUNCT
ct-9352	75	1	this	this	DET
ct-9352	75	2	combination	combination	NOUN
ct-9352	75	3	stimulates	stimulate	VERB
ct-9352	75	4	naïve	naïve	ADJ
ct-9352	75	5	t	t	NOUN
ct-9352	75	6	cells	cell	NOUN
ct-9352	75	7	to	to	PART
ct-9352	75	8	mature	mature	VERB
ct-9352	75	9	into	into	ADP
ct-9352	75	10	th17	th17	PROPN
ct-9352	75	11	cells	cell	NOUN
ct-9352	75	12	through	through	ADP
ct-9352	75	13	activation	activation	NOUN
ct-9352	75	14	of	of	ADP
ct-9352	75	15	various	various	ADJ
ct-9352	75	16	cytokines	cytokine	NOUN
ct-9352	75	17	(	(	PUNCT
ct-9352	75	18	il-6	il-6	NOUN
ct-9352	75	19	and	and	CCONJ
ct-9352	75	20	il-23	il-23	NOUN
ct-9352	75	21	)	)	PUNCT
ct-9352	75	22	,	,	PUNCT
ct-9352	75	23	cell	cell	NOUN
ct-9352	75	24	surface	surface	NOUN
ct-9352	75	25	markers	marker	NOUN
ct-9352	75	26	(	(	PUNCT
ct-9352	75	27	il-1r1	il-1r1	PROPN
ct-9352	75	28	,	,	PUNCT
ct-9352	75	29	il-6r	il-6r	VERB
ct-9352	75	30	,	,	PUNCT
ct-9352	75	31	and	and	CCONJ
ct-9352	75	32	il-21r	il-21r	PROPN
ct-9352	75	33	)	)	PUNCT
ct-9352	75	34	and	and	CCONJ
ct-9352	75	35	transcriptions	transcription	NOUN
ct-9352	75	36	factors	factor	NOUN
ct-9352	75	37	(	(	PUNCT
ct-9352	75	38	stat3	stat3	NOUN
ct-9352	75	39	and	and	CCONJ
ct-9352	75	40	irf4	irf4	PROPN
ct-9352	75	41	)	)	PUNCT
ct-9352	75	42	.	.	PUNCT
ct-9352	76	1	additionally	additionally	ADV
ct-9352	76	2	,	,	PUNCT
ct-9352	76	3	cytokines	cytokine	NOUN
ct-9352	76	4	(	(	PUNCT
ct-9352	76	5	tgf	tgf	PROPN
ct-9352	76	6	-	-	PUNCT
ct-9352	76	7	b	b	NOUN
ct-9352	76	8	)	)	PUNCT
ct-9352	76	9	,	,	PUNCT
ct-9352	76	10	cell	cell	NOUN
ct-9352	76	11	surface	surface	NOUN
ct-9352	76	12	markers	marker	NOUN
ct-9352	76	13	(	(	PUNCT
ct-9352	76	14	lrrc32	lrrc32	X
ct-9352	76	15	/	/	SYM
ct-9352	76	16	garp	garp	NOUN
ct-9352	76	17	)	)	PUNCT
ct-9352	76	18	,	,	PUNCT
ct-9352	76	19	and	and	CCONJ
ct-9352	76	20	transcription	transcription	NOUN
ct-9352	76	21	factors	factor	NOUN
ct-9352	76	22	(	(	PUNCT
ct-9352	76	23	foxp3	foxp3	NOUN
ct-9352	76	24	)	)	PUNCT
ct-9352	76	25	that	that	PRON
ct-9352	76	26	assist	assist	VERB
ct-9352	76	27	in	in	ADP
ct-9352	76	28	the	the	DET
ct-9352	76	29	maturation	maturation	NOUN
ct-9352	76	30	of	of	ADP
ct-9352	76	31	tregs	treg	NOUN
ct-9352	76	32	decreased	decrease	VERB
ct-9352	76	33	after	after	ADP
ct-9352	76	34	detection	detection	NOUN
ct-9352	76	35	of	of	ADP
ct-9352	76	36	pathogen	pathogen	NOUN
ct-9352	76	37	,	,	PUNCT
ct-9352	76	38	potentially	potentially	ADV
ct-9352	76	39	dysregulating	dysregulating	ADJ
ct-9352	76	40	treg	treg	PROPN
ct-9352	76	41	production	production	NOUN
ct-9352	76	42	.	.	PUNCT
ct-9352	77	1	this	this	DET
ct-9352	77	2	imbalance	imbalance	NOUN
ct-9352	77	3	of	of	ADP
ct-9352	77	4	th17	th17	PROPN
ct-9352	77	5	/	/	SYM
ct-9352	77	6	treg	treg	PROPN
ct-9352	77	7	maturation	maturation	PROPN
ct-9352	77	8	precedes	precede	VERB
ct-9352	77	9	abortion	abortion	NOUN
ct-9352	77	10	in	in	ADP
ct-9352	77	11	a	a	DET
ct-9352	77	12	variety	variety	NOUN
ct-9352	77	13	of	of	ADP
ct-9352	77	14	species	specie	NOUN
ct-9352	77	15	and	and	CCONJ
ct-9352	77	16	may	may	AUX
ct-9352	77	17	activate	activate	VERB
ct-9352	77	18	preterm	preterm	ADJ
ct-9352	77	19	parturition	parturition	NOUN
ct-9352	77	20	or	or	CCONJ
ct-9352	77	21	abortion	abortion	NOUN
ct-9352	77	22	in	in	ADP
ct-9352	77	23	the	the	DET
ct-9352	77	24	horse	horse	NOUN
ct-9352	77	25	after	after	ADP
ct-9352	77	26	ascending	ascend	VERB
ct-9352	77	27	placental	placental	ADJ
ct-9352	77	28	infection	infection	NOUN
ct-9352	77	29	.	.	PUNCT
ct-9352	78	1	clinical	clinical	ADJ
ct-9352	78	2	theriogenology	theriogenology	NOUN
ct-9352	78	3	2021	2021	NUM
ct-9352	78	4	;	;	PUNCT
ct-9352	78	5	13	13	NUM
ct-9352	78	6	:	:	SYM
ct-9352	78	7	242	242	NUM
ct-9352	78	8	extrapolations	extrapolation	NOUN
ct-9352	78	9	being	be	AUX
ct-9352	78	10	made	make	VERB
ct-9352	78	11	from	from	ADP
ct-9352	78	12	other	other	ADJ
ct-9352	78	13	species	specie	NOUN
ct-9352	78	14	with	with	ADP
ct-9352	78	15	differing	differ	VERB
ct-9352	78	16	placentation	placentation	NOUN
ct-9352	78	17	.	.	PUNCT
ct-9352	79	1	although	although	SCONJ
ct-9352	79	2	other	other	ADJ
ct-9352	79	3	nsaids	nsaid	NOUN
ct-9352	79	4	have	have	AUX
ct-9352	79	5	been	be	AUX
ct-9352	79	6	evaluated	evaluate	VERB
ct-9352	79	7	for	for	ADP
ct-9352	79	8	their	their	PRON
ct-9352	79	9	efficacy	efficacy	NOUN
ct-9352	79	10	in	in	ADP
ct-9352	79	11	treatment	treatment	NOUN
ct-9352	79	12	of	of	ADP
ct-9352	79	13	placentitis	placentitis	PROPN
ct-9352	79	14	,	,	PUNCT
ct-9352	79	15	none	none	NOUN
ct-9352	79	16	has	have	AUX
ct-9352	79	17	been	be	AUX
ct-9352	79	18	assessed	assess	VERB
ct-9352	79	19	as	as	ADP
ct-9352	79	20	a	a	DET
ct-9352	79	21	sole	sole	ADJ
ct-9352	79	22	modality	modality	NOUN
ct-9352	79	23	;	;	PUNCT
ct-9352	79	24	therefore	therefore	ADV
ct-9352	79	25	,	,	PUNCT
ct-9352	79	26	results	result	NOUN
ct-9352	79	27	should	should	AUX
ct-9352	79	28	be	be	AUX
ct-9352	79	29	interpreted	interpret	VERB
ct-9352	79	30	critically	critically	ADV
ct-9352	79	31	.	.	PUNCT
ct-9352	80	1	clinically	clinically	ADV
ct-9352	80	2	,	,	PUNCT
ct-9352	80	3	twice	twice	ADV
ct-9352	80	4	daily	daily	ADV
ct-9352	80	5	intravenous	intravenous	ADJ
ct-9352	80	6	flunixin	flunixin	NOUN
ct-9352	80	7	(	(	PUNCT
ct-9352	80	8	1	1	NUM
ct-9352	80	9	mg	mg	NUM
ct-9352	80	10	/	/	SYM
ct-9352	80	11	kg	kg	NOUN
ct-9352	80	12	)	)	PUNCT
ct-9352	80	13	and	and	CCONJ
ct-9352	80	14	oral	oral	ADJ
ct-9352	80	15	phenylbutazone	phenylbutazone	NOUN
ct-9352	80	16	(	(	PUNCT
ct-9352	80	17	2.2	2.2	NUM
ct-9352	80	18	4.4	4.4	NUM
ct-9352	80	19	mg	mg	PROPN
ct-9352	80	20	/	/	SYM
ct-9352	80	21	kg	kg	PROPN
ct-9352	80	22	)	)	PUNCT
ct-9352	80	23	,	,	PUNCT
ct-9352	80	24	and	and	CCONJ
ct-9352	80	25	once	once	ADV
ct-9352	80	26	daily	daily	ADJ
ct-9352	80	27	oral	oral	ADJ
ct-9352	80	28	firocoxib	firocoxib	NOUN
ct-9352	80	29	(	(	PUNCT
ct-9352	80	30	57	57	NUM
ct-9352	80	31	mg	mg	NOUN
ct-9352	80	32	)	)	PUNCT
ct-9352	80	33	are	be	AUX
ct-9352	80	34	routinely	routinely	ADV
ct-9352	80	35	used	use	VERB
ct-9352	80	36	,	,	PUNCT
ct-9352	80	37	albeit	albeit	SCONJ
ct-9352	80	38	with	with	ADP
ct-9352	80	39	only	only	ADJ
ct-9352	80	40	limited	limited	ADJ
ct-9352	80	41	data	datum	NOUN
ct-9352	80	42	to	to	PART
ct-9352	80	43	support	support	VERB
ct-9352	80	44	their	their	PRON
ct-9352	80	45	treatment.84	treatment.84	NOUN
ct-9352	80	46	-	-	PUNCT
ct-9352	80	47	88	88	NUM
ct-9352	80	48	flunixin	flunixin	NOUN
ct-9352	80	49	meglumine	meglumine	NOUN
ct-9352	80	50	has	have	AUX
ct-9352	80	51	been	be	AUX
ct-9352	80	52	investigated	investigate	VERB
ct-9352	80	53	in	in	ADP
ct-9352	80	54	conjunction	conjunction	NOUN
ct-9352	80	55	with	with	ADP
ct-9352	80	56	tms	tms	PROPN
ct-9352	80	57	,	,	PUNCT
ct-9352	80	58	altrenogest	altrenogest	NOUN
ct-9352	80	59	,	,	PUNCT
ct-9352	80	60	and	and	CCONJ
ct-9352	80	61	estradiol	estradiol	PROPN
ct-9352	80	62	cypionate.88	cypionate.88	PROPN
ct-9352	80	63	while	while	SCONJ
ct-9352	80	64	the	the	DET
ct-9352	80	65	addition	addition	NOUN
ct-9352	80	66	of	of	ADP
ct-9352	80	67	estradiol	estradiol	PROPN
ct-9352	80	68	cypionate	cypionate	PROPN
ct-9352	80	69	improved	improved	ADJ
ct-9352	80	70	pregnancy	pregnancy	NOUN
ct-9352	80	71	outcomes	outcome	NOUN
ct-9352	80	72	,	,	PUNCT
ct-9352	80	73	flunixin	flunixin	NOUN
ct-9352	80	74	meglumine	meglumine	VERB
ct-9352	80	75	as	as	SCONJ
ct-9352	80	76	a	a	DET
ct-9352	80	77	sole	sole	ADJ
ct-9352	80	78	modality	modality	NOUN
ct-9352	80	79	had	have	AUX
ct-9352	80	80	limited	limit	VERB
ct-9352	80	81	positive	positive	ADJ
ct-9352	80	82	effects	effect	NOUN
ct-9352	80	83	.	.	PUNCT
ct-9352	81	1	firocoxib	firocoxib	PROPN
ct-9352	81	2	has	have	AUX
ct-9352	81	3	also	also	ADV
ct-9352	81	4	been	be	AUX
ct-9352	81	5	used	use	VERB
ct-9352	81	6	along	along	ADP
ct-9352	81	7	with	with	ADP
ct-9352	81	8	altrenogest	altrenogest	NOUN
ct-9352	81	9	and	and	CCONJ
ct-9352	81	10	tms.87	tms.87	VERB
ct-9352	81	11	following	follow	VERB
ct-9352	81	12	treatment	treatment	NOUN
ct-9352	81	13	with	with	ADP
ct-9352	81	14	firocoxib	firocoxib	PROPN
ct-9352	81	15	,	,	PUNCT
ct-9352	81	16	a	a	DET
ct-9352	81	17	substantial	substantial	ADJ
ct-9352	81	18	decrease	decrease	NOUN
ct-9352	81	19	in	in	ADP
ct-9352	81	20	both	both	CCONJ
ct-9352	81	21	il-1β	il-1β	PROPN
ct-9352	81	22	and	and	CCONJ
ct-9352	81	23	il-6	il-6	NOUN
ct-9352	81	24	secretion	secretion	NOUN
ct-9352	81	25	was	be	AUX
ct-9352	81	26	observed	observe	VERB
ct-9352	81	27	.	.	PUNCT
ct-9352	82	1	as	as	SCONJ
ct-9352	82	2	il-6	il-6	NOUN
ct-9352	82	3	has	have	VERB
ct-9352	82	4	a	a	DET
ct-9352	82	5	4	4	NUM
ct-9352	82	6	-	-	ADJ
ct-9352	82	7	fold	fold	ADJ
ct-9352	82	8	increase	increase	NOUN
ct-9352	82	9	following	follow	VERB
ct-9352	82	10	the	the	DET
ct-9352	82	11	induction	induction	NOUN
ct-9352	82	12	of	of	ADP
ct-9352	82	13	ascending	ascend	VERB
ct-9352	82	14	placentitis	placentitis	PROPN
ct-9352	82	15	,	,	PUNCT
ct-9352	82	16	this	this	DET
ct-9352	82	17	suppression	suppression	NOUN
ct-9352	82	18	is	be	AUX
ct-9352	82	19	intriguing	intriguing	ADJ
ct-9352	82	20	and	and	CCONJ
ct-9352	82	21	deserves	deserve	VERB
ct-9352	82	22	further	further	ADJ
ct-9352	82	23	work	work	NOUN
ct-9352	82	24	.	.	PUNCT
ct-9352	83	1	immune	immune	ADJ
ct-9352	83	2	response	response	NOUN
ct-9352	83	3	to	to	ADP
ct-9352	83	4	postpartum	postpartum	NOUN
ct-9352	83	5	involution	involution	NOUN
ct-9352	83	6	equine	equine	NOUN
ct-9352	83	7	pregnancy	pregnancy	NOUN
ct-9352	83	8	lasts	last	VERB
ct-9352	83	9	340	340	NUM
ct-9352	83	10	±	±	NUM
ct-9352	83	11	20	20	NUM
ct-9352	83	12	days;89	days;89	NOUN
ct-9352	83	13	therefore	therefore	ADV
ct-9352	83	14	,	,	PUNCT
ct-9352	83	15	subsequent	subsequent	ADJ
ct-9352	83	16	pregnancy	pregnancy	NOUN
ct-9352	83	17	must	must	AUX
ct-9352	83	18	be	be	AUX
ct-9352	83	19	established	establish	VERB
ct-9352	83	20	within	within	ADP
ct-9352	83	21	the	the	DET
ct-9352	83	22	first	first	ADJ
ct-9352	83	23	month	month	NOUN
ct-9352	83	24	postpartum	postpartum	NOUN
ct-9352	83	25	to	to	PART
ct-9352	83	26	achieve	achieve	VERB
ct-9352	83	27	continued	continued	ADJ
ct-9352	83	28	commercial	commercial	ADJ
ct-9352	83	29	success	success	NOUN
ct-9352	83	30	.	.	PUNCT
ct-9352	84	1	in	in	ADP
ct-9352	84	2	the	the	DET
ct-9352	84	3	mare	mare	NOUN
ct-9352	84	4	,	,	PUNCT
ct-9352	84	5	first	first	ADJ
ct-9352	84	6	postpartum	postpartum	NOUN
ct-9352	84	7	estrus	estrus	NOUN
ct-9352	84	8	occurs	occur	VERB
ct-9352	84	9	from	from	ADP
ct-9352	84	10	7	7	NUM
ct-9352	84	11	16	16	NUM
ct-9352	84	12	days	day	NOUN
ct-9352	84	13	after	after	ADP
ct-9352	84	14	parturition	parturition	NOUN
ct-9352	84	15	and	and	CCONJ
ct-9352	84	16	is	be	AUX
ct-9352	84	17	referred	refer	VERB
ct-9352	84	18	to	to	ADP
ct-9352	84	19	as	as	ADP
ct-9352	84	20	'	'	PUNCT
ct-9352	84	21	foal	foal	NOUN
ct-9352	84	22	heat	heat	NOUN
ct-9352	84	23	'	'	PUNCT
ct-9352	84	24	.	.	PUNCT
ct-9352	85	1	this	this	PRON
ct-9352	85	2	coincides	coincide	VERB
ct-9352	85	3	with	with	ADP
ct-9352	85	4	the	the	DET
ct-9352	85	5	process	process	NOUN
ct-9352	85	6	of	of	ADP
ct-9352	85	7	uterine	uterine	ADJ
ct-9352	85	8	repair	repair	NOUN
ct-9352	85	9	needed	need	VERB
ct-9352	85	10	after	after	ADP
ct-9352	85	11	parturition	parturition	NOUN
ct-9352	85	12	.	.	PUNCT
ct-9352	86	1	uterine	uterine	ADJ
ct-9352	86	2	involution	involution	NOUN
ct-9352	86	3	includes	include	VERB
ct-9352	86	4	reduction	reduction	NOUN
ct-9352	86	5	of	of	ADP
ct-9352	86	6	uterine	uterine	ADJ
ct-9352	86	7	size	size	NOUN
ct-9352	86	8	,	,	PUNCT
ct-9352	86	9	removal	removal	NOUN
ct-9352	86	10	of	of	ADP
ct-9352	86	11	residual	residual	ADJ
ct-9352	86	12	debris	debris	NOUN
ct-9352	86	13	,	,	PUNCT
ct-9352	86	14	contraction	contraction	NOUN
ct-9352	86	15	of	of	ADP
ct-9352	86	16	endometrial	endometrial	ADJ
ct-9352	86	17	glands	gland	NOUN
ct-9352	86	18	,	,	PUNCT
ct-9352	86	19	and	and	CCONJ
ct-9352	86	20	elimination	elimination	NOUN
ct-9352	86	21	of	of	ADP
ct-9352	86	22	lingering	linger	VERB
ct-9352	86	23	immune	immune	ADJ
ct-9352	86	24	cell	cell	NOUN
ct-9352	86	25	types	type	NOUN
ct-9352	86	26	.	.	PUNCT
ct-9352	87	1	it	it	PRON
ct-9352	87	2	takes	take	VERB
ct-9352	87	3	approximately	approximately	ADV
ct-9352	87	4	13	13	NUM
ct-9352	87	5	15	15	NUM
ct-9352	87	6	days	day	NOUN
ct-9352	87	7	and	and	CCONJ
ct-9352	87	8	is	be	AUX
ct-9352	87	9	necessary	necessary	ADJ
ct-9352	87	10	to	to	PART
ct-9352	87	11	ensure	ensure	VERB
ct-9352	87	12	a	a	DET
ct-9352	87	13	uterine	uterine	ADJ
ct-9352	87	14	environment	environment	NOUN
ct-9352	87	15	that	that	PRON
ct-9352	87	16	is	be	AUX
ct-9352	87	17	not	not	PART
ct-9352	87	18	hostile	hostile	ADJ
ct-9352	87	19	to	to	ADP
ct-9352	87	20	the	the	DET
ct-9352	87	21	impending	impending	ADJ
ct-9352	87	22	embryo	embryo	NOUN
ct-9352	87	23	arrival	arrival	NOUN
ct-9352	87	24	.	.	PUNCT
ct-9352	88	1	recent	recent	ADJ
ct-9352	88	2	research	research	NOUN
ct-9352	88	3	from	from	ADP
ct-9352	88	4	our	our	PRON
ct-9352	88	5	laboratory	laboratory	NOUN
ct-9352	88	6	described	describe	VERB
ct-9352	88	7	the	the	DET
ct-9352	88	8	role	role	NOUN
ct-9352	88	9	of	of	ADP
ct-9352	88	10	the	the	DET
ct-9352	88	11	immune	immune	ADJ
ct-9352	88	12	system	system	NOUN
ct-9352	88	13	in	in	ADP
ct-9352	88	14	postpartum	postpartum	NOUN
ct-9352	88	15	involution	involution	NOUN
ct-9352	88	16	.	.	PUNCT
ct-9352	89	1	a	a	DET
ct-9352	89	2	significant	significant	ADJ
ct-9352	89	3	relationship	relationship	NOUN
ct-9352	89	4	was	be	AUX
ct-9352	89	5	noted	note	VERB
ct-9352	89	6	between	between	ADP
ct-9352	89	7	the	the	DET
ct-9352	89	8	day	day	NOUN
ct-9352	89	9	postpartum	postpartum	NOUN
ct-9352	89	10	and	and	CCONJ
ct-9352	89	11	endometrial	endometrial	ADJ
ct-9352	89	12	expression	expression	NOUN
ct-9352	89	13	of	of	ADP
ct-9352	89	14	pleiotropic	pleiotropic	NOUN
ct-9352	89	15	(	(	PUNCT
ct-9352	89	16	il-6	il-6	NOUN
ct-9352	89	17	and	and	CCONJ
ct-9352	89	18	gm	gm	PROPN
ct-9352	89	19	-	-	PUNCT
ct-9352	89	20	csf	csf	NOUN
ct-9352	89	21	)	)	PUNCT
ct-9352	89	22	and	and	CCONJ
ct-9352	89	23	antiinflammatory	antiinflammatory	NOUN
ct-9352	89	24	cytokines	cytokine	NOUN
ct-9352	89	25	(	(	PUNCT
ct-9352	89	26	il-10).90	il-10).90	CCONJ
ct-9352	89	27	expression	expression	NOUN
ct-9352	89	28	was	be	AUX
ct-9352	89	29	highest	high	ADJ
ct-9352	89	30	immediately	immediately	ADV
ct-9352	89	31	postpartum	postpartum	NOUN
ct-9352	89	32	and	and	CCONJ
ct-9352	89	33	then	then	ADV
ct-9352	89	34	declined	decline	VERB
ct-9352	89	35	as	as	SCONJ
ct-9352	89	36	involution	involution	NOUN
ct-9352	89	37	progressed	progress	VERB
ct-9352	89	38	.	.	PUNCT
ct-9352	90	1	this	this	PRON
ct-9352	90	2	coincided	coincide	VERB
ct-9352	90	3	with	with	ADP
ct-9352	90	4	a	a	DET
ct-9352	90	5	decline	decline	NOUN
ct-9352	90	6	in	in	ADP
ct-9352	90	7	both	both	CCONJ
ct-9352	90	8	bacterial	bacterial	ADJ
ct-9352	90	9	growth	growth	NOUN
ct-9352	90	10	and	and	CCONJ
ct-9352	90	11	neutrophilia	neutrophilia	PROPN
ct-9352	90	12	,	,	PUNCT
ct-9352	90	13	indicating	indicate	VERB
ct-9352	90	14	signaling	signal	VERB
ct-9352	90	15	mechanisms	mechanism	NOUN
ct-9352	90	16	required	require	VERB
ct-9352	90	17	to	to	ADP
ct-9352	90	18	disallow	disallow	VERB
ct-9352	90	19	persistent	persistent	ADJ
ct-9352	90	20	inflammation	inflammation	NOUN
ct-9352	90	21	from	from	ADP
ct-9352	90	22	occurring	occur	VERB
ct-9352	90	23	during	during	ADP
ct-9352	90	24	this	this	DET
ct-9352	90	25	physiologic	physiologic	ADJ
ct-9352	90	26	event	event	NOUN
ct-9352	90	27	.	.	PUNCT
ct-9352	91	1	several	several	ADJ
ct-9352	91	2	therapeutics	therapeutic	NOUN
ct-9352	91	3	have	have	AUX
ct-9352	91	4	been	be	AUX
ct-9352	91	5	attempted	attempt	VERB
ct-9352	91	6	to	to	PART
ct-9352	91	7	hasten	hasten	VERB
ct-9352	91	8	this	this	DET
ct-9352	91	9	physiological	physiological	ADJ
ct-9352	91	10	process	process	NOUN
ct-9352	91	11	to	to	PART
ct-9352	91	12	ensure	ensure	VERB
ct-9352	91	13	pregnancy	pregnancy	NOUN
ct-9352	91	14	success	success	NOUN
ct-9352	91	15	,	,	PUNCT
ct-9352	91	16	but	but	CCONJ
ct-9352	91	17	with	with	ADP
ct-9352	91	18	minimal	minimal	ADJ
ct-9352	91	19	success	success	NOUN
ct-9352	91	20	.	.	PUNCT
ct-9352	92	1	we	we	PRON
ct-9352	92	2	review	review	VERB
ct-9352	92	3	the	the	DET
ct-9352	92	4	use	use	NOUN
ct-9352	92	5	of	of	ADP
ct-9352	92	6	immunomodulation	immunomodulation	NOUN
ct-9352	92	7	to	to	PART
ct-9352	92	8	alter	alter	VERB
ct-9352	92	9	involution	involution	NOUN
ct-9352	92	10	and	and	CCONJ
ct-9352	92	11	improve	improve	VERB
ct-9352	92	12	'	'	PUNCT
ct-9352	92	13	foal	foal	NOUN
ct-9352	92	14	heat	heat	NOUN
ct-9352	92	15	'	'	PART
ct-9352	92	16	breeding	breeding	NOUN
ct-9352	92	17	success	success	NOUN
ct-9352	92	18	.	.	PUNCT
ct-9352	93	1	immunomodulation	immunomodulation	NOUN
ct-9352	93	2	of	of	ADP
ct-9352	93	3	postpartum	postpartum	NOUN
ct-9352	93	4	involution	involution	NOUN
ct-9352	93	5	parturition	parturition	NOUN
ct-9352	93	6	enables	enable	VERB
ct-9352	93	7	immense	immense	ADJ
ct-9352	93	8	bacterial	bacterial	ADJ
ct-9352	93	9	invasion	invasion	NOUN
ct-9352	93	10	into	into	ADP
ct-9352	93	11	the	the	DET
ct-9352	93	12	vaginal	vaginal	ADJ
ct-9352	93	13	vault	vault	NOUN
ct-9352	93	14	,	,	PUNCT
ct-9352	93	15	through	through	ADP
ct-9352	93	16	the	the	DET
ct-9352	93	17	relaxed	relaxed	ADJ
ct-9352	93	18	cervical	cervical	ADJ
ct-9352	93	19	canal	canal	NOUN
ct-9352	93	20	and	and	CCONJ
ct-9352	93	21	eventual	eventual	ADJ
ct-9352	93	22	localization	localization	NOUN
ct-9352	93	23	in	in	ADP
ct-9352	93	24	the	the	DET
ct-9352	93	25	uterine	uterine	ADJ
ct-9352	93	26	lumen	luman	NOUN
ct-9352	93	27	and	and	CCONJ
ct-9352	93	28	endometrium	endometrium	NOUN
ct-9352	93	29	.	.	PUNCT
ct-9352	94	1	this	this	PRON
ct-9352	94	2	leads	lead	VERB
ct-9352	94	3	to	to	ADP
ct-9352	94	4	increased	increase	VERB
ct-9352	94	5	neutrophilia	neutrophilia	PROPN
ct-9352	94	6	and	and	CCONJ
ct-9352	94	7	the	the	DET
ct-9352	94	8	potential	potential	NOUN
ct-9352	94	9	for	for	ADP
ct-9352	94	10	persistent	persistent	ADJ
ct-9352	94	11	inflammation/	inflammation/	NUM
ct-9352	94	12	infection	infection	NOUN
ct-9352	94	13	that	that	PRON
ct-9352	94	14	may	may	AUX
ct-9352	94	15	hinder	hinder	VERB
ct-9352	94	16	future	future	ADJ
ct-9352	94	17	fertility	fertility	NOUN
ct-9352	94	18	postpartum	postpartum	NOUN
ct-9352	94	19	.	.	PUNCT
ct-9352	95	1	intravenous	intravenous	ADJ
ct-9352	95	2	mcwf	mcwf	NOUN
ct-9352	95	3	(	(	PUNCT
ct-9352	95	4	1.5	1.5	NUM
ct-9352	95	5	mg	mg	NOUN
ct-9352	95	6	;	;	PUNCT
ct-9352	95	7	settle	settle	NOUN
ct-9352	95	8	®	®	NOUN
ct-9352	95	9	)	)	PUNCT
ct-9352	95	10	treatment	treatment	NOUN
ct-9352	95	11	administered	administer	VERB
ct-9352	95	12	24	24	NUM
ct-9352	95	13	hours	hour	NOUN
ct-9352	95	14	after	after	SCONJ
ct-9352	95	15	parturition	parturition	NOUN
ct-9352	95	16	improved	improve	VERB
ct-9352	95	17	'	'	PUNCT
ct-9352	95	18	foal	foal	NOUN
ct-9352	95	19	heat	heat	NOUN
ct-9352	95	20	'	'	PART
ct-9352	95	21	breeding	breeding	NOUN
ct-9352	95	22	success	success	NOUN
ct-9352	95	23	and	and	CCONJ
ct-9352	95	24	substantially	substantially	ADV
ct-9352	95	25	decreased	decrease	VERB
ct-9352	95	26	both	both	DET
ct-9352	95	27	bacterial	bacterial	ADJ
ct-9352	95	28	presence	presence	NOUN
ct-9352	95	29	and	and	CCONJ
ct-9352	95	30	magnitude	magnitude	NOUN
ct-9352	95	31	of	of	ADP
ct-9352	95	32	neutrophilia.91	neutrophilia.91	X
ct-9352	95	33	additional	additional	ADJ
ct-9352	95	34	studies	study	NOUN
ct-9352	95	35	(	(	PUNCT
ct-9352	95	36	1.5	1.5	NUM
ct-9352	95	37	mg	mg	NOUN
ct-9352	95	38	iv	iv	NUM
ct-9352	95	39	mcwf	mcwf	ADJ
ct-9352	95	40	treatment	treatment	NOUN
ct-9352	95	41	at	at	ADP
ct-9352	95	42	24	24	NUM
ct-9352	95	43	hours	hour	NOUN
ct-9352	95	44	and	and	CCONJ
ct-9352	95	45	at	at	ADP
ct-9352	95	46	7	7	NUM
ct-9352	95	47	days	day	NOUN
ct-9352	95	48	postpartum	postpartum	NOUN
ct-9352	95	49	)	)	PUNCT
ct-9352	95	50	increased	increase	VERB
ct-9352	95	51	endometrial	endometrial	ADJ
ct-9352	95	52	expression	expression	NOUN
ct-9352	95	53	of	of	ADP
ct-9352	95	54	proinflammatory	proinflammatory	ADJ
ct-9352	95	55	cytokines	cytokine	NOUN
ct-9352	95	56	(	(	PUNCT
ct-9352	95	57	il-1β	il-1β	NOUN
ct-9352	95	58	and	and	CCONJ
ct-9352	95	59	ifnγ).90	ifnγ).90	ADP
ct-9352	95	60	as	as	SCONJ
ct-9352	95	61	these	these	DET
ct-9352	95	62	cytokines	cytokine	NOUN
ct-9352	95	63	are	be	AUX
ct-9352	95	64	essential	essential	ADJ
ct-9352	95	65	for	for	ADP
ct-9352	95	66	the	the	DET
ct-9352	95	67	recruitment	recruitment	NOUN
ct-9352	95	68	and	and	CCONJ
ct-9352	95	69	chemotaxis	chemotaxis	NOUN
ct-9352	95	70	of	of	ADP
ct-9352	95	71	necessary	necessary	ADJ
ct-9352	95	72	immune	immune	ADJ
ct-9352	95	73	cells	cell	NOUN
ct-9352	95	74	for	for	ADP
ct-9352	95	75	bacterial	bacterial	ADJ
ct-9352	95	76	degradation	degradation	NOUN
ct-9352	95	77	and	and	CCONJ
ct-9352	95	78	clearance	clearance	NOUN
ct-9352	95	79	,	,	PUNCT
ct-9352	95	80	it	it	PRON
ct-9352	95	81	was	be	AUX
ct-9352	95	82	not	not	PART
ct-9352	95	83	surprising	surprising	ADJ
ct-9352	95	84	that	that	SCONJ
ct-9352	95	85	this	this	DET
ct-9352	95	86	increase	increase	NOUN
ct-9352	95	87	coincided	coincide	VERB
ct-9352	95	88	with	with	ADP
ct-9352	95	89	a	a	DET
ct-9352	95	90	reduction	reduction	NOUN
ct-9352	95	91	in	in	ADP
ct-9352	95	92	the	the	DET
ct-9352	95	93	severity	severity	NOUN
ct-9352	95	94	of	of	ADP
ct-9352	95	95	bacterial	bacterial	ADJ
ct-9352	95	96	growth	growth	NOUN
ct-9352	95	97	,	,	PUNCT
ct-9352	95	98	in	in	ADP
ct-9352	95	99	addition	addition	NOUN
ct-9352	95	100	to	to	ADP
ct-9352	95	101	decreasing	decrease	VERB
ct-9352	95	102	days	day	NOUN
ct-9352	95	103	required	require	VERB
ct-9352	95	104	for	for	ADP
ct-9352	95	105	a	a	DET
ct-9352	95	106	clean	clean	ADJ
ct-9352	95	107	culture	culture	NOUN
ct-9352	95	108	.	.	PUNCT
ct-9352	96	1	conclusion	conclusion	NOUN
ct-9352	96	2	reproductive	reproductive	ADJ
ct-9352	96	3	immunology	immunology	NOUN
ct-9352	96	4	is	be	AUX
ct-9352	96	5	constantly	constantly	ADV
ct-9352	96	6	advancing	advance	VERB
ct-9352	96	7	our	our	PRON
ct-9352	96	8	understanding	understanding	NOUN
ct-9352	96	9	of	of	ADP
ct-9352	96	10	mare	mare	NOUN
ct-9352	96	11	physiology	physiology	NOUN
ct-9352	96	12	.	.	PUNCT
ct-9352	97	1	continued	continue	VERB
ct-9352	97	2	work	work	NOUN
ct-9352	97	3	is	be	AUX
ct-9352	97	4	necessary	necessary	ADJ
ct-9352	97	5	to	to	PART
ct-9352	97	6	further	far	ADV
ct-9352	97	7	elucidate	elucidate	VERB
ct-9352	97	8	the	the	DET
ct-9352	97	9	pathophysiology	pathophysiology	NOUN
ct-9352	97	10	of	of	ADP
ct-9352	97	11	several	several	ADJ
ct-9352	97	12	diseases	disease	NOUN
ct-9352	97	13	and	and	CCONJ
ct-9352	97	14	disorders	disorder	NOUN
ct-9352	97	15	associated	associate	VERB
ct-9352	97	16	with	with	ADP
ct-9352	97	17	equine	equine	NOUN
ct-9352	97	18	reproduction	reproduction	NOUN
ct-9352	97	19	,	,	PUNCT
ct-9352	97	20	including	include	VERB
ct-9352	97	21	breeding	breed	VERB
ct-9352	97	22	-	-	PUNCT
ct-9352	97	23	induced	induce	VERB
ct-9352	97	24	inflammation	inflammation	NOUN
ct-9352	97	25	,	,	PUNCT
ct-9352	97	26	immune	immune	ADJ
ct-9352	97	27	tolerance	tolerance	NOUN
ct-9352	97	28	of	of	ADP
ct-9352	97	29	the	the	DET
ct-9352	97	30	semi	semi	ADJ
ct-9352	97	31	-	-	ADJ
ct-9352	97	32	allogeneic	allogeneic	ADJ
ct-9352	97	33	fetus	fetus	NOUN
ct-9352	97	34	,	,	PUNCT
ct-9352	97	35	immune	immune	ADJ
ct-9352	97	36	responses	response	NOUN
ct-9352	97	37	to	to	ADP
ct-9352	97	38	pregnancy	pregnancy	NOUN
ct-9352	97	39	-	-	PUNCT
ct-9352	97	40	related	relate	VERB
ct-9352	97	41	complications	complication	NOUN
ct-9352	97	42	,	,	PUNCT
ct-9352	97	43	and	and	CCONJ
ct-9352	97	44	immune	immune	NOUN
ct-9352	97	45	-	-	PUNCT
ct-9352	97	46	mediated	mediate	VERB
ct-9352	97	47	response	response	NOUN
ct-9352	97	48	to	to	ADP
ct-9352	97	49	parturition	parturition	NOUN
ct-9352	97	50	.	.	PUNCT
ct-9352	98	1	as	as	ADP
ct-9352	98	2	our	our	PRON
ct-9352	98	3	understanding	understanding	NOUN
ct-9352	98	4	of	of	ADP
ct-9352	98	5	this	this	DET
ct-9352	98	6	physiology	physiology	NOUN
ct-9352	98	7	broadens	broaden	VERB
ct-9352	98	8	,	,	PUNCT
ct-9352	98	9	inferences	inference	NOUN
ct-9352	98	10	can	can	AUX
ct-9352	98	11	be	be	AUX
ct-9352	98	12	made	make	VERB
ct-9352	98	13	towards	towards	ADP
ct-9352	98	14	several	several	ADJ
ct-9352	98	15	immunomodulators	immunomodulator	NOUN
ct-9352	98	16	that	that	PRON
ct-9352	98	17	may	may	AUX
ct-9352	98	18	improve	improve	VERB
ct-9352	98	19	these	these	DET
ct-9352	98	20	processes	process	NOUN
ct-9352	98	21	,	,	PUNCT
ct-9352	98	22	thereby	thereby	ADV
ct-9352	98	23	advancing	advance	VERB
ct-9352	98	24	mare	mare	NOUN
ct-9352	98	25	reproductive	reproductive	ADJ
ct-9352	98	26	performance	performance	NOUN
ct-9352	98	27	.	.	PUNCT
ct-9352	99	1	conflict	conflict	NOUN
ct-9352	99	2	of	of	ADP
ct-9352	99	3	interest	interest	NOUN
ct-9352	99	4	authors	author	NOUN
ct-9352	99	5	have	have	VERB
ct-9352	99	6	no	no	DET
ct-9352	99	7	affiliations	affiliation	NOUN
ct-9352	99	8	,	,	PUNCT
ct-9352	99	9	memberships	membership	NOUN
ct-9352	99	10	,	,	PUNCT
ct-9352	99	11	funding	funding	NOUN
ct-9352	99	12	,	,	PUNCT
ct-9352	99	13	or	or	CCONJ
ct-9352	99	14	financial	financial	ADJ
ct-9352	99	15	holdings	holding	NOUN
ct-9352	99	16	that	that	PRON
ct-9352	99	17	might	might	AUX
ct-9352	99	18	be	be	AUX
ct-9352	99	19	perceived	perceive	VERB
ct-9352	99	20	as	as	ADP
ct-9352	99	21	affecting	affect	VERB
ct-9352	99	22	the	the	DET
ct-9352	99	23	objectivity	objectivity	NOUN
ct-9352	99	24	of	of	ADP
ct-9352	99	25	this	this	DET
ct-9352	99	26	review	review	NOUN
ct-9352	99	27	.	.	PUNCT
ct-9352	100	1	references	reference	NOUN
ct-9352	100	2	1	1	NUM
ct-9352	100	3	.	.	PUNCT
ct-9352	100	4	rohrbach	rohrbach	PROPN
ct-9352	100	5	bw	bw	PROPN
ct-9352	100	6	,	,	PUNCT
ct-9352	100	7	sheerin	sheerin	NOUN
ct-9352	100	8	pc	pc	NOUN
ct-9352	100	9	,	,	PUNCT
ct-9352	100	10	cantrell	cantrell	PROPN
ct-9352	100	11	ck	ck	PROPN
ct-9352	100	12	,	,	PUNCT
ct-9352	100	13	et	et	PROPN
ct-9352	100	14	al	al	PROPN
ct-9352	100	15	:	:	PUNCT
ct-9352	100	16	effect	effect	NOUN
ct-9352	100	17	of	of	ADP
ct-9352	100	18	adjunctive	adjunctive	ADJ
ct-9352	100	19	treatment	treatment	NOUN
ct-9352	100	20	with	with	ADP
ct-9352	100	21	intravenously	intravenously	ADV
ct-9352	100	22	administered	administer	VERB
ct-9352	100	23	propionibacterium	propionibacterium	NOUN
ct-9352	100	24	acnes	acne	NOUN
ct-9352	100	25	on	on	ADP
ct-9352	100	26	reproductive	reproductive	ADJ
ct-9352	100	27	performance	performance	NOUN
ct-9352	100	28	in	in	ADP
ct-9352	100	29	mares	mare	NOUN
ct-9352	100	30	with	with	ADP
ct-9352	100	31	persistent	persistent	ADJ
ct-9352	100	32	endometritis	endometritis	NOUN
ct-9352	100	33	.	.	PUNCT
ct-9352	101	1	j	j	PROPN
ct-9352	101	2	am	be	AUX
ct-9352	101	3	vet	vet	NOUN
ct-9352	101	4	med	med	ADJ
ct-9352	101	5	assoc	assoc	PROPN
ct-9352	101	6	2007;231:107	2007;231:107	PROPN
ct-9352	101	7	-	-	SYM
ct-9352	101	8	113	113	NUM
ct-9352	101	9	.	.	PUNCT
ct-9352	102	1	2	2	X
ct-9352	102	2	.	.	X
ct-9352	102	3	janeway	janeway	PROPN
ct-9352	102	4	ca	ca	PROPN
ct-9352	102	5	,	,	PUNCT
ct-9352	102	6	jr	jr	PROPN
ct-9352	102	7	.	.	PROPN
ct-9352	102	8	,	,	PUNCT
ct-9352	102	9	medzhitov	medzhitov	ADJ
ct-9352	102	10	r	r	NOUN
ct-9352	102	11	:	:	PUNCT
ct-9352	102	12	innate	innate	ADJ
ct-9352	102	13	immune	immune	ADJ
ct-9352	102	14	recognition	recognition	NOUN
ct-9352	102	15	.	.	PUNCT
ct-9352	103	1	annu	annu	PROPN
ct-9352	103	2	rev	rev	VERB
ct-9352	103	3	immunol	immunol	NOUN
ct-9352	103	4	2002;20:197	2002;20:197	PROPN
ct-9352	103	5	-	-	SYM
ct-9352	103	6	216	216	NUM
ct-9352	103	7	.	.	PUNCT
ct-9352	104	1	3	3	X
ct-9352	104	2	.	.	X
ct-9352	104	3	troedsson	troedsson	PROPN
ct-9352	105	1	mh	mh	PROPN
ct-9352	105	2	:	:	PUNCT
ct-9352	105	3	uterine	uterine	ADJ
ct-9352	105	4	clearance	clearance	NOUN
ct-9352	105	5	and	and	CCONJ
ct-9352	105	6	resistance	resistance	NOUN
ct-9352	105	7	to	to	ADP
ct-9352	105	8	persistent	persistent	ADJ
ct-9352	105	9	endometritis	endometritis	NOUN
ct-9352	105	10	in	in	ADP
ct-9352	105	11	the	the	DET
ct-9352	105	12	mare	mare	NOUN
ct-9352	105	13	.	.	PUNCT
ct-9352	106	1	theriogenology	theriogenology	NOUN
ct-9352	106	2	1999;52:461	1999;52:461	PROPN
ct-9352	106	3	-	-	SYM
ct-9352	106	4	471	471	NUM
ct-9352	106	5	.	.	NOUN
ct-9352	107	1	4	4	NUM
ct-9352	107	2	.	.	X
ct-9352	107	3	troedsson	troedsson	PROPN
ct-9352	107	4	mh	mh	PROPN
ct-9352	107	5	,	,	PUNCT
ct-9352	107	6	liu	liu	PROPN
ct-9352	107	7	ik	ik	PROPN
ct-9352	107	8	,	,	PUNCT
ct-9352	107	9	thurmond	thurmond	PROPN
ct-9352	107	10	m	m	PROPN
ct-9352	107	11	:	:	PUNCT
ct-9352	107	12	immunoglobulin	immunoglobulin	PROPN
ct-9352	107	13	(	(	PUNCT
ct-9352	107	14	igg	igg	PROPN
ct-9352	107	15	and	and	CCONJ
ct-9352	107	16	iga	iga	PROPN
ct-9352	107	17	)	)	PUNCT
ct-9352	107	18	and	and	CCONJ
ct-9352	107	19	complement	complement	NOUN
ct-9352	107	20	(	(	PUNCT
ct-9352	107	21	c3	c3	PROPN
ct-9352	107	22	)	)	PUNCT
ct-9352	107	23	concentrations	concentration	NOUN
ct-9352	107	24	in	in	ADP
ct-9352	107	25	uterine	uterine	ADJ
ct-9352	107	26	secretion	secretion	NOUN
ct-9352	107	27	following	follow	VERB
ct-9352	107	28	an	an	DET
ct-9352	107	29	intrauterine	intrauterine	ADJ
ct-9352	107	30	challenge	challenge	NOUN
ct-9352	107	31	of	of	ADP
ct-9352	107	32	streptococcus	streptococcus	NOUN
ct-9352	107	33	zooepidemicus	zooepidemicus	NOUN
ct-9352	107	34	in	in	ADP
ct-9352	107	35	mares	mare	NOUN
ct-9352	107	36	susceptible	susceptible	ADJ
ct-9352	107	37	to	to	ADP
ct-9352	107	38	versus	versus	X
ct-9352	107	39	resistant	resistant	ADJ
ct-9352	107	40	to	to	ADP
ct-9352	107	41	chronic	chronic	VERB
ct-9352	107	42	uterine	uterine	ADJ
ct-9352	107	43	infection	infection	NOUN
ct-9352	107	44	.	.	PUNCT
ct-9352	108	1	biol	biol	PROPN
ct-9352	108	2	reprod	reprod	PROPN
ct-9352	108	3	1993;49:502	1993;49:502	PROPN
ct-9352	108	4	-	-	PUNCT
ct-9352	108	5	506	506	NUM
ct-9352	108	6	.	.	NOUN
ct-9352	109	1	5	5	NUM
ct-9352	109	2	.	.	X
ct-9352	109	3	troedsson	troedsson	PROPN
ct-9352	109	4	mh	mh	PROPN
ct-9352	109	5	,	,	PUNCT
ct-9352	109	6	loset	loset	PROPN
ct-9352	109	7	k	k	NOUN
ct-9352	109	8	,	,	PUNCT
ct-9352	109	9	alghamdi	alghamdi	NOUN
ct-9352	109	10	am	am	PROPN
ct-9352	109	11	,	,	PUNCT
ct-9352	109	12	et	et	PROPN
ct-9352	109	13	al	al	PROPN
ct-9352	109	14	:	:	PUNCT
ct-9352	109	15	interaction	interaction	NOUN
ct-9352	109	16	between	between	ADP
ct-9352	109	17	equine	equine	NOUN
ct-9352	109	18	semen	seman	NOUN
ct-9352	109	19	and	and	CCONJ
ct-9352	109	20	the	the	DET
ct-9352	109	21	endometrium	endometrium	NOUN
ct-9352	109	22	:	:	PUNCT
ct-9352	109	23	the	the	DET
ct-9352	109	24	inflammatory	inflammatory	ADJ
ct-9352	109	25	response	response	NOUN
ct-9352	109	26	to	to	ADP
ct-9352	109	27	semen	semen	NOUN
ct-9352	109	28	.	.	PUNCT
ct-9352	110	1	anim	anim	NOUN
ct-9352	110	2	reprod	reprod	PROPN
ct-9352	110	3	sci	sci	PROPN
ct-9352	110	4	2001;68:273	2001;68:273	PROPN
ct-9352	110	5	-	-	PUNCT
ct-9352	110	6	278	278	NUM
ct-9352	110	7	.	.	PUNCT
ct-9352	110	8	5	5	NUM
ct-9352	110	9	.	.	X
ct-9352	110	10	christoffersen	christoffersen	PROPN
ct-9352	110	11	m	m	PROPN
ct-9352	110	12	,	,	PUNCT
ct-9352	110	13	woodward	woodward	PROPN
ct-9352	110	14	e	e	PROPN
ct-9352	110	15	,	,	PUNCT
ct-9352	110	16	bojesen	bojesen	PROPN
ct-9352	110	17	am	am	PROPN
ct-9352	110	18	,	,	PUNCT
ct-9352	110	19	et	et	PROPN
ct-9352	110	20	al	al	PROPN
ct-9352	110	21	:	:	PUNCT
ct-9352	110	22	inflammatory	inflammatory	ADJ
ct-9352	110	23	responses	response	NOUN
ct-9352	110	24	to	to	AUX
ct-9352	110	25	induced	induce	VERB
ct-9352	110	26	infectious	infectious	ADJ
ct-9352	110	27	endometritis	endometritis	NOUN
ct-9352	110	28	in	in	ADP
ct-9352	110	29	mares	mare	NOUN
ct-9352	110	30	resistant	resistant	ADJ
ct-9352	110	31	or	or	CCONJ
ct-9352	110	32	susceptible	susceptible	ADJ
ct-9352	110	33	to	to	ADP
ct-9352	110	34	persistent	persistent	ADJ
ct-9352	110	35	endometritis	endometritis	NOUN
ct-9352	110	36	.	.	PUNCT
ct-9352	111	1	bmc	bmc	PROPN
ct-9352	111	2	vet	vet	NOUN
ct-9352	111	3	res	re	NOUN
ct-9352	111	4	2012;8:41	2012;8:41	NOUN
ct-9352	111	5	.	.	PUNCT
ct-9352	112	1	7	7	X
ct-9352	112	2	.	.	X
ct-9352	112	3	fedorka	fedorka	PROPN
ct-9352	112	4	ce	ce	PROPN
ct-9352	112	5	,	,	PUNCT
ct-9352	112	6	scoggin	scoggin	VERB
ct-9352	112	7	ke	ke	PROPN
ct-9352	112	8	,	,	PUNCT
ct-9352	112	9	woodward	woodward	NOUN
ct-9352	112	10	em	em	PRON
ct-9352	112	11	,	,	PUNCT
ct-9352	112	12	et	et	PROPN
ct-9352	112	13	al	al	PROPN
ct-9352	112	14	:	:	PUNCT
ct-9352	112	15	the	the	DET
ct-9352	112	16	effect	effect	NOUN
ct-9352	112	17	of	of	ADP
ct-9352	112	18	select	select	ADJ
ct-9352	112	19	seminal	seminal	ADJ
ct-9352	112	20	plasma	plasma	NOUN
ct-9352	112	21	proteins	protein	NOUN
ct-9352	112	22	on	on	ADP
ct-9352	112	23	endometrial	endometrial	ADJ
ct-9352	112	24	mrna	mrna	NOUN
ct-9352	112	25	cytokine	cytokine	NOUN
ct-9352	112	26	expression	expression	NOUN
ct-9352	112	27	clinical	clinical	ADJ
ct-9352	112	28	theriogenology	theriogenology	NOUN
ct-9352	112	29	2021	2021	NUM
ct-9352	112	30	;	;	PUNCT
ct-9352	112	31	13	13	NUM
ct-9352	112	32	:	:	SYM
ct-9352	112	33	243	243	NUM
ct-9352	112	34	in	in	ADP
ct-9352	112	35	mares	mare	NOUN
ct-9352	112	36	susceptible	susceptible	ADJ
ct-9352	112	37	to	to	ADP
ct-9352	112	38	persistent	persistent	ADJ
ct-9352	112	39	mating	mating	NOUN
ct-9352	112	40	-	-	PUNCT
ct-9352	112	41	induced	induce	VERB
ct-9352	112	42	endometritis	endometritis	NOUN
ct-9352	112	43	.	.	PUNCT
ct-9352	113	1	reprod	reprod	PROPN
ct-9352	113	2	domest	domest	PROPN
ct-9352	113	3	anim	anim	NOUN
ct-9352	113	4	2016;52:89	2016;52:89	NUM
ct-9352	113	5	-	-	SYM
ct-9352	113	6	96	96	NUM
ct-9352	113	7	.	.	NOUN
ct-9352	113	8	8	8	NUM
ct-9352	113	9	.	.	X
ct-9352	114	1	woodward	woodward	PROPN
ct-9352	114	2	em	em	PRON
ct-9352	114	3	,	,	PUNCT
ct-9352	114	4	christoffersen	christoffersen	VERB
ct-9352	114	5	m	m	PROPN
ct-9352	114	6	,	,	PUNCT
ct-9352	114	7	campos	campos	PROPN
ct-9352	114	8	j	j	PROPN
ct-9352	114	9	,	,	PUNCT
ct-9352	114	10	et	et	PROPN
ct-9352	114	11	al	al	PROPN
ct-9352	114	12	:	:	PUNCT
ct-9352	114	13	endometrial	endometrial	ADJ
ct-9352	114	14	inflammatory	inflammatory	ADJ
ct-9352	114	15	markers	marker	NOUN
ct-9352	114	16	of	of	ADP
ct-9352	114	17	the	the	DET
ct-9352	114	18	early	early	ADJ
ct-9352	114	19	immune	immune	ADJ
ct-9352	114	20	response	response	NOUN
ct-9352	114	21	in	in	ADP
ct-9352	114	22	mares	mare	NOUN
ct-9352	114	23	susceptible	susceptible	ADJ
ct-9352	114	24	or	or	CCONJ
ct-9352	114	25	resistant	resistant	ADJ
ct-9352	114	26	to	to	ADP
ct-9352	114	27	persistent	persistent	ADJ
ct-9352	114	28	breeding	breeding	NOUN
ct-9352	114	29	-	-	PUNCT
ct-9352	114	30	induced	induce	VERB
ct-9352	114	31	endometritis	endometritis	NOUN
ct-9352	114	32	.	.	PUNCT
ct-9352	115	1	reproduction	reproduction	NOUN
ct-9352	115	2	2013;145:289	2013;145:289	ADV
ct-9352	115	3	-	-	PUNCT
ct-9352	115	4	296	296	NUM
ct-9352	115	5	.	.	PUNCT
ct-9352	116	1	9.woodward	9.woodward	NUM
ct-9352	116	2	em	em	PRON
ct-9352	116	3	,	,	PUNCT
ct-9352	116	4	troedsson	troedsson	PROPN
ct-9352	116	5	mh	mh	PROPN
ct-9352	116	6	:	:	PUNCT
ct-9352	116	7	inflammatory	inflammatory	ADJ
ct-9352	116	8	mechanisms	mechanism	NOUN
ct-9352	116	9	of	of	ADP
ct-9352	116	10	endometritis	endometritis	PROPN
ct-9352	116	11	.	.	PUNCT
ct-9352	117	1	equine	equine	PROPN
ct-9352	117	2	vet	vet	PROPN
ct-9352	117	3	j	j	PROPN
ct-9352	117	4	2015;47:384	2015;47:384	NUM
ct-9352	117	5	-	-	NOUN
ct-9352	117	6	389	389	NUM
ct-9352	117	7	.	.	PUNCT
ct-9352	117	8	10	10	NUM
ct-9352	117	9	.	.	PUNCT
ct-9352	118	1	alghamdi	alghamdi	NOUN
ct-9352	118	2	as	as	ADP
ct-9352	118	3	,	,	PUNCT
ct-9352	118	4	foster	foster	ADJ
ct-9352	118	5	dn	dn	PROPN
ct-9352	118	6	,	,	PUNCT
ct-9352	118	7	troedsson	troedsson	PROPN
ct-9352	118	8	mh	mh	PROPN
ct-9352	118	9	:	:	PUNCT
ct-9352	118	10	equine	equine	NOUN
ct-9352	118	11	seminal	seminal	ADJ
ct-9352	118	12	plasma	plasma	NOUN
ct-9352	118	13	reduces	reduce	VERB
ct-9352	118	14	sperm	sperm	NOUN
ct-9352	118	15	binding	bind	VERB
ct-9352	118	16	to	to	ADP
ct-9352	118	17	polymorphonuclear	polymorphonuclear	ADJ
ct-9352	118	18	neutrophils	neutrophil	NOUN
ct-9352	118	19	(	(	PUNCT
ct-9352	118	20	pmns	pmn	NOUN
ct-9352	118	21	)	)	PUNCT
ct-9352	118	22	and	and	CCONJ
ct-9352	118	23	improves	improve	VERB
ct-9352	118	24	the	the	DET
ct-9352	118	25	fertility	fertility	NOUN
ct-9352	118	26	of	of	ADP
ct-9352	118	27	fresh	fresh	ADJ
ct-9352	118	28	semen	semen	NOUN
ct-9352	118	29	inseminated	inseminate	VERB
ct-9352	118	30	into	into	ADP
ct-9352	118	31	inflamed	inflamed	ADJ
ct-9352	118	32	uteri	uteri	NOUN
ct-9352	118	33	.	.	PUNCT
ct-9352	119	1	reproduction	reproduction	NOUN
ct-9352	119	2	2004;127:593	2004;127:593	NUM
ct-9352	119	3	-	-	SYM
ct-9352	119	4	600	600	NUM
ct-9352	119	5	.	.	NOUN
ct-9352	119	6	11	11	NUM
ct-9352	119	7	.	.	X
ct-9352	119	8	alghamdi	alghamdi	NOUN
ct-9352	119	9	as	as	ADP
ct-9352	119	10	,	,	PUNCT
ct-9352	119	11	madill	madill	PROPN
ct-9352	119	12	s	s	PROPN
ct-9352	119	13	,	,	PUNCT
ct-9352	119	14	foster	foster	ADJ
ct-9352	119	15	dn	dn	PROPN
ct-9352	119	16	,	,	PUNCT
ct-9352	119	17	et	et	PROPN
ct-9352	119	18	al	al	PROPN
ct-9352	119	19	:	:	PUNCT
ct-9352	119	20	equine	equine	NOUN
ct-9352	119	21	sperm	sperm	NOUN
ct-9352	119	22	-	-	PUNCT
ct-9352	119	23	neutrophil	neutrophil	ADJ
ct-9352	119	24	binding	bind	VERB
ct-9352	119	25	.	.	PUNCT
ct-9352	120	1	biol	biol	PROPN
ct-9352	120	2	reprod	reprod	PROPN
ct-9352	120	3	2015;92:94	2015;92:94	NUM
ct-9352	120	4	.	.	PUNCT
ct-9352	121	1	12	12	NUM
ct-9352	121	2	.	.	PUNCT
ct-9352	122	1	troedsson	troedsson	PROPN
ct-9352	122	2	mh	mh	PROPN
ct-9352	122	3	,	,	PUNCT
ct-9352	122	4	desvousges	desvousge	VERB
ct-9352	122	5	a	a	DET
ct-9352	122	6	,	,	PUNCT
ct-9352	122	7	alghamdi	alghamdi	NOUN
ct-9352	122	8	as	as	ADP
ct-9352	122	9	,	,	PUNCT
ct-9352	122	10	et	et	PROPN
ct-9352	122	11	al	al	PROPN
ct-9352	122	12	:	:	PUNCT
ct-9352	122	13	components	component	NOUN
ct-9352	122	14	in	in	ADP
ct-9352	122	15	seminal	seminal	ADJ
ct-9352	122	16	plasma	plasma	NOUN
ct-9352	122	17	regulating	regulate	VERB
ct-9352	122	18	sperm	sperm	NOUN
ct-9352	122	19	transport	transport	NOUN
ct-9352	122	20	and	and	CCONJ
ct-9352	122	21	elimination	elimination	NOUN
ct-9352	122	22	.	.	PUNCT
ct-9352	123	1	anim	anim	NOUN
ct-9352	123	2	reprod	reprod	PROPN
ct-9352	123	3	sci	sci	PROPN
ct-9352	123	4	2005;89:171	2005;89:171	PROPN
ct-9352	123	5	-	-	PROPN
ct-9352	123	6	186	186	NUM
ct-9352	123	7	.	.	PUNCT
ct-9352	123	8	13	13	NUM
ct-9352	123	9	.	.	PUNCT
ct-9352	124	1	troedsson	troedsson	PROPN
ct-9352	124	2	mh	mh	PROPN
ct-9352	124	3	,	,	PUNCT
ct-9352	124	4	woodward	woodward	VERB
ct-9352	124	5	em	em	PRON
ct-9352	124	6	:	:	PUNCT
ct-9352	124	7	our	our	PRON
ct-9352	124	8	current	current	ADJ
ct-9352	124	9	understanding	understanding	NOUN
ct-9352	124	10	of	of	ADP
ct-9352	124	11	the	the	DET
ct-9352	124	12	pathophysiology	pathophysiology	NOUN
ct-9352	124	13	of	of	ADP
ct-9352	124	14	equine	equine	NOUN
ct-9352	124	15	endometritis	endometritis	NOUN
ct-9352	124	16	with	with	ADP
ct-9352	124	17	an	an	DET
ct-9352	124	18	emphasis	emphasis	NOUN
ct-9352	124	19	on	on	ADP
ct-9352	124	20	breeding	breed	VERB
ct-9352	124	21	-	-	PUNCT
ct-9352	124	22	induced	induce	VERB
ct-9352	124	23	endometritis	endometritis	NOUN
ct-9352	124	24	.	.	PUNCT
ct-9352	125	1	reprod	reprod	PROPN
ct-9352	125	2	biol	biol	PROPN
ct-9352	125	3	2016;16:8	2016;16:8	PROPN
ct-9352	125	4	-	-	SYM
ct-9352	125	5	12	12	NUM
ct-9352	125	6	.	.	PUNCT
ct-9352	126	1	14	14	NUM
ct-9352	126	2	.	.	PUNCT
ct-9352	127	1	woodward	woodward	PROPN
ct-9352	127	2	em	em	PRON
ct-9352	127	3	,	,	PUNCT
ct-9352	127	4	christoffersen	christoffersen	VERB
ct-9352	127	5	m	m	PROPN
ct-9352	127	6	,	,	PUNCT
ct-9352	127	7	campos	campos	PROPN
ct-9352	127	8	j	j	PROPN
ct-9352	127	9	,	,	PUNCT
ct-9352	127	10	et	et	PROPN
ct-9352	127	11	al	al	PROPN
ct-9352	127	12	:	:	PUNCT
ct-9352	127	13	an	an	DET
ct-9352	127	14	investigation	investigation	NOUN
ct-9352	127	15	of	of	ADP
ct-9352	127	16	uterine	uterine	ADJ
ct-9352	127	17	nitric	nitric	ADJ
ct-9352	127	18	oxide	oxide	NOUN
ct-9352	127	19	production	production	NOUN
ct-9352	127	20	in	in	ADP
ct-9352	127	21	mares	mare	NOUN
ct-9352	127	22	susceptible	susceptible	ADJ
ct-9352	127	23	and	and	CCONJ
ct-9352	127	24	resistant	resistant	ADJ
ct-9352	127	25	to	to	ADP
ct-9352	127	26	persistent	persistent	ADJ
ct-9352	127	27	breeding	breeding	NOUN
ct-9352	127	28	-	-	PUNCT
ct-9352	127	29	induced	induce	VERB
ct-9352	127	30	endometritis	endometritis	NOUN
ct-9352	127	31	and	and	CCONJ
ct-9352	127	32	the	the	DET
ct-9352	127	33	effects	effect	NOUN
ct-9352	127	34	of	of	ADP
ct-9352	127	35	immunomodulation	immunomodulation	NOUN
ct-9352	127	36	.	.	PUNCT
ct-9352	128	1	reprod	reprod	PROPN
ct-9352	128	2	domest	domest	PROPN
ct-9352	128	3	anim	anim	PROPN
ct-9352	128	4	2013;48:554	2013;48:554	PROPN
ct-9352	128	5	-	-	SYM
ct-9352	128	6	561	561	NUM
ct-9352	128	7	.	.	PUNCT
ct-9352	128	8	15	15	NUM
ct-9352	128	9	.	.	PUNCT
ct-9352	129	1	brooks	brooks	PROPN
ct-9352	129	2	ac	ac	PROPN
ct-9352	129	3	,	,	PUNCT
ct-9352	129	4	rickards	rickards	PROPN
ct-9352	129	5	kj	kj	PROPN
ct-9352	129	6	,	,	PUNCT
ct-9352	129	7	cunningham	cunningham	PROPN
ct-9352	129	8	fm	fm	PROPN
ct-9352	129	9	:	:	PUNCT
ct-9352	129	10	cxcl8	cxcl8	NOUN
ct-9352	129	11	attenuates	attenuate	VERB
ct-9352	129	12	chemoattractant	chemoattractant	NOUN
ct-9352	129	13	-	-	PUNCT
ct-9352	129	14	induced	induce	VERB
ct-9352	129	15	equine	equine	NOUN
ct-9352	129	16	neutrophil	neutrophil	ADJ
ct-9352	129	17	migration	migration	NOUN
ct-9352	129	18	.	.	PUNCT
ct-9352	130	1	vet	vet	NOUN
ct-9352	130	2	immunol	immunol	NOUN
ct-9352	130	3	immunopathol	immunopathol	PROPN
ct-9352	130	4	2011;139:141	2011;139:141	NUM
ct-9352	130	5	-	-	SYM
ct-9352	130	6	147	147	NUM
ct-9352	130	7	.	.	PUNCT
ct-9352	131	1	16	16	NUM
ct-9352	131	2	.	.	PUNCT
ct-9352	131	3	alghamdi	alghamdi	NOUN
ct-9352	131	4	as	as	ADP
ct-9352	131	5	,	,	PUNCT
ct-9352	131	6	foster	foster	ADJ
ct-9352	131	7	dn	dn	PROPN
ct-9352	131	8	,	,	PUNCT
ct-9352	131	9	carlson	carlson	PROPN
ct-9352	131	10	cs	cs	PROPN
ct-9352	131	11	,	,	PUNCT
ct-9352	131	12	et	et	PROPN
ct-9352	131	13	al	al	PROPN
ct-9352	131	14	:	:	PUNCT
ct-9352	131	15	nitric	nitric	ADJ
ct-9352	131	16	oxide	oxide	NOUN
ct-9352	131	17	levels	level	NOUN
ct-9352	131	18	and	and	CCONJ
ct-9352	131	19	nitric	nitric	ADJ
ct-9352	131	20	oxide	oxide	NOUN
ct-9352	131	21	synthase	synthase	NOUN
ct-9352	131	22	expression	expression	NOUN
ct-9352	131	23	in	in	ADP
ct-9352	131	24	uterine	uterine	ADJ
ct-9352	131	25	samples	sample	NOUN
ct-9352	131	26	from	from	ADP
ct-9352	131	27	mares	mare	NOUN
ct-9352	131	28	susceptible	susceptible	ADJ
ct-9352	131	29	and	and	CCONJ
ct-9352	131	30	resistant	resistant	ADJ
ct-9352	131	31	to	to	ADP
ct-9352	131	32	persistent	persistent	ADJ
ct-9352	131	33	breeding	breeding	NOUN
ct-9352	131	34	-	-	PUNCT
ct-9352	131	35	induced	induce	VERB
ct-9352	131	36	endometritis	endometritis	NOUN
ct-9352	131	37	.	.	PUNCT
ct-9352	132	1	am	be	AUX
ct-9352	132	2	j	j	PROPN
ct-9352	132	3	reprod	reprod	PROPN
ct-9352	132	4	immunol	immunol	NOUN
ct-9352	132	5	2005;53:230	2005;53:230	PROPN
ct-9352	132	6	-	-	SYM
ct-9352	132	7	237	237	NUM
ct-9352	132	8	.	.	PUNCT
ct-9352	133	1	17	17	NUM
ct-9352	133	2	.	.	PUNCT
ct-9352	134	1	troedsson	troedsson	PROPN
ct-9352	134	2	mh	mh	PROPN
ct-9352	134	3	,	,	PUNCT
ct-9352	134	4	liu	liu	PROPN
ct-9352	134	5	ik	ik	PROPN
ct-9352	134	6	:	:	PUNCT
ct-9352	134	7	uterine	uterine	ADJ
ct-9352	134	8	clearance	clearance	NOUN
ct-9352	134	9	of	of	ADP
ct-9352	134	10	non	non	ADJ
ct-9352	134	11	-	-	ADJ
ct-9352	134	12	antigenic	antigenic	ADJ
ct-9352	134	13	markers	marker	NOUN
ct-9352	134	14	(	(	PUNCT
ct-9352	134	15	51cr	51cr	ADJ
ct-9352	134	16	)	)	PUNCT
ct-9352	134	17	in	in	ADP
ct-9352	134	18	response	response	NOUN
ct-9352	134	19	to	to	ADP
ct-9352	134	20	a	a	DET
ct-9352	134	21	bacterial	bacterial	ADJ
ct-9352	134	22	challenge	challenge	NOUN
ct-9352	134	23	in	in	ADP
ct-9352	134	24	mares	mare	NOUN
ct-9352	134	25	potentially	potentially	ADV
ct-9352	134	26	susceptible	susceptible	ADJ
ct-9352	134	27	and	and	CCONJ
ct-9352	134	28	resistant	resistant	ADJ
ct-9352	134	29	to	to	AUX
ct-9352	134	30	chronic	chronic	VERB
ct-9352	134	31	uterine	uterine	ADJ
ct-9352	134	32	infections	infection	NOUN
ct-9352	134	33	.	.	PUNCT
ct-9352	135	1	j	j	PROPN
ct-9352	135	2	reprod	reprod	PROPN
ct-9352	135	3	fertil	fertil	PROPN
ct-9352	135	4	suppl	suppl	ADJ
ct-9352	135	5	1991;44:283	1991;44:283	PROPN
ct-9352	135	6	-	-	SYM
ct-9352	135	7	288	288	NUM
ct-9352	135	8	.	.	PUNCT
ct-9352	136	1	18	18	NUM
ct-9352	136	2	.	.	PUNCT
ct-9352	137	1	troedsson	troedsson	PROPN
ct-9352	137	2	mh	mh	PROPN
ct-9352	137	3	,	,	PUNCT
ct-9352	137	4	liu	liu	PROPN
ct-9352	137	5	ik	ik	PROPN
ct-9352	137	6	,	,	PUNCT
ct-9352	137	7	ing	ing	NOUN
ct-9352	137	8	m	m	PROPN
ct-9352	137	9	,	,	PUNCT
ct-9352	137	10	et	et	PROPN
ct-9352	137	11	al	al	PROPN
ct-9352	137	12	:	:	PUNCT
ct-9352	137	13	multiple	multiple	ADJ
ct-9352	137	14	site	site	NOUN
ct-9352	137	15	electromyography	electromyography	NOUN
ct-9352	137	16	recordings	recording	NOUN
ct-9352	137	17	of	of	ADP
ct-9352	137	18	uterine	uterine	ADJ
ct-9352	137	19	activity	activity	NOUN
ct-9352	137	20	following	follow	VERB
ct-9352	137	21	an	an	DET
ct-9352	137	22	intrauterine	intrauterine	ADJ
ct-9352	137	23	bacterial	bacterial	ADJ
ct-9352	137	24	challenge	challenge	NOUN
ct-9352	137	25	in	in	ADP
ct-9352	137	26	mares	mare	NOUN
ct-9352	137	27	susceptible	susceptible	ADJ
ct-9352	137	28	and	and	CCONJ
ct-9352	137	29	resistant	resistant	ADJ
ct-9352	137	30	to	to	ADP
ct-9352	137	31	chronic	chronic	VERB
ct-9352	137	32	uterine	uterine	ADJ
ct-9352	137	33	infection	infection	NOUN
ct-9352	137	34	.	.	PUNCT
ct-9352	138	1	j	j	PROPN
ct-9352	138	2	reprod	reprod	PROPN
ct-9352	138	3	fertil	fertil	VERB
ct-9352	138	4	1993;99:307	1993;99:307	NUM
ct-9352	138	5	-	-	SYM
ct-9352	138	6	313	313	NUM
ct-9352	138	7	.	.	NOUN
ct-9352	139	1	19	19	NUM
ct-9352	139	2	.	.	PUNCT
ct-9352	140	1	katila	katila	PROPN
ct-9352	140	2	t	t	PROPN
ct-9352	140	3	:	:	PUNCT
ct-9352	140	4	post	post	ADJ
ct-9352	140	5	-	-	ADJ
ct-9352	140	6	mating	mating	ADJ
ct-9352	140	7	inflammatory	inflammatory	ADJ
ct-9352	140	8	responses	response	NOUN
ct-9352	140	9	of	of	ADP
ct-9352	140	10	the	the	DET
ct-9352	140	11	uterus	uterus	NOUN
ct-9352	140	12	.	.	PUNCT
ct-9352	140	13	reprod	reprod	PROPN
ct-9352	140	14	domest	domest	PROPN
ct-9352	140	15	anim	anim	NOUN
ct-9352	140	16	2012;47	2012;47	PROPN
ct-9352	140	17	suppl	suppl	PROPN
ct-9352	141	1	5:31	5:31	NUM
ct-9352	141	2	-	-	SYM
ct-9352	141	3	41	41	NUM
ct-9352	141	4	.	.	NOUN
ct-9352	141	5	20	20	NUM
ct-9352	141	6	.	.	PUNCT
ct-9352	142	1	risco	risco	PROPN
ct-9352	142	2	am	am	PROPN
ct-9352	142	3	,	,	PUNCT
ct-9352	142	4	reilas	reilas	PROPN
ct-9352	142	5	t	t	PROPN
ct-9352	142	6	,	,	PUNCT
ct-9352	142	7	muilu	muilu	PROPN
ct-9352	142	8	l	l	NOUN
ct-9352	142	9	,	,	PUNCT
ct-9352	142	10	et	et	PROPN
ct-9352	142	11	al	al	PROPN
ct-9352	142	12	:	:	PUNCT
ct-9352	142	13	effect	effect	NOUN
ct-9352	142	14	of	of	ADP
ct-9352	142	15	oxytocin	oxytocin	PROPN
ct-9352	142	16	and	and	CCONJ
ct-9352	142	17	flunixin	flunixin	NOUN
ct-9352	142	18	meglumine	meglumine	VERB
ct-9352	142	19	on	on	ADP
ct-9352	142	20	uterine	uterine	ADJ
ct-9352	142	21	response	response	NOUN
ct-9352	142	22	to	to	ADP
ct-9352	142	23	insemination	insemination	NOUN
ct-9352	142	24	in	in	ADP
ct-9352	142	25	mares	mare	NOUN
ct-9352	142	26	.	.	PUNCT
ct-9352	143	1	theriogenology	theriogenology	NOUN
ct-9352	143	2	2009;72:1195	2009;72:1195	PROPN
ct-9352	143	3	-	-	SYM
ct-9352	143	4	11201	11201	NUM
ct-9352	143	5	.	.	PUNCT
ct-9352	144	1	21	21	NUM
ct-9352	144	2	.	.	X
ct-9352	145	1	friso	friso	PROPN
ct-9352	145	2	am	be	AUX
ct-9352	145	3	,	,	PUNCT
ct-9352	145	4	segabinazzi	segabinazzi	NOUN
ct-9352	145	5	l	l	NOUN
ct-9352	145	6	,	,	PUNCT
ct-9352	145	7	cyrino	cyrino	PROPN
ct-9352	145	8	m	m	PROPN
ct-9352	145	9	,	,	PUNCT
ct-9352	145	10	et	et	PROPN
ct-9352	145	11	al	al	PROPN
ct-9352	145	12	:	:	PUNCT
ct-9352	145	13	periovulatory	periovulatory	PROPN
ct-9352	145	14	administration	administration	NOUN
ct-9352	145	15	of	of	ADP
ct-9352	145	16	firocoxib	firocoxib	PROPN
ct-9352	145	17	did	do	AUX
ct-9352	145	18	not	not	PART
ct-9352	145	19	alter	alter	VERB
ct-9352	145	20	ovulation	ovulation	NOUN
ct-9352	145	21	rates	rate	NOUN
ct-9352	145	22	and	and	CCONJ
ct-9352	145	23	mitigated	mitigate	VERB
ct-9352	145	24	post	post	ADJ
ct-9352	145	25	-	-	ADJ
ct-9352	145	26	breeding	breeding	ADJ
ct-9352	145	27	inflammatory	inflammatory	ADJ
ct-9352	145	28	response	response	NOUN
ct-9352	145	29	in	in	ADP
ct-9352	145	30	mares	mare	NOUN
ct-9352	145	31	.	.	PUNCT
ct-9352	146	1	theriogenology	theriogenology	NOUN
ct-9352	146	2	2019;138:24	2019;138:24	NUM
ct-9352	146	3	-	-	SYM
ct-9352	146	4	30	30	NUM
ct-9352	146	5	.	.	PUNCT
ct-9352	146	6	22	22	NUM
ct-9352	146	7	.	.	PUNCT
ct-9352	147	1	okada	okada	PROPN
ct-9352	147	2	ctc	ctc	PROPN
ct-9352	147	3	,	,	PUNCT
ct-9352	147	4	andrade	andrade	PROPN
ct-9352	147	5	vp	vp	PROPN
ct-9352	147	6	,	,	PUNCT
ct-9352	147	7	freitas	freitas	PROPN
ct-9352	147	8	-	-	PUNCT
ct-9352	147	9	dell'aqua	dell'aqua	NOUN
ct-9352	147	10	cp	cp	PROPN
ct-9352	147	11	,	,	PUNCT
ct-9352	147	12	et	et	PROPN
ct-9352	147	13	al	al	PROPN
ct-9352	147	14	:	:	PUNCT
ct-9352	147	15	the	the	DET
ct-9352	147	16	effect	effect	NOUN
ct-9352	147	17	of	of	ADP
ct-9352	147	18	flunixin	flunixin	PROPN
ct-9352	147	19	meglumine	meglumine	PROPN
ct-9352	147	20	,	,	PUNCT
ct-9352	147	21	firocoxib	firocoxib	NOUN
ct-9352	147	22	and	and	CCONJ
ct-9352	147	23	meloxicam	meloxicam	NOUN
ct-9352	147	24	on	on	ADP
ct-9352	147	25	the	the	DET
ct-9352	147	26	uterine	uterine	ADJ
ct-9352	147	27	mobility	mobility	NOUN
ct-9352	147	28	of	of	ADP
ct-9352	147	29	equine	equine	NOUN
ct-9352	147	30	embryos	embryo	NOUN
ct-9352	147	31	.	.	PUNCT
ct-9352	148	1	theriogenology	theriogenology	NOUN
ct-9352	148	2	2019;123:132	2019;123:132	PROPN
ct-9352	148	3	-	-	SYM
ct-9352	148	4	138	138	NUM
ct-9352	148	5	.	.	PUNCT
ct-9352	148	6	23	23	NUM
ct-9352	148	7	.	.	PUNCT
ct-9352	149	1	rojer	rojer	NOUN
ct-9352	149	2	h	h	PROPN
ct-9352	149	3	,	,	PUNCT
ct-9352	149	4	aurich	aurich	PROPN
ct-9352	149	5	c	c	NOUN
ct-9352	149	6	:	:	PUNCT
ct-9352	149	7	treatment	treatment	NOUN
ct-9352	149	8	of	of	ADP
ct-9352	149	9	persistent	persistent	ADJ
ct-9352	149	10	mating	mating	NOUN
ct-9352	149	11	-	-	PUNCT
ct-9352	149	12	induced	induce	VERB
ct-9352	149	13	endometritis	endometritis	NOUN
ct-9352	149	14	in	in	ADP
ct-9352	149	15	mares	mare	NOUN
ct-9352	149	16	with	with	ADP
ct-9352	149	17	the	the	DET
ct-9352	149	18	non	non	ADJ
ct-9352	149	19	-	-	ADJ
ct-9352	149	20	steroid	steroid	ADJ
ct-9352	149	21	anti	anti	ADJ
ct-9352	149	22	-	-	ADJ
ct-9352	149	23	inflammatory	inflammatory	ADJ
ct-9352	149	24	drug	drug	NOUN
ct-9352	149	25	vedaprofen	vedaprofen	NOUN
ct-9352	149	26	.	.	PUNCT
ct-9352	150	1	reprod	reprod	PROPN
ct-9352	150	2	domest	domest	PROPN
ct-9352	150	3	anim	anim	NOUN
ct-9352	150	4	2010;45	2010;45	NUM
ct-9352	150	5	:	:	PUNCT
ct-9352	150	6	e458	e458	NUM
ct-9352	150	7	-	-	SYM
ct-9352	150	8	460	460	NUM
ct-9352	150	9	.	.	PUNCT
ct-9352	151	1	24	24	NUM
ct-9352	151	2	.	.	PUNCT
ct-9352	152	1	christoffersen	christoffersen	PROPN
ct-9352	152	2	m	m	PROPN
ct-9352	152	3	,	,	PUNCT
ct-9352	152	4	woodward	woodward	PROPN
ct-9352	152	5	em	em	PRON
ct-9352	152	6	,	,	PUNCT
ct-9352	152	7	bojesen	bojesen	PROPN
ct-9352	152	8	am	am	PROPN
ct-9352	152	9	,	,	PUNCT
ct-9352	152	10	et	et	PROPN
ct-9352	152	11	al	al	PROPN
ct-9352	152	12	:	:	PUNCT
ct-9352	152	13	effect	effect	NOUN
ct-9352	152	14	of	of	ADP
ct-9352	152	15	immunomodulatory	immunomodulatory	ADJ
ct-9352	152	16	therapy	therapy	NOUN
ct-9352	152	17	on	on	ADP
ct-9352	152	18	the	the	DET
ct-9352	152	19	endometrial	endometrial	ADJ
ct-9352	152	20	inflammatory	inflammatory	ADJ
ct-9352	152	21	response	response	NOUN
ct-9352	152	22	to	to	AUX
ct-9352	152	23	induced	induce	VERB
ct-9352	152	24	infectious	infectious	ADJ
ct-9352	152	25	endometritis	endometritis	NOUN
ct-9352	152	26	in	in	ADP
ct-9352	152	27	susceptible	susceptible	ADJ
ct-9352	152	28	mares	mare	NOUN
ct-9352	152	29	.	.	PUNCT
ct-9352	153	1	theriogenology	theriogenology	NOUN
ct-9352	153	2	2012;78:991	2012;78:991	NUM
ct-9352	153	3	-	-	SYM
ct-9352	153	4	1004	1004	NUM
ct-9352	153	5	.	.	PUNCT
ct-9352	154	1	25	25	NUM
ct-9352	154	2	.	.	X
ct-9352	154	3	woodward	woodward	PROPN
ct-9352	154	4	em	em	PRON
ct-9352	154	5	,	,	PUNCT
ct-9352	154	6	christoffersen	christoffersen	VERB
ct-9352	154	7	m	m	PROPN
ct-9352	154	8	,	,	PUNCT
ct-9352	154	9	horohov	horohov	ADJ
ct-9352	154	10	d	d	NOUN
ct-9352	154	11	,	,	PUNCT
ct-9352	154	12	et	et	PROPN
ct-9352	154	13	al	al	PROPN
ct-9352	154	14	:	:	PUNCT
ct-9352	154	15	the	the	DET
ct-9352	154	16	effect	effect	NOUN
ct-9352	154	17	of	of	ADP
ct-9352	154	18	treatment	treatment	NOUN
ct-9352	154	19	with	with	ADP
ct-9352	154	20	immune	immune	ADJ
ct-9352	154	21	modulators	modulator	NOUN
ct-9352	154	22	on	on	ADP
ct-9352	154	23	endometrial	endometrial	ADJ
ct-9352	154	24	cytokine	cytokine	NOUN
ct-9352	154	25	expression	expression	NOUN
ct-9352	154	26	in	in	ADP
ct-9352	154	27	mares	mare	NOUN
ct-9352	154	28	susceptible	susceptible	ADJ
ct-9352	154	29	to	to	ADP
ct-9352	154	30	persistent	persistent	ADJ
ct-9352	154	31	breeding	breeding	NOUN
ct-9352	154	32	-	-	PUNCT
ct-9352	154	33	induced	induce	VERB
ct-9352	154	34	endometritis	endometritis	NOUN
ct-9352	154	35	.	.	PUNCT
ct-9352	155	1	equine	equine	PROPN
ct-9352	155	2	vet	vet	NOUN
ct-9352	155	3	j	j	PROPN
ct-9352	155	4	2015;47:235	2015;47:235	NUM
ct-9352	155	5	-	-	SYM
ct-9352	155	6	239	239	NUM
ct-9352	155	7	.	.	PUNCT
ct-9352	155	8	26	26	NUM
ct-9352	155	9	.	.	PUNCT
ct-9352	156	1	arlas	arla	NOUN
ct-9352	156	2	tr	tr	VERB
ct-9352	156	3	,	,	PUNCT
ct-9352	156	4	wolf	wolf	PROPN
ct-9352	156	5	ca	can	AUX
ct-9352	156	6	,	,	PUNCT
ct-9352	156	7	petrucci	petrucci	PROPN
ct-9352	156	8	bp	bp	PROPN
ct-9352	156	9	,	,	PUNCT
ct-9352	156	10	et	et	PROPN
ct-9352	156	11	al	al	PROPN
ct-9352	156	12	:	:	PUNCT
ct-9352	156	13	proteomics	proteomic	NOUN
ct-9352	156	14	of	of	ADP
ct-9352	156	15	endometrial	endometrial	ADJ
ct-9352	156	16	fluid	fluid	NOUN
ct-9352	156	17	after	after	ADP
ct-9352	156	18	dexamethasone	dexamethasone	NOUN
ct-9352	156	19	treatment	treatment	NOUN
ct-9352	156	20	in	in	ADP
ct-9352	156	21	mares	mare	NOUN
ct-9352	156	22	susceptible	susceptible	ADJ
ct-9352	156	23	to	to	ADP
ct-9352	156	24	endometritis	endometritis	PROPN
ct-9352	156	25	.	.	PUNCT
ct-9352	157	1	theriogenology	theriogenology	PROPN
ct-9352	157	2	2015;84:617	2015;84:617	PROPN
ct-9352	157	3	-	-	SYM
ct-9352	157	4	623	623	NUM
ct-9352	157	5	.	.	PUNCT
ct-9352	157	6	27	27	NUM
ct-9352	157	7	.	.	PUNCT
ct-9352	158	1	wolf	wolf	PROPN
ct-9352	158	2	ca	can	AUX
ct-9352	158	3	,	,	PUNCT
ct-9352	158	4	maslchitzky	maslchitzky	ADJ
ct-9352	158	5	e	e	PROPN
ct-9352	158	6	,	,	PUNCT
ct-9352	158	7	gregory	gregory	PROPN
ct-9352	158	8	rm	rm	PROPN
ct-9352	158	9	,	,	PUNCT
ct-9352	158	10	et	et	PROPN
ct-9352	158	11	al	al	PROPN
ct-9352	158	12	:	:	PUNCT
ct-9352	158	13	effect	effect	NOUN
ct-9352	158	14	of	of	ADP
ct-9352	158	15	corticotherapy	corticotherapy	NOUN
ct-9352	158	16	on	on	ADP
ct-9352	158	17	proteomics	proteomic	NOUN
ct-9352	158	18	of	of	ADP
ct-9352	158	19	endometrial	endometrial	ADJ
ct-9352	158	20	fluid	fluid	NOUN
ct-9352	158	21	from	from	ADP
ct-9352	158	22	mares	mare	NOUN
ct-9352	158	23	susceptible	susceptible	ADJ
ct-9352	158	24	to	to	ADP
ct-9352	158	25	persistent	persistent	ADJ
ct-9352	158	26	postbreeding	postbreeding	NOUN
ct-9352	158	27	endometritis	endometritis	NOUN
ct-9352	158	28	.	.	PUNCT
ct-9352	159	1	theriogenology	theriogenology	NOUN
ct-9352	159	2	2012;77:1351	2012;77:1351	NUM
ct-9352	159	3	-	-	SYM
ct-9352	159	4	1359	1359	NUM
ct-9352	159	5	.	.	PUNCT
ct-9352	160	1	28	28	NUM
ct-9352	160	2	.	.	PUNCT
ct-9352	161	1	bucca	bucca	PROPN
ct-9352	161	2	s	s	PROPN
ct-9352	161	3	,	,	PUNCT
ct-9352	161	4	carli	carli	PROPN
ct-9352	161	5	a	a	NOUN
ct-9352	161	6	,	,	PUNCT
ct-9352	161	7	buckley	buckley	PROPN
ct-9352	161	8	t	t	PROPN
ct-9352	161	9	,	,	PUNCT
ct-9352	161	10	et	et	PROPN
ct-9352	161	11	al	al	PROPN
ct-9352	161	12	:	:	PUNCT
ct-9352	161	13	the	the	DET
ct-9352	161	14	use	use	NOUN
ct-9352	161	15	of	of	ADP
ct-9352	161	16	dexamethasone	dexamethasone	NOUN
ct-9352	161	17	administered	administer	VERB
ct-9352	161	18	to	to	ADP
ct-9352	161	19	mares	mare	NOUN
ct-9352	161	20	at	at	ADP
ct-9352	161	21	breeding	breeding	NOUN
ct-9352	161	22	time	time	NOUN
ct-9352	161	23	in	in	ADP
ct-9352	161	24	the	the	DET
ct-9352	161	25	modulation	modulation	NOUN
ct-9352	161	26	of	of	ADP
ct-9352	161	27	persistent	persistent	ADJ
ct-9352	161	28	mating	mating	NOUN
ct-9352	161	29	induced	induce	VERB
ct-9352	161	30	endometritis	endometritis	NOUN
ct-9352	161	31	.	.	PUNCT
ct-9352	162	1	theriogenology	theriogenology	NOUN
ct-9352	162	2	2008;70:1093	2008;70:1093	NUM
ct-9352	162	3	-	-	SYM
ct-9352	162	4	1100	1100	NUM
ct-9352	162	5	.	.	PUNCT
ct-9352	163	1	29	29	NUM
ct-9352	163	2	.	.	PUNCT
ct-9352	164	1	dell’aqua	dell’aqua	PROPN
ct-9352	164	2	jr	jr	PROPN
ct-9352	164	3	.	.	PROPN
ct-9352	164	4	ja	ja	PROPN
ct-9352	164	5	,	,	PUNCT
ct-9352	164	6	papa	papa	NOUN
ct-9352	164	7	fo	fo	PROPN
ct-9352	164	8	,	,	PUNCT
ct-9352	164	9	lopes	lopes	PROPN
ct-9352	164	10	md	md	PROPN
ct-9352	164	11	,	,	PUNCT
ct-9352	164	12	et	et	PROPN
ct-9352	164	13	al	al	PROPN
ct-9352	164	14	:	:	PUNCT
ct-9352	164	15	fertility	fertility	NOUN
ct-9352	164	16	rates	rate	NOUN
ct-9352	164	17	with	with	ADP
ct-9352	164	18	equine	equine	NOUN
ct-9352	164	19	frozen	frozen	ADJ
ct-9352	164	20	semen	semen	NOUN
ct-9352	164	21	after	after	ADP
ct-9352	164	22	modulation	modulation	NOUN
ct-9352	164	23	of	of	ADP
ct-9352	164	24	inflammatory	inflammatory	ADJ
ct-9352	164	25	uterine	uterine	ADJ
ct-9352	164	26	response	response	NOUN
ct-9352	164	27	.	.	PUNCT
ct-9352	165	1	journal	journal	PROPN
ct-9352	165	2	2004	2004	NUM
ct-9352	165	3	.	.	PUNCT
ct-9352	166	1	p.	p.	NOUN
ct-9352	166	2	391	391	NUM
ct-9352	166	3	.	.	PUNCT
ct-9352	166	4	30	30	NUM
ct-9352	166	5	.	.	PUNCT
ct-9352	167	1	thompson	thompson	PROPN
ct-9352	167	2	dl	dl	PROPN
ct-9352	167	3	,	,	PUNCT
ct-9352	167	4	jr	jr	PROPN
ct-9352	167	5	.	.	PROPN
ct-9352	167	6	,	,	PUNCT
ct-9352	167	7	garza	garza	PROPN
ct-9352	167	8	f	f	PROPN
ct-9352	167	9	,	,	PUNCT
ct-9352	167	10	jr	jr	PROPN
ct-9352	167	11	.	.	PROPN
ct-9352	167	12	,	,	PUNCT
ct-9352	167	13	st	st	PROPN
ct-9352	167	14	george	george	PROPN
ct-9352	167	15	rl	rl	PROPN
ct-9352	167	16	,	,	PUNCT
ct-9352	167	17	et	et	PROPN
ct-9352	167	18	al	al	PROPN
ct-9352	167	19	:	:	PUNCT
ct-9352	167	20	relationships	relationship	NOUN
ct-9352	167	21	among	among	ADP
ct-9352	167	22	lh	lh	PROPN
ct-9352	167	23	,	,	PUNCT
ct-9352	167	24	fsh	fsh	NOUN
ct-9352	167	25	and	and	CCONJ
ct-9352	167	26	prolactin	prolactin	ADJ
ct-9352	167	27	secretion	secretion	NOUN
ct-9352	167	28	,	,	PUNCT
ct-9352	167	29	storage	storage	NOUN
ct-9352	167	30	and	and	CCONJ
ct-9352	167	31	response	response	NOUN
ct-9352	167	32	to	to	ADP
ct-9352	167	33	secretagogue	secretagogue	NOUN
ct-9352	167	34	and	and	CCONJ
ct-9352	167	35	hypothalamic	hypothalamic	ADJ
ct-9352	167	36	gnrh	gnrh	NOUN
ct-9352	167	37	content	content	NOUN
ct-9352	167	38	in	in	ADP
ct-9352	167	39	ovariectomized	ovariectomize	VERB
ct-9352	167	40	pony	pony	NOUN
ct-9352	167	41	mares	mare	NOUN
ct-9352	167	42	administered	administer	VERB
ct-9352	167	43	testosterone	testosterone	NOUN
ct-9352	167	44	,	,	PUNCT
ct-9352	167	45	dihydrotestosterone	dihydrotestosterone	NOUN
ct-9352	167	46	,	,	PUNCT
ct-9352	167	47	estradiol	estradiol	PROPN
ct-9352	167	48	,	,	PUNCT
ct-9352	167	49	progesterone	progesterone	NOUN
ct-9352	167	50	,	,	PUNCT
ct-9352	167	51	dexamethasone	dexamethasone	NOUN
ct-9352	167	52	or	or	CCONJ
ct-9352	167	53	follicular	follicular	ADJ
ct-9352	167	54	fluid	fluid	NOUN
ct-9352	167	55	.	.	PUNCT
ct-9352	168	1	domest	domest	PROPN
ct-9352	168	2	anim	anim	NOUN
ct-9352	168	3	endocrinol	endocrinol	NOUN
ct-9352	168	4	1991;8:189	1991;8:189	PROPN
ct-9352	168	5	-	-	PUNCT
ct-9352	168	6	199	199	NUM
ct-9352	168	7	.	.	PUNCT
ct-9352	168	8	31	31	NUM
ct-9352	168	9	.	.	PUNCT
ct-9352	169	1	ferris	ferris	PROPN
ct-9352	169	2	ra	ra	PROPN
ct-9352	169	3	,	,	PUNCT
ct-9352	169	4	mccue	mccue	PROPN
ct-9352	169	5	pm	pm	PROPN
ct-9352	169	6	:	:	PUNCT
ct-9352	169	7	the	the	DET
ct-9352	169	8	effects	effect	NOUN
ct-9352	169	9	of	of	ADP
ct-9352	169	10	dexamethasone	dexamethasone	NOUN
ct-9352	169	11	and	and	CCONJ
ct-9352	169	12	prednisolone	prednisolone	PROPN
ct-9352	169	13	on	on	ADP
ct-9352	169	14	pituitary	pituitary	ADJ
ct-9352	169	15	and	and	CCONJ
ct-9352	169	16	ovarian	ovarian	ADJ
ct-9352	169	17	function	function	NOUN
ct-9352	169	18	in	in	ADP
ct-9352	169	19	the	the	DET
ct-9352	169	20	mare	mare	NOUN
ct-9352	169	21	.	.	PUNCT
ct-9352	170	1	equine	equine	PROPN
ct-9352	170	2	vet	vet	PROPN
ct-9352	170	3	j	j	PROPN
ct-9352	170	4	2010;42:438	2010;42:438	PROPN
ct-9352	170	5	-	-	NUM
ct-9352	170	6	443	443	NUM
ct-9352	170	7	.	.	PUNCT
ct-9352	170	8	32	32	NUM
ct-9352	170	9	.	.	PUNCT
ct-9352	171	1	fumuso	fumuso	PROPN
ct-9352	171	2	ea	ea	PROPN
ct-9352	171	3	,	,	PUNCT
ct-9352	171	4	aguilar	aguilar	PROPN
ct-9352	171	5	j	j	PROPN
ct-9352	171	6	,	,	PUNCT
ct-9352	171	7	giguere	giguere	NOUN
ct-9352	171	8	s	s	X
ct-9352	171	9	,	,	PUNCT
ct-9352	171	10	et	et	PROPN
ct-9352	171	11	al	al	PROPN
ct-9352	171	12	:	:	PUNCT
ct-9352	171	13	immune	immune	ADJ
ct-9352	171	14	parameters	parameter	NOUN
ct-9352	171	15	in	in	ADP
ct-9352	171	16	mares	mare	NOUN
ct-9352	171	17	resistant	resistant	ADJ
ct-9352	171	18	and	and	CCONJ
ct-9352	171	19	susceptible	susceptible	ADJ
ct-9352	171	20	to	to	ADP
ct-9352	171	21	persistent	persistent	ADJ
ct-9352	171	22	post	post	ADJ
ct-9352	171	23	-	-	ADJ
ct-9352	171	24	breeding	breeding	ADJ
ct-9352	171	25	endometritis	endometritis	NOUN
ct-9352	171	26	:	:	PUNCT
ct-9352	171	27	effects	effect	NOUN
ct-9352	171	28	of	of	ADP
ct-9352	171	29	immunomodulation	immunomodulation	NOUN
ct-9352	171	30	.	.	PUNCT
ct-9352	172	1	vet	vet	NOUN
ct-9352	172	2	immunol	immunol	NOUN
ct-9352	172	3	immunopathol	immunopathol	VERB
ct-9352	172	4	2007:30	2007:30	NOUN
ct-9352	172	5	-	-	SYM
ct-9352	172	6	39	39	NUM
ct-9352	172	7	.	.	PUNCT
ct-9352	173	1	33	33	NUM
ct-9352	173	2	.	.	PUNCT
ct-9352	174	1	rogan	rogan	PROPN
ct-9352	174	2	d	d	PROPN
ct-9352	174	3	,	,	PUNCT
ct-9352	174	4	fumuso	fumuso	PROPN
ct-9352	174	5	e	e	PROPN
ct-9352	174	6	,	,	PUNCT
ct-9352	174	7	rodriguez	rodriguez	PROPN
ct-9352	174	8	e	e	PROPN
ct-9352	174	9	,	,	PUNCT
ct-9352	174	10	et	et	PROPN
ct-9352	174	11	al	al	PROPN
ct-9352	174	12	:	:	PUNCT
ct-9352	174	13	use	use	NOUN
ct-9352	174	14	of	of	ADP
ct-9352	174	15	a	a	DET
ct-9352	174	16	mycobacterial	mycobacterial	ADJ
ct-9352	174	17	cell	cell	NOUN
ct-9352	174	18	wall	wall	NOUN
ct-9352	174	19	extract	extract	NOUN
ct-9352	174	20	(	(	PUNCT
ct-9352	174	21	mcwe	mcwe	NOUN
ct-9352	174	22	)	)	PUNCT
ct-9352	174	23	in	in	ADP
ct-9352	174	24	susceptible	susceptible	ADJ
ct-9352	174	25	mares	mare	NOUN
ct-9352	174	26	to	to	PART
ct-9352	174	27	clear	clear	VERB
ct-9352	174	28	experimentally	experimentally	ADV
ct-9352	174	29	induced	induce	VERB
ct-9352	174	30	endometritis	endometritis	NOUN
ct-9352	174	31	with	with	ADP
ct-9352	174	32	streptococcus	streptococcus	NOUN
ct-9352	174	33	zooepidemicus	zooepidemicus	NOUN
ct-9352	174	34	.	.	PUNCT
ct-9352	175	1	j	j	PROPN
ct-9352	175	2	eq	eq	PROPN
ct-9352	175	3	vet	vet	PROPN
ct-9352	175	4	sci	sci	PROPN
ct-9352	175	5	2007;27:112	2007;27:112	PROPN
ct-9352	175	6	-	-	PUNCT
ct-9352	175	7	117	117	NUM
ct-9352	175	8	.	.	PUNCT
ct-9352	175	9	34	34	NUM
ct-9352	175	10	.	.	PUNCT
ct-9352	176	1	dewes	dewes	PROPN
ct-9352	176	2	hf	hf	PROPN
ct-9352	176	3	.	.	PUNCT
ct-9352	177	1	preliminary	preliminary	ADJ
ct-9352	177	2	observations	observation	NOUN
ct-9352	177	3	on	on	ADP
ct-9352	177	4	the	the	DET
ct-9352	177	5	use	use	NOUN
ct-9352	177	6	of	of	ADP
ct-9352	177	7	colostrum	colostrum	NOUN
ct-9352	177	8	as	as	ADP
ct-9352	177	9	an	an	DET
ct-9352	177	10	uterine	uterine	ADJ
ct-9352	177	11	infusion	infusion	NOUN
ct-9352	177	12	in	in	ADP
ct-9352	177	13	thoroughbred	thoroughbred	ADJ
ct-9352	177	14	mares	mare	NOUN
ct-9352	177	15	.	.	PUNCT
ct-9352	178	1	n	n	PRON
ct-9352	178	2	z	z	PROPN
ct-9352	178	3	vet	vet	NOUN
ct-9352	178	4	j	j	PROPN
ct-9352	178	5	1980;28:7	1980;28:7	NUM
ct-9352	178	6	-	-	SYM
ct-9352	178	7	8	8	NUM
ct-9352	178	8	.	.	NOUN
ct-9352	178	9	35	35	NUM
ct-9352	178	10	.	.	PUNCT
ct-9352	179	1	troedsson	troedsson	PROPN
ct-9352	179	2	mh	mh	PROPN
ct-9352	179	3	,	,	PUNCT
ct-9352	179	4	liu	liu	PROPN
ct-9352	179	5	ik	ik	PROPN
ct-9352	179	6	,	,	PUNCT
ct-9352	179	7	thurmond	thurmond	PROPN
ct-9352	179	8	m	m	PROPN
ct-9352	179	9	:	:	PUNCT
ct-9352	179	10	function	function	NOUN
ct-9352	179	11	of	of	ADP
ct-9352	179	12	uterine	uterine	NOUN
ct-9352	179	13	and	and	CCONJ
ct-9352	179	14	blood	blood	NOUN
ct-9352	179	15	-	-	PUNCT
ct-9352	179	16	derived	derive	VERB
ct-9352	179	17	polymorphonuclear	polymorphonuclear	NOUN
ct-9352	179	18	neutrophils	neutrophil	NOUN
ct-9352	179	19	in	in	ADP
ct-9352	179	20	mares	mare	NOUN
ct-9352	179	21	susceptible	susceptible	ADJ
ct-9352	179	22	and	and	CCONJ
ct-9352	179	23	resistant	resistant	ADJ
ct-9352	179	24	to	to	ADP
ct-9352	179	25	chronic	chronic	ADJ
ct-9352	179	26	uterine	uterine	ADJ
ct-9352	179	27	infection	infection	NOUN
ct-9352	179	28	:	:	PUNCT
ct-9352	179	29	phagocytosis	phagocytosis	NOUN
ct-9352	179	30	and	and	CCONJ
ct-9352	179	31	chemotaxis	chemotaxis	ADJ
ct-9352	179	32	.	.	PUNCT
ct-9352	180	1	biol	biol	PROPN
ct-9352	180	2	reprod	reprod	PROPN
ct-9352	180	3	1993;49:507	1993;49:507	NUM
ct-9352	180	4	-	-	SYM
ct-9352	180	5	514	514	NUM
ct-9352	180	6	.	.	PUNCT
ct-9352	180	7	36	36	NUM
ct-9352	180	8	.	.	PUNCT
ct-9352	181	1	mattos	mattos	PROPN
ct-9352	181	2	rc	rc	PROPN
ct-9352	181	3	,	,	PUNCT
ct-9352	181	4	malschitzky	malschitzky	ADJ
ct-9352	181	5	e	e	NOUN
ct-9352	181	6	,	,	PUNCT
ct-9352	181	7	mattos	mattos	PROPN
ct-9352	181	8	r	r	NOUN
ct-9352	181	9	,	,	PUNCT
ct-9352	181	10	et	et	PROPN
ct-9352	181	11	al	al	PROPN
ct-9352	181	12	:	:	PUNCT
ct-9352	181	13	effects	effect	NOUN
ct-9352	181	14	of	of	ADP
ct-9352	181	15	different	different	ADJ
ct-9352	181	16	post	post	ADJ
ct-9352	181	17	-	-	ADJ
ct-9352	181	18	breeding	breeding	ADJ
ct-9352	181	19	treatments	treatment	NOUN
ct-9352	181	20	on	on	ADP
ct-9352	181	21	fertility	fertility	NOUN
ct-9352	181	22	of	of	ADP
ct-9352	181	23	thoroughbred	thoroughbred	ADJ
ct-9352	181	24	mares	mare	NOUN
ct-9352	181	25	.	.	PUNCT
ct-9352	182	1	pferdeheilkunde	pferdeheilkunde	ADJ
ct-9352	182	2	1997;13:512	1997;13:512	NOUN
ct-9352	182	3	-	-	SYM
ct-9352	182	4	515	515	NUM
ct-9352	182	5	.	.	PUNCT
ct-9352	182	6	37	37	NUM
ct-9352	182	7	.	.	PUNCT
ct-9352	183	1	asbury	asbury	PROPN
ct-9352	183	2	ac	ac	PROPN
ct-9352	183	3	.	.	PROPN
ct-9352	183	4	uterine	uterine	PROPN
ct-9352	183	5	defense	defense	NOUN
ct-9352	183	6	mechanisms	mechanism	NOUN
ct-9352	183	7	in	in	ADP
ct-9352	183	8	the	the	DET
ct-9352	183	9	mare	mare	NOUN
ct-9352	183	10	:	:	PUNCT
ct-9352	183	11	the	the	DET
ct-9352	183	12	use	use	NOUN
ct-9352	183	13	of	of	ADP
ct-9352	183	14	intrauterine	intrauterine	ADJ
ct-9352	183	15	plasma	plasma	NOUN
ct-9352	183	16	in	in	ADP
ct-9352	183	17	the	the	DET
ct-9352	183	18	management	management	NOUN
ct-9352	183	19	of	of	ADP
ct-9352	183	20	endometritis	endometritis	PROPN
ct-9352	183	21	.	.	PUNCT
ct-9352	184	1	theriogenology	theriogenology	NOUN
ct-9352	184	2	1984;21:387	1984;21:387	ADV
ct-9352	184	3	-	-	SYM
ct-9352	184	4	393	393	NUM
ct-9352	184	5	.	.	PUNCT
ct-9352	185	1	38	38	NUM
ct-9352	185	2	.	.	PUNCT
ct-9352	186	1	colbern	colbern	PROPN
ct-9352	186	2	gt	gt	PROPN
ct-9352	186	3	,	,	PUNCT
ct-9352	186	4	voss	voss	PROPN
ct-9352	186	5	jl	jl	PROPN
ct-9352	186	6	,	,	PUNCT
ct-9352	186	7	squires	squires	PROPN
ct-9352	186	8	el	el	PROPN
ct-9352	186	9	,	,	PUNCT
ct-9352	186	10	et	et	PROPN
ct-9352	186	11	al	al	PROPN
ct-9352	186	12	:	:	PUNCT
ct-9352	186	13	intrauterine	intrauterine	ADJ
ct-9352	186	14	equine	equine	NOUN
ct-9352	186	15	plasma	plasma	NOUN
ct-9352	186	16	as	as	ADP
ct-9352	186	17	an	an	DET
ct-9352	186	18	endometritis	endometritis	NOUN
ct-9352	186	19	therapy	therapy	NOUN
ct-9352	186	20	:	:	PUNCT
ct-9352	186	21	use	use	NOUN
ct-9352	186	22	of	of	ADP
ct-9352	186	23	an	an	DET
ct-9352	186	24	endometritis	endometritis	NOUN
ct-9352	186	25	model	model	NOUN
ct-9352	186	26	to	to	PART
ct-9352	186	27	evaluate	evaluate	VERB
ct-9352	186	28	efficacy	efficacy	NOUN
ct-9352	186	29	.	.	PUNCT
ct-9352	187	1	equine	equine	NOUN
ct-9352	187	2	vet	vet	PROPN
ct-9352	187	3	j	j	PROPN
ct-9352	187	4	1987;7:66	1987;7:66	PROPN
ct-9352	187	5	-	-	PUNCT
ct-9352	187	6	68	68	NUM
ct-9352	187	7	.	.	NOUN
ct-9352	187	8	39	39	NUM
ct-9352	187	9	.	.	PUNCT
ct-9352	188	1	troedsson	troedsson	PROPN
ct-9352	188	2	mh	mh	PROPN
ct-9352	188	3	,	,	PUNCT
ct-9352	188	4	scott	scott	PROPN
ct-9352	188	5	ma	ma	PROPN
ct-9352	188	6	,	,	PUNCT
ct-9352	188	7	liu	liu	PROPN
ct-9352	188	8	ik	ik	PROPN
ct-9352	188	9	:	:	PUNCT
ct-9352	188	10	comparative	comparative	ADJ
ct-9352	188	11	treatment	treatment	NOUN
ct-9352	188	12	of	of	ADP
ct-9352	188	13	mares	mare	NOUN
ct-9352	188	14	susceptible	susceptible	ADJ
ct-9352	188	15	to	to	ADP
ct-9352	188	16	chronic	chronic	ADJ
ct-9352	188	17	uterine	uterine	ADJ
ct-9352	188	18	infection	infection	NOUN
ct-9352	188	19	.	.	PUNCT
ct-9352	189	1	am	be	AUX
ct-9352	189	2	j	j	PROPN
ct-9352	189	3	vet	vet	NOUN
ct-9352	189	4	res	re	NOUN
ct-9352	189	5	1995;56:468	1995;56:468	NUM
ct-9352	189	6	-	-	SYM
ct-9352	189	7	472	472	NUM
ct-9352	189	8	.	.	PUNCT
ct-9352	190	1	40	40	NUM
ct-9352	190	2	.	.	PUNCT
ct-9352	191	1	andia	andia	PROPN
ct-9352	191	2	i	i	PRON
ct-9352	191	3	,	,	PUNCT
ct-9352	191	4	abate	abate	VERB
ct-9352	191	5	m	m	PRON
ct-9352	191	6	:	:	PUNCT
ct-9352	191	7	platelet	platelet	ADJ
ct-9352	191	8	-	-	PUNCT
ct-9352	191	9	rich	rich	ADJ
ct-9352	191	10	plasma	plasma	NOUN
ct-9352	191	11	:	:	PUNCT
ct-9352	191	12	combinational	combinational	ADJ
ct-9352	191	13	treatment	treatment	NOUN
ct-9352	191	14	modalities	modality	NOUN
ct-9352	191	15	for	for	ADP
ct-9352	191	16	musculoskeletal	musculoskeletal	ADJ
ct-9352	191	17	conditions	condition	NOUN
ct-9352	191	18	.	.	PUNCT
ct-9352	192	1	front	front	ADJ
ct-9352	192	2	med	med	ADJ
ct-9352	192	3	2018;12:139	2018;12:139	PROPN
ct-9352	192	4	-	-	SYM
ct-9352	192	5	152	152	NUM
ct-9352	192	6	.	.	PUNCT
ct-9352	192	7	41	41	NUM
ct-9352	192	8	.	.	PUNCT
ct-9352	193	1	emer	emer	PROPN
ct-9352	193	2	j	j	PROPN
ct-9352	193	3	:	:	PUNCT
ct-9352	193	4	platelet	platelet	ADJ
ct-9352	193	5	-	-	PUNCT
ct-9352	193	6	rich	rich	ADJ
ct-9352	193	7	plasma	plasma	NOUN
ct-9352	193	8	(	(	PUNCT
ct-9352	193	9	prp	prp	NOUN
ct-9352	193	10	):	):	PUNCT
ct-9352	193	11	current	current	ADJ
ct-9352	193	12	applications	application	NOUN
ct-9352	193	13	in	in	ADP
ct-9352	193	14	dermatology	dermatology	NOUN
ct-9352	193	15	.	.	PUNCT
ct-9352	194	1	skin	skin	NOUN
ct-9352	194	2	therapy	therapy	NOUN
ct-9352	194	3	lett	lett	PROPN
ct-9352	194	4	2019;24:1	2019;24:1	PROPN
ct-9352	194	5	-	-	SYM
ct-9352	194	6	6	6	NUM
ct-9352	194	7	.	.	PUNCT
ct-9352	194	8	clinical	clinical	ADJ
ct-9352	194	9	theriogenology	theriogenology	NOUN
ct-9352	194	10	2021	2021	NUM
ct-9352	194	11	;	;	PUNCT
ct-9352	194	12	13	13	NUM
ct-9352	194	13	:	:	SYM
ct-9352	194	14	244	244	NUM
ct-9352	194	15	42	42	NUM
ct-9352	194	16	.	.	PUNCT
ct-9352	195	1	etulain	etulain	VERB
ct-9352	195	2	j	j	NOUN
ct-9352	195	3	:	:	PUNCT
ct-9352	195	4	platelets	platelet	VERB
ct-9352	195	5	in	in	ADP
ct-9352	195	6	wound	wound	NOUN
ct-9352	195	7	healing	healing	NOUN
ct-9352	195	8	and	and	CCONJ
ct-9352	195	9	regenerative	regenerative	ADJ
ct-9352	195	10	medicine	medicine	NOUN
ct-9352	195	11	.	.	PUNCT
ct-9352	196	1	platelets	platelet	NOUN
ct-9352	196	2	.	.	PUNCT
ct-9352	197	1	2018;29:556	2018;29:556	X
ct-9352	197	2	-	-	SYM
ct-9352	197	3	68	68	NUM
ct-9352	197	4	.	.	PUNCT
ct-9352	198	1	43	43	NUM
ct-9352	198	2	.	.	PUNCT
ct-9352	199	1	harmon	harmon	PROPN
ct-9352	199	2	kg	kg	PROPN
ct-9352	199	3	,	,	PUNCT
ct-9352	199	4	rao	rao	PROPN
ct-9352	199	5	al	al	PROPN
ct-9352	199	6	:	:	PUNCT
ct-9352	199	7	the	the	DET
ct-9352	199	8	use	use	NOUN
ct-9352	199	9	of	of	ADP
ct-9352	199	10	platelet	platelet	ADJ
ct-9352	199	11	-	-	PUNCT
ct-9352	199	12	rich	rich	ADJ
ct-9352	199	13	plasma	plasma	NOUN
ct-9352	199	14	in	in	ADP
ct-9352	199	15	the	the	DET
ct-9352	199	16	nonsurgical	nonsurgical	ADJ
ct-9352	199	17	management	management	NOUN
ct-9352	199	18	of	of	ADP
ct-9352	199	19	sports	sport	NOUN
ct-9352	199	20	injuries	injury	NOUN
ct-9352	199	21	:	:	PUNCT
ct-9352	199	22	hype	hype	NOUN
ct-9352	199	23	or	or	CCONJ
ct-9352	199	24	hope	hope	NOUN
ct-9352	199	25	?	?	PUNCT
ct-9352	200	1	hematology	hematology	NOUN
ct-9352	200	2	am	be	AUX
ct-9352	200	3	soc	soc	NOUN
ct-9352	200	4	hematol	hematol	NOUN
ct-9352	200	5	educ	educ	PROPN
ct-9352	200	6	program	program	NOUN
ct-9352	200	7	2013;2013:620	2013;2013:620	NUM
ct-9352	200	8	-	-	PUNCT
ct-9352	200	9	626	626	NUM
ct-9352	200	10	.	.	PUNCT
ct-9352	201	1	44	44	NUM
ct-9352	201	2	segabinazzi	segabinazzi	NOUN
ct-9352	201	3	lg	lg	NOUN
ct-9352	201	4	,	,	PUNCT
ct-9352	201	5	friso	friso	PROPN
ct-9352	201	6	am	be	AUX
ct-9352	201	7	,	,	PUNCT
ct-9352	201	8	correal	correal	NOUN
ct-9352	201	9	sb	sb	PROPN
ct-9352	201	10	,	,	PUNCT
ct-9352	201	11	et	et	PROPN
ct-9352	201	12	al	al	PROPN
ct-9352	201	13	.	.	PROPN
ct-9352	201	14	uterine	uterine	ADJ
ct-9352	201	15	clinical	clinical	ADJ
ct-9352	201	16	findings	finding	NOUN
ct-9352	201	17	,	,	PUNCT
ct-9352	201	18	fertility	fertility	NOUN
ct-9352	201	19	rate	rate	NOUN
ct-9352	201	20	,	,	PUNCT
ct-9352	201	21	leucocyte	leucocyte	PROPN
ct-9352	201	22	migration	migration	NOUN
ct-9352	201	23	,	,	PUNCT
ct-9352	201	24	and	and	CCONJ
ct-9352	201	25	cox-2	cox-2	NOUN
ct-9352	201	26	protein	protein	NOUN
ct-9352	201	27	levels	level	NOUN
ct-9352	201	28	in	in	ADP
ct-9352	201	29	the	the	DET
ct-9352	201	30	endometrial	endometrial	ADJ
ct-9352	201	31	tissue	tissue	NOUN
ct-9352	201	32	of	of	ADP
ct-9352	201	33	susceptible	susceptible	ADJ
ct-9352	201	34	mares	mare	NOUN
ct-9352	201	35	treated	treat	VERB
ct-9352	201	36	with	with	ADP
ct-9352	201	37	platelet	platelet	ADJ
ct-9352	201	38	-	-	PUNCT
ct-9352	201	39	rich	rich	ADJ
ct-9352	201	40	plasma	plasma	NOUN
ct-9352	201	41	before	before	ADP
ct-9352	201	42	and	and	CCONJ
ct-9352	201	43	after	after	ADP
ct-9352	201	44	ai	ai	PROPN
ct-9352	201	45	.	.	PROPN
ct-9352	201	46	theriogenology	theriogenology	NOUN
ct-9352	201	47	2017;104:120	2017;104:120	PROPN
ct-9352	201	48	-	-	SYM
ct-9352	201	49	126	126	NUM
ct-9352	201	50	.	.	PUNCT
ct-9352	202	1	45	45	NUM
ct-9352	202	2	.	.	PUNCT
ct-9352	202	3	reghini	reghini	PROPN
ct-9352	202	4	mf	mf	PROPN
ct-9352	202	5	,	,	PUNCT
ct-9352	202	6	ramires	ramires	PROPN
ct-9352	202	7	neto	neto	PROPN
ct-9352	202	8	c	c	PROPN
ct-9352	202	9	,	,	PUNCT
ct-9352	202	10	segabinazzi	segabinazzi	NOUN
ct-9352	202	11	lg	lg	NOUN
ct-9352	202	12	,	,	PUNCT
ct-9352	202	13	et	et	PROPN
ct-9352	202	14	al	al	PROPN
ct-9352	202	15	:	:	PUNCT
ct-9352	202	16	inflammatory	inflammatory	ADJ
ct-9352	202	17	response	response	NOUN
ct-9352	202	18	in	in	ADP
ct-9352	202	19	chronic	chronic	ADJ
ct-9352	202	20	degenerative	degenerative	ADJ
ct-9352	202	21	endometritis	endometritis	PROPN
ct-9352	202	22	mares	mare	NOUN
ct-9352	202	23	treated	treat	VERB
ct-9352	202	24	with	with	ADP
ct-9352	202	25	platelet	platelet	ADJ
ct-9352	202	26	-	-	PUNCT
ct-9352	202	27	rich	rich	ADJ
ct-9352	202	28	plasma	plasma	NOUN
ct-9352	202	29	.	.	PUNCT
ct-9352	203	1	theriogenology	theriogenology	NOUN
ct-9352	203	2	2016;86:516	2016;86:516	NUM
ct-9352	203	3	-	-	SYM
ct-9352	203	4	522	522	NUM
ct-9352	203	5	.	.	PUNCT
ct-9352	203	6	46	46	NUM
ct-9352	203	7	.	.	PUNCT
ct-9352	203	8	metcalf	metcalf	PROPN
ct-9352	203	9	es	es	PROPN
ct-9352	203	10	,	,	PUNCT
ct-9352	203	11	scoggin	scoggin	NOUN
ct-9352	203	12	ke	ke	PROPN
ct-9352	203	13	,	,	PUNCT
ct-9352	203	14	troedsson	troedsson	NOUN
ct-9352	203	15	mht	mht	NOUN
ct-9352	203	16	:	:	PUNCT
ct-9352	203	17	the	the	DET
ct-9352	203	18	effect	effect	NOUN
ct-9352	203	19	of	of	ADP
ct-9352	203	20	platelet	platelet	ADJ
ct-9352	203	21	-	-	PUNCT
ct-9352	203	22	rich	rich	ADJ
ct-9352	203	23	plasma	plasma	NOUN
ct-9352	203	24	on	on	ADP
ct-9352	203	25	endometrial	endometrial	ADJ
ct-9352	203	26	pro	pro	ADJ
ct-9352	203	27	-	-	ADJ
ct-9352	203	28	inflammatory	inflammatory	ADJ
ct-9352	203	29	cytokines	cytokine	NOUN
ct-9352	203	30	in	in	ADP
ct-9352	203	31	susceptible	susceptible	ADJ
ct-9352	203	32	mares	mare	NOUN
ct-9352	203	33	following	follow	VERB
ct-9352	203	34	semen	semen	NOUN
ct-9352	203	35	deposition	deposition	NOUN
ct-9352	203	36	.	.	PUNCT
ct-9352	204	1	j	j	PROPN
ct-9352	204	2	eq	eq	PROPN
ct-9352	204	3	vet	vet	PROPN
ct-9352	204	4	sci	sci	PROPN
ct-9352	204	5	2012;32:498	2012;32:498	NUM
ct-9352	204	6	.	.	PUNCT
ct-9352	205	1	47	47	NUM
ct-9352	205	2	.	.	PUNCT
ct-9352	206	1	metcalf	metcalf	PROPN
ct-9352	206	2	es	es	PROPN
ct-9352	206	3	:	:	PUNCT
ct-9352	206	4	the	the	DET
ct-9352	206	5	effect	effect	NOUN
ct-9352	206	6	of	of	ADP
ct-9352	206	7	platelet	platelet	ADJ
ct-9352	206	8	-	-	PUNCT
ct-9352	206	9	rich	rich	ADJ
ct-9352	206	10	plasma	plasma	NOUN
ct-9352	206	11	(	(	PUNCT
ct-9352	206	12	prp	prp	PROPN
ct-9352	206	13	)	)	PUNCT
ct-9352	206	14	on	on	ADP
ct-9352	206	15	intraluminal	intraluminal	ADJ
ct-9352	206	16	fluid	fluid	NOUN
ct-9352	206	17	and	and	CCONJ
ct-9352	206	18	pregnancy	pregnancy	NOUN
ct-9352	206	19	rates	rate	NOUN
ct-9352	206	20	in	in	ADP
ct-9352	206	21	mares	mare	NOUN
ct-9352	206	22	susceptible	susceptible	ADJ
ct-9352	206	23	to	to	ADP
ct-9352	206	24	persistent	persistent	ADJ
ct-9352	206	25	mating	mating	NOUN
ct-9352	206	26	-	-	PUNCT
ct-9352	206	27	induced	induce	VERB
ct-9352	206	28	endometritis	endometritis	NOUN
ct-9352	206	29	(	(	PUNCT
ct-9352	206	30	pmie	pmie	PROPN
ct-9352	206	31	)	)	PUNCT
ct-9352	206	32	.	.	PUNCT
ct-9352	207	1	j	j	PROPN
ct-9352	207	2	equine	equine	PROPN
ct-9352	207	3	vet	vet	NOUN
ct-9352	207	4	sci	sci	PROPN
ct-9352	207	5	2014;34	2014;34	NUM
ct-9352	207	6	.	.	PUNCT
ct-9352	208	1	48	48	NUM
ct-9352	208	2	.	.	PUNCT
ct-9352	209	1	actor	actor	PROPN
ct-9352	209	2	jk	jk	PROPN
ct-9352	209	3	,	,	PUNCT
ct-9352	209	4	hwang	hwang	PROPN
ct-9352	209	5	sa	sa	PROPN
ct-9352	209	6	,	,	PUNCT
ct-9352	209	7	kruzel	kruzel	PROPN
ct-9352	209	8	ml	ml	PART
ct-9352	209	9	:	:	PUNCT
ct-9352	209	10	lactoferrin	lactoferrin	VERB
ct-9352	209	11	as	as	ADP
ct-9352	209	12	a	a	DET
ct-9352	209	13	natural	natural	ADJ
ct-9352	209	14	immune	immune	ADJ
ct-9352	209	15	modulator	modulator	NOUN
ct-9352	209	16	.	.	PUNCT
ct-9352	210	1	curr	curr	PROPN
ct-9352	210	2	pharm	pharm	PROPN
ct-9352	210	3	des	des	PROPN
ct-9352	210	4	2009;15:1956	2009;15:1956	PROPN
ct-9352	210	5	-	-	SYM
ct-9352	210	6	1973	1973	NUM
ct-9352	210	7	.	.	PUNCT
ct-9352	211	1	49	49	NUM
ct-9352	211	2	.	.	PUNCT
ct-9352	212	1	arnold	arnold	PROPN
ct-9352	212	2	rr	rr	PROPN
ct-9352	212	3	,	,	PUNCT
ct-9352	212	4	cole	cole	PROPN
ct-9352	212	5	mf	mf	PROPN
ct-9352	212	6	,	,	PUNCT
ct-9352	212	7	mcghee	mcghee	PROPN
ct-9352	212	8	jr	jr	PROPN
ct-9352	212	9	.	.	PUNCT
ct-9352	213	1	a	a	DET
ct-9352	213	2	bactericidal	bactericidal	ADJ
ct-9352	213	3	effect	effect	NOUN
ct-9352	213	4	for	for	ADP
ct-9352	213	5	human	human	ADJ
ct-9352	213	6	lactoferrin	lactoferrin	NOUN
ct-9352	213	7	.	.	PUNCT
ct-9352	214	1	science	science	NOUN
ct-9352	214	2	1977;197:263	1977;197:263	PROPN
ct-9352	214	3	-	-	SYM
ct-9352	214	4	265	265	NUM
ct-9352	214	5	.	.	PUNCT
ct-9352	214	6	50	50	NUM
ct-9352	214	7	.	.	PUNCT
ct-9352	215	1	gonzalez	gonzalez	PROPN
ct-9352	215	2	-	-	PUNCT
ct-9352	215	3	chavez	chavez	PROPN
ct-9352	215	4	sa	sa	PROPN
ct-9352	215	5	,	,	PUNCT
ct-9352	215	6	arevalo	arevalo	PROPN
ct-9352	215	7	-	-	PUNCT
ct-9352	215	8	gallegos	gallegos	PROPN
ct-9352	215	9	s	s	PROPN
ct-9352	215	10	,	,	PUNCT
ct-9352	215	11	rascon	rascon	NOUN
ct-9352	215	12	-	-	PUNCT
ct-9352	215	13	cruz	cruz	NOUN
ct-9352	215	14	q	q	NOUN
ct-9352	215	15	:	:	PUNCT
ct-9352	215	16	lactoferrin	lactoferrin	NOUN
ct-9352	215	17	:	:	PUNCT
ct-9352	215	18	structure	structure	NOUN
ct-9352	215	19	,	,	PUNCT
ct-9352	215	20	function	function	NOUN
ct-9352	215	21	and	and	CCONJ
ct-9352	215	22	applications	application	NOUN
ct-9352	215	23	.	.	PUNCT
ct-9352	216	1	int	int	NOUN
ct-9352	216	2	j	j	PROPN
ct-9352	216	3	antimicrob	antimicrob	PROPN
ct-9352	216	4	agents	agent	NOUN
ct-9352	216	5	2009;33:301	2009;33:301	NUM
ct-9352	216	6	e1	e1	NOUN
ct-9352	216	7	-	-	PUNCT
ct-9352	216	8	8	8	NUM
ct-9352	216	9	.	.	PUNCT
ct-9352	216	10	51	51	NUM
ct-9352	216	11	.	.	PUNCT
ct-9352	217	1	fedorka	fedorka	PROPN
ct-9352	217	2	ce	ce	PROPN
ct-9352	217	3	,	,	PUNCT
ct-9352	217	4	scoggin	scoggin	VERB
ct-9352	217	5	ke	ke	PROPN
ct-9352	217	6	,	,	PUNCT
ct-9352	217	7	boakari	boakari	NOUN
ct-9352	217	8	yl	yl	NOUN
ct-9352	217	9	,	,	PUNCT
ct-9352	217	10	et	et	PROPN
ct-9352	217	11	al	al	PROPN
ct-9352	217	12	:	:	PUNCT
ct-9352	217	13	the	the	DET
ct-9352	217	14	anti	anti	ADJ
ct-9352	217	15	-	-	ADJ
ct-9352	217	16	inflammatory	inflammatory	ADJ
ct-9352	217	17	effect	effect	NOUN
ct-9352	217	18	of	of	ADP
ct-9352	217	19	exogenous	exogenous	ADJ
ct-9352	217	20	lactoferrin	lactoferrin	NOUN
ct-9352	217	21	on	on	ADP
ct-9352	217	22	breeding	breed	VERB
ct-9352	217	23	-	-	PUNCT
ct-9352	217	24	induced	induce	VERB
ct-9352	217	25	endometritis	endometritis	NOUN
ct-9352	217	26	when	when	SCONJ
ct-9352	217	27	administered	administer	VERB
ct-9352	217	28	post	post	NOUN
ct-9352	217	29	-	-	ADJ
ct-9352	217	30	breeding	breeding	NOUN
ct-9352	217	31	in	in	ADP
ct-9352	217	32	susceptible	susceptible	ADJ
ct-9352	217	33	mares	mare	NOUN
ct-9352	217	34	.	.	PUNCT
ct-9352	218	1	theriogenology	theriogenology	NOUN
ct-9352	218	2	2018;114:63	2018;114:63	NUM
ct-9352	218	3	-	-	SYM
ct-9352	218	4	69	69	NUM
ct-9352	218	5	.	.	PUNCT
ct-9352	218	6	52	52	NUM
ct-9352	218	7	.	.	PUNCT
ct-9352	219	1	fedorka	fedorka	PROPN
ct-9352	219	2	ce	ce	PROPN
ct-9352	219	3	,	,	PUNCT
ct-9352	219	4	scoggin	scoggin	VERB
ct-9352	219	5	ke	ke	PROPN
ct-9352	219	6	,	,	PUNCT
ct-9352	219	7	woodward	woodward	NOUN
ct-9352	219	8	em	em	PRON
ct-9352	219	9	,	,	PUNCT
ct-9352	219	10	et	et	PROPN
ct-9352	219	11	al	al	PROPN
ct-9352	219	12	:	:	PUNCT
ct-9352	219	13	the	the	DET
ct-9352	219	14	effect	effect	NOUN
ct-9352	219	15	of	of	ADP
ct-9352	219	16	select	select	ADJ
ct-9352	219	17	seminal	seminal	ADJ
ct-9352	219	18	plasma	plasma	NOUN
ct-9352	219	19	proteins	protein	NOUN
ct-9352	219	20	on	on	ADP
ct-9352	219	21	endometrial	endometrial	ADJ
ct-9352	219	22	mrna	mrna	NOUN
ct-9352	219	23	cytokine	cytokine	NOUN
ct-9352	219	24	expression	expression	NOUN
ct-9352	219	25	in	in	ADP
ct-9352	219	26	mares	mare	NOUN
ct-9352	219	27	susceptible	susceptible	ADJ
ct-9352	219	28	to	to	ADP
ct-9352	219	29	persistent	persistent	ADJ
ct-9352	219	30	mating	mating	NOUN
ct-9352	219	31	-	-	PUNCT
ct-9352	219	32	induced	induce	VERB
ct-9352	219	33	endometritis	endometritis	NOUN
ct-9352	219	34	.	.	PUNCT
ct-9352	220	1	reprod	reprod	PROPN
ct-9352	220	2	domest	domest	PROPN
ct-9352	220	3	anim	anim	PROPN
ct-9352	220	4	2017;52:89	2017;52:89	NUM
ct-9352	220	5	-	-	SYM
ct-9352	220	6	96	96	NUM
ct-9352	220	7	.	.	PUNCT
ct-9352	221	1	53	53	NUM
ct-9352	221	2	.	.	PUNCT
ct-9352	221	3	coutinho	coutinho	PROPN
ct-9352	221	4	da	da	PROPN
ct-9352	221	5	silva	silva	PROPN
ct-9352	221	6	ma	ma	PROPN
ct-9352	221	7	,	,	PUNCT
ct-9352	221	8	darr	darr	PROPN
ct-9352	221	9	cr	cr	PROPN
ct-9352	221	10	,	,	PUNCT
ct-9352	221	11	et	et	PROPN
ct-9352	221	12	al	al	PROPN
ct-9352	221	13	:	:	PUNCT
ct-9352	221	14	lactoferrin	lactoferrin	PROPN
ct-9352	221	15	modulates	modulate	VERB
ct-9352	221	16	uterine	uterine	ADJ
ct-9352	221	17	inflammation	inflammation	NOUN
ct-9352	221	18	postbreeding	postbreeding	NOUN
ct-9352	221	19	in	in	ADP
ct-9352	221	20	the	the	DET
ct-9352	221	21	mare	mare	NOUN
ct-9352	221	22	.	.	PUNCT
ct-9352	222	1	j	j	PROPN
ct-9352	222	2	equine	equine	PROPN
ct-9352	222	3	vet	vet	NOUN
ct-9352	222	4	sci	sci	PROPN
ct-9352	222	5	2017;56:63	2017;56:63	PROPN
ct-9352	222	6	-	-	SYM
ct-9352	222	7	67	67	NUM
ct-9352	222	8	.	.	PUNCT
ct-9352	222	9	54	54	NUM
ct-9352	222	10	.	.	PUNCT
ct-9352	223	1	shi	shi	PROPN
ct-9352	223	2	y	y	PROPN
ct-9352	223	3	,	,	PUNCT
ct-9352	223	4	wang	wang	PROPN
ct-9352	223	5	y	y	PROPN
ct-9352	223	6	,	,	PUNCT
ct-9352	223	7	li	li	PROPN
ct-9352	223	8	q	q	PROPN
ct-9352	223	9	,	,	PUNCT
ct-9352	223	10	liu	liu	PROPN
ct-9352	223	11	k	k	PROPN
ct-9352	223	12	,	,	PUNCT
ct-9352	223	13	et	et	PROPN
ct-9352	223	14	al	al	PROPN
ct-9352	223	15	:	:	PUNCT
ct-9352	223	16	immunoregulatory	immunoregulatory	ADJ
ct-9352	223	17	mechanisms	mechanism	NOUN
ct-9352	223	18	of	of	ADP
ct-9352	223	19	mesenchymal	mesenchymal	NOUN
ct-9352	223	20	stem	stem	NOUN
ct-9352	223	21	and	and	CCONJ
ct-9352	223	22	stromal	stromal	ADJ
ct-9352	223	23	cells	cell	NOUN
ct-9352	223	24	in	in	ADP
ct-9352	223	25	inflammatory	inflammatory	ADJ
ct-9352	223	26	diseases	disease	NOUN
ct-9352	223	27	.	.	PUNCT
ct-9352	224	1	nat	nat	PROPN
ct-9352	224	2	rev	rev	VERB
ct-9352	224	3	nephrol	nephrol	NOUN
ct-9352	224	4	2018;14:493	2018;14:493	ADV
ct-9352	224	5	-	-	SYM
ct-9352	224	6	507	507	NUM
ct-9352	224	7	.	.	PUNCT
ct-9352	225	1	55	55	NUM
ct-9352	225	2	.	.	PUNCT
ct-9352	226	1	ferris	ferris	PROPN
ct-9352	226	2	ra	ra	PROPN
ct-9352	226	3	,	,	PUNCT
ct-9352	226	4	frisbie	frisbie	PROPN
ct-9352	226	5	dd	dd	PROPN
ct-9352	226	6	,	,	PUNCT
ct-9352	226	7	mccue	mccue	PROPN
ct-9352	226	8	pm	pm	PROPN
ct-9352	226	9	:	:	PUNCT
ct-9352	226	10	use	use	NOUN
ct-9352	226	11	of	of	ADP
ct-9352	226	12	mesenchymal	mesenchymal	ADJ
ct-9352	226	13	stem	stem	NOUN
ct-9352	226	14	cells	cell	NOUN
ct-9352	226	15	or	or	CCONJ
ct-9352	226	16	autologous	autologous	ADJ
ct-9352	226	17	conditioned	condition	VERB
ct-9352	226	18	serum	serum	NOUN
ct-9352	226	19	to	to	PART
ct-9352	226	20	modulate	modulate	VERB
ct-9352	226	21	the	the	DET
ct-9352	226	22	inflammatory	inflammatory	ADJ
ct-9352	226	23	response	response	NOUN
ct-9352	226	24	to	to	ADP
ct-9352	226	25	spermatozoa	spermatozoon	NOUN
ct-9352	226	26	in	in	ADP
ct-9352	226	27	mares	mare	NOUN
ct-9352	226	28	.	.	PUNCT
ct-9352	227	1	theriogenology	theriogenology	NOUN
ct-9352	227	2	.	.	PUNCT
ct-9352	228	1	2014;82:36	2014;82:36	NUM
ct-9352	228	2	-	-	SYM
ct-9352	228	3	42	42	NUM
ct-9352	228	4	.	.	PUNCT
ct-9352	229	1	56	56	NUM
ct-9352	229	2	.	.	PUNCT
ct-9352	230	1	navarrete	navarrete	PROPN
ct-9352	230	2	f	f	PROPN
ct-9352	230	3	,	,	PUNCT
ct-9352	230	4	saravia	saravia	PROPN
ct-9352	230	5	f	f	PROPN
ct-9352	230	6	,	,	PUNCT
ct-9352	230	7	cisterna	cisterna	PROPN
ct-9352	230	8	g	g	PROPN
ct-9352	230	9	,	,	PUNCT
ct-9352	230	10	et	et	PROPN
ct-9352	230	11	al	al	PROPN
ct-9352	230	12	:	:	PUNCT
ct-9352	230	13	assessment	assessment	NOUN
ct-9352	230	14	of	of	ADP
ct-9352	230	15	the	the	DET
ct-9352	230	16	anti	anti	ADJ
ct-9352	230	17	-	-	ADJ
ct-9352	230	18	inflammatory	inflammatory	ADJ
ct-9352	230	19	and	and	CCONJ
ct-9352	230	20	engraftment	engraftment	ADJ
ct-9352	230	21	potential	potential	NOUN
ct-9352	230	22	of	of	ADP
ct-9352	230	23	horse	horse	NOUN
ct-9352	230	24	endometrial	endometrial	NOUN
ct-9352	230	25	and	and	CCONJ
ct-9352	230	26	adipose	adipose	ADJ
ct-9352	230	27	mesenchymal	mesenchymal	ADJ
ct-9352	230	28	stem	stem	NOUN
ct-9352	230	29	cells	cell	NOUN
ct-9352	230	30	in	in	ADP
ct-9352	230	31	an	an	DET
ct-9352	230	32	in	in	ADP
ct-9352	230	33	vivo	vivo	NOUN
ct-9352	230	34	model	model	NOUN
ct-9352	230	35	of	of	ADP
ct-9352	230	36	post	post	NOUN
ct-9352	230	37	breeding	breed	VERB
ct-9352	230	38	induced	induced	ADJ
ct-9352	230	39	endometritis	endometritis	NOUN
ct-9352	230	40	.	.	PUNCT
ct-9352	231	1	theriogenology	theriogenology	NOUN
ct-9352	231	2	2020;155:33	2020;155:33	NUM
ct-9352	231	3	-	-	SYM
ct-9352	231	4	42	42	NUM
ct-9352	231	5	.	.	PUNCT
ct-9352	231	6	57	57	NUM
ct-9352	231	7	.	.	PUNCT
ct-9352	232	1	rink	rink	NOUN
ct-9352	232	2	be	be	AUX
ct-9352	232	3	,	,	PUNCT
ct-9352	232	4	aurich	aurich	PROPN
ct-9352	232	5	c	c	NOUN
ct-9352	232	6	,	,	PUNCT
ct-9352	232	7	french	french	ADJ
ct-9352	232	8	h	h	NOUN
ct-9352	232	9	,	,	PUNCT
ct-9352	232	10	et	et	PROPN
ct-9352	232	11	al	al	PROPN
ct-9352	232	12	:	:	PUNCT
ct-9352	232	13	the	the	DET
ct-9352	232	14	fate	fate	NOUN
ct-9352	232	15	of	of	ADP
ct-9352	232	16	endometrial	endometrial	ADJ
ct-9352	232	17	mesenchymal	mesenchymal	NOUN
ct-9352	232	18	stem	stem	NOUN
ct-9352	232	19	cells	cell	NOUN
ct-9352	232	20	after	after	ADP
ct-9352	232	21	application	application	NOUN
ct-9352	232	22	in	in	ADP
ct-9352	232	23	the	the	DET
ct-9352	232	24	healthy	healthy	ADJ
ct-9352	232	25	equine	equine	NOUN
ct-9352	232	26	uterus	uterus	NOUN
ct-9352	232	27	.	.	PUNCT
ct-9352	233	1	in	in	ADP
ct-9352	233	2	:	:	PUNCT
ct-9352	233	3	squires	squires	PROPN
ct-9352	233	4	el	el	PROPN
ct-9352	233	5	,	,	PUNCT
ct-9352	233	6	editor	editor	NOUN
ct-9352	233	7	.	.	PUNCT
ct-9352	234	1	international	international	ADJ
ct-9352	234	2	symposium	symposium	NOUN
ct-9352	234	3	on	on	ADP
ct-9352	234	4	equine	equine	NOUN
ct-9352	234	5	reproduction	reproduction	NOUN
ct-9352	234	6	.	.	PUNCT
ct-9352	235	1	cambridge	cambridge	PROPN
ct-9352	235	2	,	,	PUNCT
ct-9352	235	3	uk2018	uk2018	NOUN
ct-9352	235	4	.	.	PUNCT
ct-9352	236	1	p.	p.	NOUN
ct-9352	236	2	108	108	NUM
ct-9352	236	3	.	.	PUNCT
ct-9352	237	1	58	58	NUM
ct-9352	237	2	.	.	PUNCT
ct-9352	238	1	collins	collins	PROPN
ct-9352	238	2	mk	mk	PROPN
ct-9352	238	3	,	,	PUNCT
ct-9352	238	4	tay	tay	PROPN
ct-9352	238	5	cs	cs	PROPN
ct-9352	238	6	,	,	PUNCT
ct-9352	238	7	erlebacher	erlebacher	ADV
ct-9352	238	8	a	a	DET
ct-9352	238	9	:	:	PUNCT
ct-9352	238	10	dendritic	dendritic	ADJ
ct-9352	238	11	cell	cell	NOUN
ct-9352	238	12	entrapment	entrapment	ADJ
ct-9352	238	13	within	within	ADP
ct-9352	238	14	the	the	DET
ct-9352	238	15	pregnant	pregnant	ADJ
ct-9352	238	16	uterus	uterus	NOUN
ct-9352	238	17	inhibits	inhibit	VERB
ct-9352	238	18	immune	immune	ADJ
ct-9352	238	19	surveillance	surveillance	NOUN
ct-9352	238	20	of	of	ADP
ct-9352	238	21	the	the	DET
ct-9352	238	22	maternal	maternal	ADJ
ct-9352	238	23	/	/	SYM
ct-9352	238	24	fetal	fetal	ADJ
ct-9352	238	25	interface	interface	NOUN
ct-9352	238	26	in	in	ADP
ct-9352	238	27	mice	mouse	NOUN
ct-9352	238	28	.	.	PUNCT
ct-9352	239	1	j	j	PROPN
ct-9352	239	2	clin	clin	PROPN
ct-9352	239	3	invest	invest	VERB
ct-9352	239	4	2009;119:2062	2009;119:2062	NUM
ct-9352	239	5	-	-	SYM
ct-9352	239	6	2073	2073	NUM
ct-9352	239	7	.	.	PUNCT
ct-9352	240	1	59	59	NUM
ct-9352	240	2	.	.	PUNCT
ct-9352	240	3	figueiredo	figueiredo	PROPN
ct-9352	240	4	as	as	ADP
ct-9352	240	5	,	,	PUNCT
ct-9352	240	6	schumacher	schumacher	PROPN
ct-9352	240	7	a	a	X
ct-9352	240	8	:	:	PUNCT
ct-9352	240	9	the	the	DET
ct-9352	240	10	t	t	PROPN
ct-9352	240	11	helper	helper	NOUN
ct-9352	240	12	type	type	NOUN
ct-9352	240	13	17	17	NUM
ct-9352	240	14	/	/	SYM
ct-9352	240	15	regulatory	regulatory	ADJ
ct-9352	240	16	t	t	NOUN
ct-9352	240	17	cell	cell	NOUN
ct-9352	240	18	paradigm	paradigm	NOUN
ct-9352	240	19	in	in	ADP
ct-9352	240	20	pregnancy	pregnancy	NOUN
ct-9352	240	21	.	.	PUNCT
ct-9352	241	1	immunology	immunology	NOUN
ct-9352	241	2	2016;148:13	2016;148:13	NUM
ct-9352	241	3	-	-	SYM
ct-9352	241	4	21	21	NUM
ct-9352	241	5	.	.	PUNCT
ct-9352	241	6	60	60	NUM
ct-9352	241	7	.	.	PUNCT
ct-9352	242	1	saito	saito	PROPN
ct-9352	242	2	s	s	PROPN
ct-9352	242	3	,	,	PUNCT
ct-9352	242	4	nakashima	nakashima	PROPN
ct-9352	242	5	a	a	PROPN
ct-9352	242	6	,	,	PUNCT
ct-9352	242	7	shima	shima	PROPN
ct-9352	242	8	t	t	PROPN
ct-9352	242	9	,	,	PUNCT
ct-9352	242	10	et	et	PROPN
ct-9352	242	11	al	al	PROPN
ct-9352	242	12	:	:	PUNCT
ct-9352	242	13	th1	th1	PROPN
ct-9352	242	14	/	/	SYM
ct-9352	242	15	th2	th2	PROPN
ct-9352	242	16	/	/	SYM
ct-9352	242	17	th17	th17	PROPN
ct-9352	242	18	and	and	CCONJ
ct-9352	242	19	regulatory	regulatory	ADJ
ct-9352	242	20	t	t	PROPN
ct-9352	242	21	-	-	PUNCT
ct-9352	242	22	cell	cell	NOUN
ct-9352	242	23	paradigm	paradigm	NOUN
ct-9352	242	24	in	in	ADP
ct-9352	242	25	pregnancy	pregnancy	NOUN
ct-9352	242	26	.	.	PUNCT
ct-9352	243	1	am	be	AUX
ct-9352	243	2	j	j	PROPN
ct-9352	243	3	reprod	reprod	PROPN
ct-9352	243	4	immunol	immunol	NOUN
ct-9352	243	5	2010;63:601	2010;63:601	PROPN
ct-9352	243	6	-	-	SYM
ct-9352	243	7	610	610	NUM
ct-9352	243	8	.	.	NOUN
ct-9352	244	1	61	61	NUM
ct-9352	244	2	.	.	PUNCT
ct-9352	245	1	fedorka	fedorka	PROPN
ct-9352	245	2	ce	ce	PROPN
ct-9352	245	3	,	,	PUNCT
ct-9352	245	4	loux	loux	ADJ
ct-9352	245	5	sl	sl	PROPN
ct-9352	245	6	,	,	PUNCT
ct-9352	245	7	scoggin	scoggin	NOUN
ct-9352	245	8	ke	ke	PROPN
ct-9352	245	9	,	,	PUNCT
ct-9352	245	10	et	et	PROPN
ct-9352	245	11	al	al	PROPN
ct-9352	245	12	:	:	PUNCT
ct-9352	245	13	alterations	alteration	NOUN
ct-9352	245	14	in	in	ADP
ct-9352	245	15	t	t	PROPN
ct-9352	245	16	cell	cell	NOUN
ct-9352	245	17	-	-	PUNCT
ct-9352	245	18	related	relate	VERB
ct-9352	245	19	transcripts	transcript	NOUN
ct-9352	245	20	at	at	ADP
ct-9352	245	21	the	the	DET
ct-9352	245	22	feto	feto	ADJ
ct-9352	245	23	-	-	PUNCT
ct-9352	245	24	maternal	maternal	ADJ
ct-9352	245	25	interface	interface	NOUN
ct-9352	245	26	throughout	throughout	ADP
ct-9352	245	27	equine	equine	NOUN
ct-9352	245	28	gestation	gestation	NOUN
ct-9352	245	29	.	.	PUNCT
ct-9352	246	1	placenta	placenta	PROPN
ct-9352	246	2	2020;89:78	2020;89:78	PROPN
ct-9352	246	3	-	-	PUNCT
ct-9352	246	4	87	87	NUM
ct-9352	246	5	.	.	PUNCT
ct-9352	247	1	62	62	NUM
ct-9352	247	2	.	.	PUNCT
ct-9352	248	1	carp	carp	NOUN
ct-9352	248	2	h	h	NOUN
ct-9352	248	3	:	:	PUNCT
ct-9352	248	4	immunotherapy	immunotherapy	NOUN
ct-9352	248	5	for	for	ADP
ct-9352	248	6	recurrent	recurrent	ADJ
ct-9352	248	7	pregnancy	pregnancy	NOUN
ct-9352	248	8	loss	loss	NOUN
ct-9352	248	9	.	.	PUNCT
ct-9352	249	1	best	good	ADJ
ct-9352	249	2	pract	pract	PROPN
ct-9352	249	3	res	re	NOUN
ct-9352	249	4	clin	clin	PROPN
ct-9352	249	5	obstet	obstet	PROPN
ct-9352	249	6	gynaecol	gynaecol	PROPN
ct-9352	249	7	2019;60:77	2019;60:77	NUM
ct-9352	249	8	-	-	SYM
ct-9352	249	9	86	86	NUM
ct-9352	249	10	.	.	PUNCT
ct-9352	250	1	63	63	NUM
ct-9352	250	2	.	.	X
ct-9352	251	1	tevkin	tevkin	PROPN
ct-9352	251	2	s	s	PROPN
ct-9352	251	3	,	,	PUNCT
ct-9352	251	4	lokshin	lokshin	ADJ
ct-9352	251	5	v	v	PROPN
ct-9352	251	6	,	,	PUNCT
ct-9352	251	7	shishimorova	shishimorova	PROPN
ct-9352	251	8	m	m	PROPN
ct-9352	251	9	,	,	PUNCT
ct-9352	251	10	et	et	PROPN
ct-9352	251	11	al	al	PROPN
ct-9352	251	12	:	:	PUNCT
ct-9352	251	13	the	the	DET
ct-9352	251	14	frequency	frequency	NOUN
ct-9352	251	15	of	of	ADP
ct-9352	251	16	clinical	clinical	ADJ
ct-9352	251	17	pregnancy	pregnancy	NOUN
ct-9352	251	18	and	and	CCONJ
ct-9352	251	19	implantation	implantation	NOUN
ct-9352	251	20	rate	rate	NOUN
ct-9352	251	21	after	after	ADP
ct-9352	251	22	cultivation	cultivation	NOUN
ct-9352	251	23	of	of	ADP
ct-9352	251	24	embryos	embryo	NOUN
ct-9352	251	25	in	in	ADP
ct-9352	251	26	a	a	DET
ct-9352	251	27	medium	medium	NOUN
ct-9352	251	28	with	with	ADP
ct-9352	251	29	granulocyte	granulocyte	ADJ
ct-9352	251	30	macrophage	macrophage	ADJ
ct-9352	251	31	colony	colony	NOUN
ct-9352	251	32	-	-	PUNCT
ct-9352	251	33	stimulating	stimulate	VERB
ct-9352	251	34	factor	factor	NOUN
ct-9352	251	35	(	(	PUNCT
ct-9352	251	36	gm	gm	PROPN
ct-9352	251	37	-	-	PUNCT
ct-9352	251	38	csf	csf	NOUN
ct-9352	251	39	)	)	PUNCT
ct-9352	251	40	in	in	ADP
ct-9352	251	41	patients	patient	NOUN
ct-9352	251	42	with	with	ADP
ct-9352	251	43	preceding	precede	VERB
ct-9352	251	44	failed	fail	VERB
ct-9352	251	45	attempts	attempt	NOUN
ct-9352	251	46	of	of	ADP
ct-9352	251	47	art	art	NOUN
ct-9352	251	48	.	.	PUNCT
ct-9352	252	1	gynecol	gynecol	ADJ
ct-9352	252	2	endocrinol	endocrinol	NOUN
ct-9352	252	3	2014;30	2014;30	NUM
ct-9352	252	4	suppl	suppl	ADJ
ct-9352	252	5	1:9	1:9	NUM
ct-9352	252	6	-	-	SYM
ct-9352	252	7	12	12	NUM
ct-9352	252	8	.	.	PUNCT
ct-9352	253	1	64	64	NUM
ct-9352	253	2	.	.	PUNCT
ct-9352	254	1	ahmadi	ahmadi	PROPN
ct-9352	254	2	m	m	PROPN
ct-9352	254	3	,	,	PUNCT
ct-9352	254	4	abdolmohammadi	abdolmohammadi	NOUN
ct-9352	254	5	-	-	PUNCT
ct-9352	254	6	vahid	vahid	NOUN
ct-9352	254	7	s	s	PROPN
ct-9352	254	8	,	,	PUNCT
ct-9352	254	9	ghaebi	ghaebi	PROPN
ct-9352	254	10	m	m	PROPN
ct-9352	254	11	,	,	PUNCT
ct-9352	254	12	et	et	PROPN
ct-9352	254	13	al	al	PROPN
ct-9352	254	14	:	:	PUNCT
ct-9352	254	15	effect	effect	NOUN
ct-9352	254	16	of	of	ADP
ct-9352	254	17	intravenous	intravenous	ADJ
ct-9352	254	18	immunoglobulin	immunoglobulin	NOUN
ct-9352	254	19	on	on	ADP
ct-9352	254	20	th1	th1	PROPN
ct-9352	254	21	and	and	CCONJ
ct-9352	254	22	th2	th2	PROPN
ct-9352	254	23	lymphocytes	lymphocyte	NOUN
ct-9352	254	24	and	and	CCONJ
ct-9352	254	25	improvement	improvement	NOUN
ct-9352	254	26	of	of	ADP
ct-9352	254	27	pregnancy	pregnancy	NOUN
ct-9352	254	28	outcome	outcome	NOUN
ct-9352	254	29	in	in	ADP
ct-9352	254	30	recurrent	recurrent	ADJ
ct-9352	254	31	pregnancy	pregnancy	NOUN
ct-9352	254	32	loss	loss	NOUN
ct-9352	254	33	(	(	PUNCT
ct-9352	254	34	rpl	rpl	NOUN
ct-9352	254	35	)	)	PUNCT
ct-9352	254	36	.	.	PUNCT
ct-9352	255	1	biomed	biome	VERB
ct-9352	255	2	pharmacother	pharmacother	ADJ
ct-9352	255	3	2017;92:1095	2017;92:1095	NUM
ct-9352	255	4	-	-	SYM
ct-9352	255	5	1102	1102	NUM
ct-9352	255	6	.	.	PUNCT
ct-9352	256	1	65	65	NUM
ct-9352	256	2	.	.	PUNCT
ct-9352	257	1	ballow	ballow	PROPN
ct-9352	257	2	m	m	PART
ct-9352	257	3	:	:	PUNCT
ct-9352	257	4	mechanisms	mechanism	NOUN
ct-9352	257	5	of	of	ADP
ct-9352	257	6	immune	immune	ADJ
ct-9352	257	7	regulation	regulation	NOUN
ct-9352	257	8	by	by	ADP
ct-9352	257	9	ivig	ivig	NOUN
ct-9352	257	10	.	.	PUNCT
ct-9352	258	1	curr	curr	PROPN
ct-9352	258	2	opin	opin	PROPN
ct-9352	258	3	allergy	allergy	NOUN
ct-9352	258	4	clin	clin	PROPN
ct-9352	258	5	immunol	immunol	PROPN
ct-9352	258	6	2014;14:509	2014;14:509	PROPN
ct-9352	258	7	-	-	SYM
ct-9352	258	8	515	515	NUM
ct-9352	258	9	.	.	PUNCT
ct-9352	258	10	66	66	NUM
ct-9352	258	11	.	.	PUNCT
ct-9352	259	1	jafarzadeh	jafarzadeh	PROPN
ct-9352	259	2	s	s	PROPN
ct-9352	259	3	,	,	PUNCT
ct-9352	259	4	ahmadi	ahmadi	PROPN
ct-9352	259	5	m	m	PROPN
ct-9352	259	6	,	,	PUNCT
ct-9352	259	7	dolati	dolati	PROPN
ct-9352	259	8	s	s	PROPN
ct-9352	259	9	,	,	PUNCT
ct-9352	259	10	et	et	PROPN
ct-9352	259	11	al	al	PROPN
ct-9352	259	12	:	:	PUNCT
ct-9352	259	13	intravenous	intravenous	ADJ
ct-9352	259	14	immunoglobulin	immunoglobulin	NOUN
ct-9352	259	15	g	g	PROPN
ct-9352	259	16	treatment	treatment	NOUN
ct-9352	259	17	increases	increase	NOUN
ct-9352	259	18	live	live	VERB
ct-9352	259	19	birth	birth	NOUN
ct-9352	259	20	rate	rate	NOUN
ct-9352	259	21	in	in	ADP
ct-9352	259	22	women	woman	NOUN
ct-9352	259	23	with	with	ADP
ct-9352	259	24	recurrent	recurrent	ADJ
ct-9352	259	25	miscarriage	miscarriage	NOUN
ct-9352	259	26	and	and	CCONJ
ct-9352	259	27	modulates	modulate	NOUN
ct-9352	259	28	regulatory	regulatory	ADJ
ct-9352	259	29	and	and	CCONJ
ct-9352	259	30	exhausted	exhausted	ADJ
ct-9352	259	31	regulatory	regulatory	ADJ
ct-9352	259	32	t	t	NOUN
ct-9352	259	33	cells	cell	NOUN
ct-9352	259	34	frequency	frequency	NOUN
ct-9352	259	35	and	and	CCONJ
ct-9352	259	36	function	function	NOUN
ct-9352	259	37	.	.	PUNCT
ct-9352	260	1	j	j	PROPN
ct-9352	260	2	cell	cell	PROPN
ct-9352	260	3	biochem	biochem	PROPN
ct-9352	260	4	.	.	PUNCT
ct-9352	261	1	2019;120:5424	2019;120:5424	NUM
ct-9352	261	2	-	-	SYM
ct-9352	261	3	5434	5434	NUM
ct-9352	261	4	.	.	PUNCT
ct-9352	262	1	67	67	NUM
ct-9352	262	2	.	.	PUNCT
ct-9352	263	1	kessel	kessel	PROPN
ct-9352	263	2	a	a	DET
ct-9352	263	3	,	,	PUNCT
ct-9352	263	4	ammuri	ammuri	PROPN
ct-9352	263	5	h	h	NOUN
ct-9352	263	6	,	,	PUNCT
ct-9352	263	7	peri	peri	NOUN
ct-9352	263	8	r	r	PROPN
ct-9352	263	9	,	,	PUNCT
ct-9352	263	10	et	et	PROPN
ct-9352	263	11	al	al	PROPN
ct-9352	263	12	:	:	PUNCT
ct-9352	263	13	intravenous	intravenous	ADJ
ct-9352	263	14	immunoglobulin	immunoglobulin	NOUN
ct-9352	263	15	therapy	therapy	NOUN
ct-9352	263	16	affects	affect	VERB
ct-9352	263	17	t	t	PROPN
ct-9352	263	18	regulatory	regulatory	ADJ
ct-9352	263	19	cells	cell	NOUN
ct-9352	263	20	by	by	ADP
ct-9352	263	21	increasing	increase	VERB
ct-9352	263	22	their	their	PRON
ct-9352	263	23	suppressive	suppressive	ADJ
ct-9352	263	24	function	function	NOUN
ct-9352	263	25	.	.	PUNCT
ct-9352	264	1	j	j	PROPN
ct-9352	264	2	immunol	immunol	NOUN
ct-9352	264	3	2007;179:5571	2007;179:5571	NUM
ct-9352	264	4	-	-	SYM
ct-9352	264	5	5575	5575	NUM
ct-9352	264	6	.	.	PUNCT
ct-9352	265	1	68	68	NUM
ct-9352	265	2	.	.	PUNCT
ct-9352	266	1	pandey	pandey	PROPN
ct-9352	266	2	mk	mk	PROPN
ct-9352	266	3	,	,	PUNCT
ct-9352	266	4	thakur	thakur	PROPN
ct-9352	266	5	s	s	PROPN
ct-9352	266	6	,	,	PUNCT
ct-9352	266	7	agrawal	agrawal	PROPN
ct-9352	266	8	s	s	PART
ct-9352	266	9	:	:	PUNCT
ct-9352	266	10	lymphocyte	lymphocyte	ADJ
ct-9352	266	11	immunotherapy	immunotherapy	NOUN
ct-9352	266	12	and	and	CCONJ
ct-9352	266	13	its	its	PRON
ct-9352	266	14	probable	probable	ADJ
ct-9352	266	15	mechanism	mechanism	NOUN
ct-9352	266	16	in	in	ADP
ct-9352	266	17	the	the	DET
ct-9352	266	18	maintenance	maintenance	NOUN
ct-9352	266	19	of	of	ADP
ct-9352	266	20	pregnancy	pregnancy	NOUN
ct-9352	266	21	in	in	ADP
ct-9352	266	22	women	woman	NOUN
ct-9352	266	23	with	with	ADP
ct-9352	266	24	recurrent	recurrent	ADJ
ct-9352	266	25	spontaneous	spontaneous	ADJ
ct-9352	266	26	abortion	abortion	NOUN
ct-9352	266	27	.	.	PUNCT
ct-9352	267	1	arch	arch	PROPN
ct-9352	267	2	gynecol	gynecol	PROPN
ct-9352	267	3	obstet	obstet	NOUN
ct-9352	267	4	2004;269:161	2004;269:161	NUM
ct-9352	267	5	-	-	SYM
ct-9352	267	6	172	172	NUM
ct-9352	267	7	.	.	PUNCT
ct-9352	267	8	69	69	NUM
ct-9352	267	9	.	.	PUNCT
ct-9352	268	1	mathias	mathias	PROPN
ct-9352	268	2	s	s	PROPN
ct-9352	268	3	,	,	PUNCT
ct-9352	268	4	allen	allen	PROPN
ct-9352	268	5	wr	wr	PROPN
ct-9352	268	6	:	:	PUNCT
ct-9352	268	7	immunization	immunization	NOUN
ct-9352	268	8	with	with	ADP
ct-9352	268	9	stallion	stallion	NOUN
ct-9352	268	10	lymphocytes	lymphocyte	VERB
ct-9352	268	11	for	for	ADP
ct-9352	268	12	treatment	treatment	NOUN
ct-9352	268	13	of	of	ADP
ct-9352	268	14	recurrent	recurrent	ADJ
ct-9352	268	15	spontaneous	spontaneous	ADJ
ct-9352	268	16	abortion	abortion	NOUN
ct-9352	268	17	in	in	ADP
ct-9352	268	18	thoroughbred	thoroughbred	ADJ
ct-9352	268	19	mares	mare	NOUN
ct-9352	268	20	.	.	PUNCT
ct-9352	269	1	j	j	PROPN
ct-9352	269	2	reprod	reprod	PROPN
ct-9352	269	3	fertil	fertil	PROPN
ct-9352	269	4	suppl	suppl	PROPN
ct-9352	269	5	2000:645	2000:645	NUM
ct-9352	269	6	-	-	PUNCT
ct-9352	269	7	650	650	NUM
ct-9352	269	8	.	.	PUNCT
ct-9352	270	1	70	70	NUM
ct-9352	270	2	.	.	PUNCT
ct-9352	271	1	aurich	aurich	PROPN
ct-9352	271	2	c	c	PROPN
ct-9352	271	3	,	,	PUNCT
ct-9352	271	4	weber	weber	PROPN
ct-9352	271	5	j	j	PROPN
ct-9352	271	6	,	,	PUNCT
ct-9352	271	7	nagel	nagel	PROPN
ct-9352	271	8	c	c	PROPN
ct-9352	271	9	,	,	PUNCT
ct-9352	271	10	et	et	PROPN
ct-9352	271	11	al	al	PROPN
ct-9352	271	12	:	:	PUNCT
ct-9352	271	13	low	low	ADJ
ct-9352	271	14	levels	level	NOUN
ct-9352	271	15	of	of	ADP
ct-9352	271	16	naturally	naturally	ADV
ct-9352	271	17	occurring	occur	VERB
ct-9352	271	18	regulatory	regulatory	ADJ
ct-9352	271	19	t	t	NOUN
ct-9352	271	20	lymphocytes	lymphocyte	NOUN
ct-9352	271	21	in	in	ADP
ct-9352	271	22	blood	blood	NOUN
ct-9352	271	23	of	of	ADP
ct-9352	271	24	mares	mare	NOUN
ct-9352	271	25	with	with	ADP
ct-9352	271	26	early	early	ADJ
ct-9352	271	27	pregnancy	pregnancy	NOUN
ct-9352	271	28	loss	loss	NOUN
ct-9352	271	29	.	.	PUNCT
ct-9352	272	1	reprod	reprod	PROPN
ct-9352	272	2	fertil	fertil	PROPN
ct-9352	272	3	dev	dev	PROPN
ct-9352	272	4	2014;26:827	2014;26:827	PROPN
ct-9352	272	5	-	-	PUNCT
ct-9352	272	6	833	833	NUM
ct-9352	272	7	.	.	PUNCT
ct-9352	273	1	71	71	NUM
ct-9352	273	2	.	.	PUNCT
ct-9352	274	1	eghbal	eghbal	ADJ
ct-9352	274	2	-	-	PUNCT
ct-9352	274	3	fard	fard	NOUN
ct-9352	274	4	s	s	PROPN
ct-9352	274	5	,	,	PUNCT
ct-9352	274	6	yousefi	yousefi	PROPN
ct-9352	274	7	m	m	PROPN
ct-9352	274	8	,	,	PUNCT
ct-9352	274	9	heydarlou	heydarlou	PROPN
ct-9352	274	10	h	h	PROPN
ct-9352	274	11	,	,	PUNCT
ct-9352	274	12	et	et	PROPN
ct-9352	274	13	al	al	PROPN
ct-9352	274	14	:	:	PUNCT
ct-9352	274	15	the	the	DET
ct-9352	274	16	imbalance	imbalance	NOUN
ct-9352	274	17	of	of	ADP
ct-9352	274	18	th17	th17	PROPN
ct-9352	274	19	/	/	SYM
ct-9352	274	20	treg	treg	PROPN
ct-9352	274	21	axis	axis	PROPN
ct-9352	274	22	involved	involve	VERB
ct-9352	274	23	in	in	ADP
ct-9352	274	24	the	the	DET
ct-9352	274	25	pathogenesis	pathogenesis	NOUN
ct-9352	274	26	of	of	ADP
ct-9352	274	27	preeclampsia	preeclampsia	NOUN
ct-9352	274	28	.	.	PUNCT
ct-9352	275	1	j	j	PROPN
ct-9352	275	2	cell	cell	PROPN
ct-9352	275	3	physiol	physiol	PROPN
ct-9352	275	4	2019;234:5106	2019;234:5106	NUM
ct-9352	275	5	-	-	SYM
ct-9352	275	6	116	116	NUM
ct-9352	275	7	.	.	PUNCT
ct-9352	276	1	72	72	NUM
ct-9352	276	2	.	.	PUNCT
ct-9352	277	1	hao	hao	PROPN
ct-9352	277	2	h	h	PROPN
ct-9352	277	3	,	,	PUNCT
ct-9352	277	4	he	he	PRON
ct-9352	277	5	m	m	PROPN
ct-9352	277	6	,	,	PUNCT
ct-9352	277	7	li	li	PROPN
ct-9352	277	8	j	j	PROPN
ct-9352	277	9	,	,	PUNCT
ct-9352	277	10	zhou	zhou	PROPN
ct-9352	277	11	y	y	PROPN
ct-9352	277	12	,	,	PUNCT
ct-9352	277	13	et	et	PROPN
ct-9352	277	14	al	al	PROPN
ct-9352	277	15	:	:	PUNCT
ct-9352	277	16	upregulation	upregulation	NOUN
ct-9352	277	17	of	of	ADP
ct-9352	277	18	the	the	DET
ct-9352	277	19	tim-3	tim-3	NUM
ct-9352	277	20	/	/	SYM
ct-9352	277	21	gal-9	gal-9	NOUN
ct-9352	277	22	pathway	pathway	NOUN
ct-9352	277	23	and	and	CCONJ
ct-9352	277	24	correlation	correlation	NOUN
ct-9352	277	25	with	with	ADP
ct-9352	277	26	the	the	DET
ct-9352	277	27	development	development	NOUN
ct-9352	277	28	of	of	ADP
ct-9352	277	29	preeclampsia	preeclampsia	NOUN
ct-9352	277	30	.	.	PUNCT
ct-9352	278	1	eur	eur	PROPN
ct-9352	278	2	j	j	PROPN
ct-9352	278	3	obstet	obstet	PROPN
ct-9352	278	4	gynecol	gynecol	PROPN
ct-9352	278	5	reprod	reprod	PROPN
ct-9352	278	6	biol	biol	PROPN
ct-9352	278	7	2015;194:85	2015;194:85	NOUN
ct-9352	278	8	-	-	SYM
ct-9352	278	9	91	91	NUM
ct-9352	278	10	.	.	PUNCT
ct-9352	278	11	73	73	NUM
ct-9352	278	12	.	.	PUNCT
ct-9352	279	1	maeda	maeda	PROPN
ct-9352	279	2	y	y	PROPN
ct-9352	279	3	,	,	PUNCT
ct-9352	279	4	ohtsuka	ohtsuka	PROPN
ct-9352	279	5	h	h	NOUN
ct-9352	279	6	,	,	PUNCT
ct-9352	279	7	tomioka	tomioka	NOUN
ct-9352	279	8	m	m	PROPN
ct-9352	279	9	,	,	PUNCT
ct-9352	279	10	et	et	PROPN
ct-9352	279	11	al	al	PROPN
ct-9352	279	12	:	:	PUNCT
ct-9352	279	13	effect	effect	NOUN
ct-9352	279	14	of	of	ADP
ct-9352	279	15	progesterone	progesterone	NOUN
ct-9352	279	16	on	on	ADP
ct-9352	279	17	th1	th1	PROPN
ct-9352	279	18	/	/	SYM
ct-9352	279	19	th2	th2	PROPN
ct-9352	279	20	/	/	SYM
ct-9352	279	21	th17	th17	PROPN
ct-9352	279	22	and	and	CCONJ
ct-9352	279	23	regulatory	regulatory	ADJ
ct-9352	279	24	t	t	NOUN
ct-9352	279	25	cell	cell	NOUN
ct-9352	279	26	-	-	PUNCT
ct-9352	279	27	related	relate	VERB
ct-9352	279	28	genes	gene	NOUN
ct-9352	279	29	in	in	ADP
ct-9352	279	30	peripheral	peripheral	ADJ
ct-9352	279	31	blood	blood	NOUN
ct-9352	279	32	mononuclear	mononuclear	ADJ
ct-9352	279	33	cells	cell	NOUN
ct-9352	279	34	during	during	ADP
ct-9352	279	35	pregnancy	pregnancy	NOUN
ct-9352	279	36	in	in	ADP
ct-9352	279	37	cows	cow	NOUN
ct-9352	279	38	.	.	PUNCT
ct-9352	280	1	vet	vet	NOUN
ct-9352	280	2	res	re	NOUN
ct-9352	280	3	commun	commun	PROPN
ct-9352	280	4	2013;37:43	2013;37:43	PROPN
ct-9352	280	5	-	-	SYM
ct-9352	280	6	49	49	NUM
ct-9352	280	7	.	.	PUNCT
ct-9352	281	1	74	74	NUM
ct-9352	281	2	.	.	PUNCT
ct-9352	282	1	nakashima	nakashima	PROPN
ct-9352	282	2	a	a	PROPN
ct-9352	282	3	,	,	PUNCT
ct-9352	282	4	ito	ito	PROPN
ct-9352	282	5	m	m	PROPN
ct-9352	282	6	,	,	PUNCT
ct-9352	282	7	shima	shima	PROPN
ct-9352	282	8	t	t	PROPN
ct-9352	282	9	,	,	PUNCT
ct-9352	282	10	et	et	PROPN
ct-9352	282	11	al	al	PROPN
ct-9352	282	12	:	:	PUNCT
ct-9352	282	13	accumulation	accumulation	NOUN
ct-9352	282	14	of	of	ADP
ct-9352	282	15	il-17positive	il-17positive	ADJ
ct-9352	282	16	cells	cell	NOUN
ct-9352	282	17	in	in	ADP
ct-9352	282	18	decidua	decidua	NOUN
ct-9352	282	19	of	of	ADP
ct-9352	282	20	inevitable	inevitable	ADJ
ct-9352	282	21	abortion	abortion	NOUN
ct-9352	282	22	cases	case	NOUN
ct-9352	282	23	.	.	PUNCT
ct-9352	282	24	am	be	AUX
ct-9352	282	25	j	j	PROPN
ct-9352	282	26	reprod	reprod	PROPN
ct-9352	282	27	immunol	immunol	PROPN
ct-9352	282	28	2010;64:4	2010;64:4	PROPN
ct-9352	282	29	-	-	SYM
ct-9352	282	30	11	11	NUM
ct-9352	282	31	.	.	PUNCT
ct-9352	283	1	75	75	NUM
ct-9352	283	2	.	.	PUNCT
ct-9352	284	1	hong	hong	PROPN
ct-9352	284	2	cb	cb	PROPN
ct-9352	284	3	,	,	PUNCT
ct-9352	284	4	donahue	donahue	PROPN
ct-9352	284	5	jm	jm	PROPN
ct-9352	284	6	,	,	PUNCT
ct-9352	284	7	giles	giles	PROPN
ct-9352	284	8	rc	rc	PROPN
ct-9352	284	9	,	,	PUNCT
ct-9352	284	10	et	et	PROPN
ct-9352	284	11	al	al	PROPN
ct-9352	284	12	:	:	PUNCT
ct-9352	284	13	equine	equine	NOUN
ct-9352	284	14	abortion	abortion	NOUN
ct-9352	284	15	and	and	CCONJ
ct-9352	284	16	stillbirth	stillbirth	NOUN
ct-9352	284	17	in	in	ADP
ct-9352	284	18	central	central	ADJ
ct-9352	284	19	kentucky	kentucky	PROPN
ct-9352	284	20	during	during	ADP
ct-9352	284	21	1988	1988	NUM
ct-9352	284	22	and	and	CCONJ
ct-9352	284	23	1989	1989	NUM
ct-9352	284	24	foaling	foal	VERB
ct-9352	284	25	seasons	season	NOUN
ct-9352	284	26	.	.	PUNCT
ct-9352	285	1	j	j	PROPN
ct-9352	285	2	vet	vet	PROPN
ct-9352	285	3	diagn	diagn	PROPN
ct-9352	285	4	invest	invest	VERB
ct-9352	285	5	1993;5:560	1993;5:560	NUM
ct-9352	285	6	-	-	SYM
ct-9352	285	7	566	566	NUM
ct-9352	285	8	.	.	NUM
ct-9352	285	9	76	76	NUM
ct-9352	285	10	.	.	PUNCT
ct-9352	286	1	giles	giles	PROPN
ct-9352	286	2	rc	rc	PROPN
ct-9352	286	3	,	,	PUNCT
ct-9352	286	4	donahue	donahue	PROPN
ct-9352	286	5	jm	jm	PROPN
ct-9352	286	6	,	,	PUNCT
ct-9352	286	7	hong	hong	PROPN
ct-9352	286	8	cb	cb	PROPN
ct-9352	286	9	,	,	PUNCT
ct-9352	286	10	et	et	PROPN
ct-9352	286	11	al	al	PROPN
ct-9352	286	12	:	:	PUNCT
ct-9352	286	13	causes	cause	NOUN
ct-9352	286	14	of	of	ADP
ct-9352	286	15	abortion	abortion	NOUN
ct-9352	286	16	,	,	PUNCT
ct-9352	286	17	stillbirth	stillbirth	NOUN
ct-9352	286	18	,	,	PUNCT
ct-9352	286	19	and	and	CCONJ
ct-9352	286	20	perinatal	perinatal	ADJ
ct-9352	286	21	death	death	NOUN
ct-9352	286	22	in	in	ADP
ct-9352	286	23	horses	horse	NOUN
ct-9352	286	24	:	:	PUNCT
ct-9352	286	25	3,527	3,527	NUM
ct-9352	286	26	cases	case	NOUN
ct-9352	286	27	(	(	PUNCT
ct-9352	286	28	1986	1986	NUM
ct-9352	286	29	-	-	SYM
ct-9352	286	30	1991	1991	NUM
ct-9352	286	31	)	)	PUNCT
ct-9352	286	32	.	.	PUNCT
ct-9352	287	1	j	j	PROPN
ct-9352	287	2	am	be	AUX
ct-9352	287	3	vet	vet	NOUN
ct-9352	287	4	med	med	ADJ
ct-9352	287	5	assoc	assoc	PROPN
ct-9352	287	6	1993;203:1170	1993;203:1170	PROPN
ct-9352	287	7	-	-	SYM
ct-9352	287	8	1175	1175	NUM
ct-9352	287	9	.	.	PUNCT
ct-9352	288	1	77	77	NUM
ct-9352	288	2	.	.	PUNCT
ct-9352	289	1	fedorka	fedorka	PROPN
ct-9352	289	2	ce	ce	PROPN
ct-9352	289	3	,	,	PUNCT
ct-9352	289	4	el	el	PROPN
ct-9352	289	5	-	-	PUNCT
ct-9352	289	6	sheikh	sheikh	PROPN
ct-9352	289	7	ali	ali	PROPN
ct-9352	289	8	h	h	PROPN
ct-9352	289	9	,	,	PUNCT
ct-9352	289	10	scoggin	scoggin	VERB
ct-9352	289	11	ke	ke	PROPN
ct-9352	289	12	,	,	PUNCT
ct-9352	289	13	et	et	PROPN
ct-9352	289	14	al	al	PROPN
ct-9352	289	15	:	:	PUNCT
ct-9352	289	16	the	the	DET
ct-9352	289	17	imbalance	imbalance	NOUN
ct-9352	289	18	of	of	ADP
ct-9352	289	19	the	the	DET
ct-9352	289	20	th17	th17	PROPN
ct-9352	289	21	/	/	SYM
ct-9352	289	22	treg	treg	PROPN
ct-9352	289	23	axis	axis	NOUN
ct-9352	289	24	following	follow	VERB
ct-9352	289	25	equine	equine	NOUN
ct-9352	289	26	ascending	ascend	VERB
ct-9352	289	27	placental	placental	ADJ
ct-9352	289	28	infection	infection	NOUN
ct-9352	289	29	.	.	PUNCT
ct-9352	290	1	am	be	AUX
ct-9352	290	2	j	j	PROPN
ct-9352	290	3	reprod	reprod	PROPN
ct-9352	290	4	mmunol	mmunol	PROPN
ct-9352	290	5	2021;144:103268	2021;144:103268	NUM
ct-9352	290	6	.	.	PUNCT
ct-9352	291	1	clinical	clinical	ADJ
ct-9352	291	2	theriogenology	theriogenology	NOUN
ct-9352	291	3	2021	2021	NUM
ct-9352	291	4	;	;	PUNCT
ct-9352	291	5	13	13	NUM
ct-9352	291	6	:	:	SYM
ct-9352	291	7	245	245	NUM
ct-9352	291	8	78	78	NUM
ct-9352	291	9	.	.	PUNCT
ct-9352	292	1	fedorka	fedorka	PROPN
ct-9352	292	2	ce	ce	PROPN
ct-9352	292	3	,	,	PUNCT
ct-9352	292	4	el	el	PROPN
ct-9352	292	5	-	-	PUNCT
ct-9352	292	6	sheikh	sheikh	PROPN
ct-9352	292	7	ali	ali	PROPN
ct-9352	292	8	h	h	PROPN
ct-9352	292	9	,	,	PUNCT
ct-9352	292	10	walker	walker	PROPN
ct-9352	292	11	of	of	ADP
ct-9352	292	12	,	,	PUNCT
ct-9352	292	13	et	et	PROPN
ct-9352	292	14	al	al	PROPN
ct-9352	292	15	:	:	PUNCT
ct-9352	292	16	the	the	DET
ct-9352	292	17	imbalance	imbalance	NOUN
ct-9352	292	18	of	of	ADP
ct-9352	292	19	the	the	DET
ct-9352	292	20	th17	th17	PROPN
ct-9352	292	21	/	/	SYM
ct-9352	292	22	treg	treg	PROPN
ct-9352	292	23	axis	axis	NOUN
ct-9352	292	24	following	follow	VERB
ct-9352	292	25	equine	equine	NOUN
ct-9352	292	26	ascending	ascend	VERB
ct-9352	292	27	placental	placental	ADJ
ct-9352	292	28	infection	infection	NOUN
ct-9352	292	29	.	.	PUNCT
ct-9352	293	1	j	j	PROPN
ct-9352	293	2	reprod	reprod	PROPN
ct-9352	293	3	immunol	immunol	PROPN
ct-9352	293	4	2021;144:103268	2021;144:103268	NUM
ct-9352	293	5	.	.	PUNCT
ct-9352	294	1	79	79	NUM
ct-9352	294	2	.	.	PUNCT
ct-9352	295	1	fedorka	fedorka	PROPN
ct-9352	295	2	ce	ce	PROPN
ct-9352	295	3	,	,	PUNCT
ct-9352	295	4	ball	ball	PROPN
ct-9352	295	5	ba	ba	PROPN
ct-9352	295	6	,	,	PUNCT
ct-9352	295	7	scoggin	scoggin	VERB
ct-9352	295	8	ke	ke	PROPN
ct-9352	295	9	,	,	PUNCT
ct-9352	295	10	et	et	PROPN
ct-9352	295	11	al	al	PROPN
ct-9352	295	12	:	:	PUNCT
ct-9352	295	13	the	the	DET
ct-9352	295	14	feto	feto	VERB
ct-9352	295	15	-	-	PUNCT
ct-9352	295	16	maternal	maternal	ADJ
ct-9352	295	17	immune	immune	ADJ
ct-9352	295	18	response	response	NOUN
ct-9352	295	19	to	to	AUX
ct-9352	295	20	equine	equine	VERB
ct-9352	295	21	placentitis	placentitis	PROPN
ct-9352	295	22	.	.	PUNCT
ct-9352	296	1	am	be	AUX
ct-9352	296	2	j	j	PROPN
ct-9352	296	3	reprod	reprod	PROPN
ct-9352	296	4	immunol	immunol	PROPN
ct-9352	296	5	2019	2019	NUM
ct-9352	296	6	:	:	PUNCT
ct-9352	296	7	e13179	e13179	PROPN
ct-9352	296	8	.	.	PUNCT
ct-9352	297	1	80	80	NUM
ct-9352	297	2	.	.	PUNCT
ct-9352	298	1	fedorka	fedorka	PROPN
ct-9352	298	2	ce	ce	PROPN
ct-9352	298	3	,	,	PUNCT
ct-9352	298	4	scoggin	scoggin	VERB
ct-9352	298	5	ke	ke	PROPN
ct-9352	298	6	,	,	PUNCT
ct-9352	298	7	el	el	PROPN
ct-9352	298	8	-	-	PUNCT
ct-9352	298	9	sheikh	sheikh	PROPN
ct-9352	298	10	ali	ali	PROPN
ct-9352	298	11	h	h	PROPN
ct-9352	298	12	,	,	PUNCT
ct-9352	298	13	et	et	PROPN
ct-9352	298	14	al	al	PROPN
ct-9352	298	15	:	:	PUNCT
ct-9352	298	16	interleukin-6	interleukin-6	NUM
ct-9352	298	17	pathobiology	pathobiology	NOUN
ct-9352	298	18	in	in	ADP
ct-9352	298	19	equine	equine	NOUN
ct-9352	298	20	placental	placental	ADJ
ct-9352	298	21	infection	infection	NOUN
ct-9352	298	22	.	.	PUNCT
ct-9352	299	1	am	be	AUX
ct-9352	299	2	j	j	PROPN
ct-9352	299	3	reprod	reprod	PROPN
ct-9352	299	4	immunol	immunol	NOUN
ct-9352	299	5	2020	2020	NUM
ct-9352	299	6	:	:	PUNCT
ct-9352	300	1	e13363	e13363	ADV
ct-9352	300	2	.	.	PUNCT
ct-9352	301	1	81	81	NUM
ct-9352	301	2	.	.	PUNCT
ct-9352	302	1	fedorka	fedorka	PROPN
ct-9352	302	2	ce	ce	PROPN
ct-9352	302	3	,	,	PUNCT
ct-9352	302	4	ball	ball	PROPN
ct-9352	302	5	ba	ba	PROPN
ct-9352	302	6	,	,	PUNCT
ct-9352	302	7	walker	walker	PROPN
ct-9352	302	8	of	of	ADP
ct-9352	302	9	,	,	PUNCT
ct-9352	302	10	et	et	PROPN
ct-9352	302	11	al	al	PROPN
ct-9352	302	12	:	:	PUNCT
ct-9352	302	13	alterations	alteration	NOUN
ct-9352	302	14	of	of	ADP
ct-9352	302	15	circulating	circulate	VERB
ct-9352	302	16	biomarkers	biomarker	NOUN
ct-9352	302	17	during	during	ADP
ct-9352	302	18	late	late	ADJ
ct-9352	302	19	termp	termp	ADJ
ct-9352	302	20	pregnancy	pregnancy	NOUN
ct-9352	302	21	complications	complication	NOUN
ct-9352	302	22	in	in	ADP
ct-9352	302	23	the	the	DET
ct-9352	302	24	horse	horse	NOUN
ct-9352	302	25	part	part	NOUN
ct-9352	302	26	i	i	PRON
ct-9352	302	27	:	:	PUNCT
ct-9352	302	28	cytokines	cytokine	NOUN
ct-9352	302	29	.	.	PUNCT
ct-9352	303	1	j	j	PROPN
ct-9352	303	2	equine	equine	PROPN
ct-9352	303	3	vet	vet	NOUN
ct-9352	303	4	sci	sci	PROPN
ct-9352	303	5	2020	2020	NUM
ct-9352	303	6	.	.	PUNCT
ct-9352	304	1	82	82	NUM
ct-9352	304	2	.	.	PUNCT
ct-9352	305	1	bailey	bailey	PROPN
ct-9352	305	2	cs	cs	PROPN
ct-9352	305	3	,	,	PUNCT
ct-9352	305	4	macpherson	macpherson	PROPN
ct-9352	305	5	ml	ml	PROPN
ct-9352	305	6	,	,	PUNCT
ct-9352	305	7	pozor	pozor	PROPN
ct-9352	305	8	ma	ma	PROPN
ct-9352	305	9	,	,	PUNCT
ct-9352	305	10	et	et	PROPN
ct-9352	305	11	al	al	PROPN
ct-9352	305	12	:	:	PUNCT
ct-9352	305	13	treatment	treatment	NOUN
ct-9352	305	14	efficacy	efficacy	NOUN
ct-9352	305	15	of	of	ADP
ct-9352	305	16	trimethoprim	trimethoprim	ADJ
ct-9352	305	17	sulfamethoxazole	sulfamethoxazole	NOUN
ct-9352	305	18	,	,	PUNCT
ct-9352	305	19	pentoxifylline	pentoxifylline	NOUN
ct-9352	305	20	and	and	CCONJ
ct-9352	305	21	altrenogest	altrenogest	NOUN
ct-9352	305	22	in	in	ADP
ct-9352	305	23	experimentally	experimentally	ADV
ct-9352	305	24	induced	induce	VERB
ct-9352	305	25	equine	equine	NOUN
ct-9352	305	26	placentitis	placentitis	PROPN
ct-9352	305	27	.	.	PUNCT
ct-9352	306	1	theriogenology	theriogenology	NOUN
ct-9352	306	2	2010;74:402	2010;74:402	PROPN
ct-9352	306	3	-	-	SYM
ct-9352	306	4	412	412	NUM
ct-9352	306	5	.	.	NOUN
ct-9352	306	6	83	83	NUM
ct-9352	306	7	.	.	PUNCT
ct-9352	307	1	alijotas	alijota	NOUN
ct-9352	307	2	-	-	PUNCT
ct-9352	307	3	reig	reig	PROPN
ct-9352	307	4	j	j	PROPN
ct-9352	307	5	,	,	PUNCT
ct-9352	307	6	esteve	esteve	PROPN
ct-9352	307	7	-	-	PUNCT
ct-9352	307	8	valverde	valverde	PROPN
ct-9352	307	9	e	e	PROPN
ct-9352	307	10	,	,	PUNCT
ct-9352	307	11	ferrer	ferrer	PROPN
ct-9352	307	12	-	-	ADJ
ct-9352	307	13	oliveras	oliveras	ADJ
ct-9352	307	14	r	r	NOUN
ct-9352	307	15	,	,	PUNCT
ct-9352	307	16	et	et	PROPN
ct-9352	307	17	al	al	PROPN
ct-9352	307	18	:	:	PUNCT
ct-9352	307	19	tumor	tumor	NOUN
ct-9352	307	20	necrosis	necrosis	NOUN
ct-9352	307	21	factor	factor	NOUN
ct-9352	307	22	-	-	PUNCT
ct-9352	307	23	alpha	alpha	NOUN
ct-9352	307	24	and	and	CCONJ
ct-9352	307	25	pregnancy	pregnancy	NOUN
ct-9352	307	26	:	:	PUNCT
ct-9352	307	27	focus	focus	VERB
ct-9352	307	28	on	on	ADP
ct-9352	307	29	biologics	biologic	NOUN
ct-9352	307	30	.	.	PUNCT
ct-9352	308	1	an	an	DET
ct-9352	308	2	updated	update	VERB
ct-9352	308	3	and	and	CCONJ
ct-9352	308	4	comprehensive	comprehensive	ADJ
ct-9352	308	5	review	review	NOUN
ct-9352	308	6	.	.	PUNCT
ct-9352	309	1	clin	clin	PROPN
ct-9352	309	2	rev	rev	PROPN
ct-9352	309	3	allergy	allergy	PROPN
ct-9352	309	4	immunol	immunol	NOUN
ct-9352	309	5	2017;53:40	2017;53:40	NUM
ct-9352	309	6	-	-	SYM
ct-9352	309	7	53	53	NUM
ct-9352	309	8	.	.	PUNCT
ct-9352	310	1	84	84	NUM
ct-9352	310	2	.	.	PUNCT
ct-9352	311	1	macpherson	macpherson	PROPN
ct-9352	311	2	ml	ml	NOUN
ct-9352	311	3	:	:	PUNCT
ct-9352	311	4	treatment	treatment	NOUN
ct-9352	311	5	strategies	strategy	NOUN
ct-9352	311	6	for	for	ADP
ct-9352	311	7	mares	mare	NOUN
ct-9352	311	8	with	with	ADP
ct-9352	311	9	placentitis	placentitis	PROPN
ct-9352	311	10	.	.	PUNCT
ct-9352	312	1	theriogenology	theriogenology	NOUN
ct-9352	312	2	2005;64:528	2005;64:528	NUM
ct-9352	312	3	-	-	PUNCT
ct-9352	312	4	534	534	NUM
ct-9352	312	5	.	.	PUNCT
ct-9352	312	6	85	85	NUM
ct-9352	312	7	.	.	PUNCT
ct-9352	313	1	macpherson	macpherson	PROPN
ct-9352	313	2	ml	ml	PROPN
ct-9352	313	3	,	,	PUNCT
ct-9352	313	4	bailey	bailey	PROPN
ct-9352	313	5	cs	cs	PROPN
ct-9352	313	6	:	:	PUNCT
ct-9352	313	7	a	a	DET
ct-9352	313	8	clinical	clinical	ADJ
ct-9352	313	9	approach	approach	NOUN
ct-9352	313	10	to	to	ADP
ct-9352	313	11	managing	manage	VERB
ct-9352	313	12	the	the	DET
ct-9352	313	13	mare	mare	NOUN
ct-9352	313	14	with	with	ADP
ct-9352	313	15	placentitis	placentitis	PROPN
ct-9352	313	16	.	.	PUNCT
ct-9352	314	1	theriogenology	theriogenology	PROPN
ct-9352	314	2	2008;70:435	2008;70:435	NUM
ct-9352	314	3	-	-	SYM
ct-9352	314	4	440	440	NUM
ct-9352	314	5	.	.	PUNCT
ct-9352	314	6	86	86	NUM
ct-9352	314	7	.	.	PUNCT
ct-9352	315	1	macpherson	macpherson	PROPN
ct-9352	315	2	ml	ml	NOUN
ct-9352	315	3	:	:	PUNCT
ct-9352	315	4	diagnosis	diagnosis	NOUN
ct-9352	315	5	and	and	CCONJ
ct-9352	315	6	treatment	treatment	NOUN
ct-9352	315	7	of	of	ADP
ct-9352	315	8	equine	equine	NOUN
ct-9352	315	9	placentitis	placentitis	PROPN
ct-9352	315	10	.	.	PUNCT
ct-9352	316	1	vet	vet	PROPN
ct-9352	316	2	clin	clin	PROPN
ct-9352	316	3	north	north	PROPN
ct-9352	316	4	am	be	AUX
ct-9352	316	5	equine	equine	NOUN
ct-9352	316	6	pract	pract	NOUN
ct-9352	316	7	2006;22:763	2006;22:763	NUM
ct-9352	316	8	-	-	SYM
ct-9352	316	9	776	776	NUM
ct-9352	316	10	.	.	PUNCT
ct-9352	317	1	87	87	NUM
ct-9352	317	2	.	.	PUNCT
ct-9352	318	1	macpherson	macpherson	PROPN
ct-9352	318	2	ml	ml	PROPN
ct-9352	318	3	,	,	PUNCT
ct-9352	318	4	giguere	giguere	NOUN
ct-9352	318	5	s	s	X
ct-9352	318	6	,	,	PUNCT
ct-9352	318	7	pozor	pozor	PROPN
ct-9352	318	8	ma	ma	PROPN
ct-9352	318	9	,	,	PUNCT
ct-9352	318	10	et	et	PROPN
ct-9352	318	11	al	al	PROPN
ct-9352	318	12	:	:	PUNCT
ct-9352	318	13	evidence	evidence	NOUN
ct-9352	318	14	for	for	ADP
ct-9352	318	15	anti	anti	ADJ
ct-9352	318	16	-	-	ADJ
ct-9352	318	17	inflammatory	inflammatory	ADJ
ct-9352	318	18	effects	effect	NOUN
ct-9352	318	19	of	of	ADP
ct-9352	318	20	firocoxib	firocoxib	NOUN
ct-9352	318	21	administered	administer	VERB
ct-9352	318	22	to	to	ADP
ct-9352	318	23	mares	mare	NOUN
ct-9352	318	24	with	with	ADP
ct-9352	318	25	experimentally	experimentally	ADV
ct-9352	318	26	induced	induce	VERB
ct-9352	318	27	placentitis	placentitis	PROPN
ct-9352	318	28	.	.	PUNCT
ct-9352	318	29	am	be	AUX
ct-9352	318	30	j	j	PROPN
ct-9352	318	31	reprod	reprod	PROPN
ct-9352	318	32	immunol	immunol	PROPN
ct-9352	318	33	2021	2021	NUM
ct-9352	318	34	:	:	PUNCT
ct-9352	318	35	e13396	e13396	NOUN
ct-9352	318	36	.	.	PUNCT
ct-9352	319	1	88	88	NUM
ct-9352	319	2	.	.	PUNCT
ct-9352	320	1	curcio	curcio	PROPN
ct-9352	320	2	br	br	PROPN
ct-9352	320	3	,	,	PUNCT
ct-9352	320	4	canisso	canisso	VERB
ct-9352	320	5	if	if	SCONJ
ct-9352	320	6	,	,	PUNCT
ct-9352	320	7	pazinato	pazinato	PROPN
ct-9352	320	8	,	,	PUNCT
ct-9352	320	9	et	et	PROPN
ct-9352	320	10	al	al	PROPN
ct-9352	320	11	:	:	PUNCT
ct-9352	320	12	estradiol	estradiol	PROPN
ct-9352	320	13	cypionate	cypionate	PROPN
ct-9352	320	14	aided	aid	VERB
ct-9352	320	15	treatment	treatment	NOUN
ct-9352	320	16	for	for	ADP
ct-9352	320	17	experimentally	experimentally	ADV
ct-9352	320	18	induced	induce	VERB
ct-9352	320	19	ascending	ascend	VERB
ct-9352	320	20	placentitis	placentitis	PROPN
ct-9352	320	21	in	in	ADP
ct-9352	320	22	mares	mare	NOUN
ct-9352	320	23	.	.	PUNCT
ct-9352	321	1	theriogenology	theriogenology	NOUN
ct-9352	321	2	2017;102:98	2017;102:98	NUM
ct-9352	321	3	-	-	SYM
ct-9352	321	4	107	107	NUM
ct-9352	321	5	.	.	PUNCT
ct-9352	321	6	89	89	NUM
ct-9352	321	7	.	.	PUNCT
ct-9352	321	8	rossdale	rossdale	PROPN
ct-9352	321	9	pd	pd	PROPN
ct-9352	321	10	,	,	PUNCT
ct-9352	321	11	silver	silver	NOUN
ct-9352	321	12	m	m	PROPN
ct-9352	321	13	:	:	PUNCT
ct-9352	321	14	the	the	DET
ct-9352	321	15	concept	concept	NOUN
ct-9352	321	16	of	of	ADP
ct-9352	321	17	readiness	readiness	NOUN
ct-9352	321	18	for	for	ADP
ct-9352	321	19	birth	birth	NOUN
ct-9352	321	20	.	.	PUNCT
ct-9352	322	1	j	j	PROPN
ct-9352	322	2	reprod	reprod	PROPN
ct-9352	322	3	fertil	fertil	PROPN
ct-9352	322	4	suppl	suppl	ADJ
ct-9352	322	5	1982;32:507	1982;32:507	PROPN
ct-9352	322	6	-	-	SYM
ct-9352	322	7	510	510	NUM
ct-9352	322	8	.	.	PUNCT
ct-9352	323	1	90	90	NUM
ct-9352	323	2	.	.	PUNCT
ct-9352	324	1	fedorka	fedorka	PROPN
ct-9352	324	2	ce	ce	PROPN
ct-9352	324	3	,	,	PUNCT
ct-9352	324	4	murase	murase	NOUN
ct-9352	324	5	h	h	NOUN
ct-9352	324	6	,	,	PUNCT
ct-9352	324	7	loux	loux	PROPN
ct-9352	324	8	sc	sc	PROPN
ct-9352	324	9	,	,	PUNCT
ct-9352	324	10	et	et	PROPN
ct-9352	324	11	al	al	PROPN
ct-9352	324	12	:	:	PUNCT
ct-9352	324	13	the	the	DET
ct-9352	324	14	effect	effect	NOUN
ct-9352	324	15	of	of	ADP
ct-9352	324	16	mycobacterium	mycobacterium	NOUN
ct-9352	324	17	cell	cell	NOUN
ct-9352	324	18	wall	wall	NOUN
ct-9352	324	19	fraction	fraction	PROPN
ct-9352	324	20	on	on	ADP
ct-9352	324	21	histologic	histologic	ADJ
ct-9352	324	22	,	,	PUNCT
ct-9352	324	23	immunologic	immunologic	ADJ
ct-9352	324	24	,	,	PUNCT
ct-9352	324	25	and	and	CCONJ
ct-9352	324	26	clinical	clinical	ADJ
ct-9352	324	27	parameters	parameter	NOUN
ct-9352	324	28	of	of	ADP
ct-9352	324	29	postpartum	postpartum	NOUN
ct-9352	324	30	involution	involution	NOUN
ct-9352	324	31	in	in	ADP
ct-9352	324	32	the	the	DET
ct-9352	324	33	mare	mare	NOUN
ct-9352	324	34	.	.	PUNCT
ct-9352	325	1	j	j	PROPN
ct-9352	325	2	equine	equine	PROPN
ct-9352	325	3	vet	vet	NOUN
ct-9352	325	4	sci	sci	PROPN
ct-9352	325	5	2020;90:103013	2020;90:103013	PROPN
ct-9352	325	6	.	.	PROPN
ct-9352	325	7	91	91	NUM
ct-9352	325	8	.	.	PUNCT
ct-9352	326	1	fumuso	fumuso	PROPN
ct-9352	326	2	e	e	PROPN
ct-9352	326	3	,	,	PUNCT
ct-9352	326	4	alvarez	alvarez	PROPN
ct-9352	326	5	g	g	PROPN
ct-9352	326	6	,	,	PUNCT
ct-9352	326	7	bruno	bruno	PROPN
ct-9352	326	8	s	s	PROPN
ct-9352	326	9	,	,	PUNCT
ct-9352	326	10	et	et	PROPN
ct-9352	326	11	al	al	PROPN
ct-9352	326	12	:	:	PUNCT
ct-9352	326	13	non	non	ADJ
ct-9352	326	14	-	-	ADJ
ct-9352	326	15	specific	specific	ADJ
ct-9352	326	16	immunomodulation	immunomodulation	NOUN
ct-9352	326	17	at	at	ADP
ct-9352	326	18	post	post	ADJ
ct-9352	326	19	-	-	ADJ
ct-9352	326	20	partum	partum	NOUN
ct-9352	326	21	improves	improve	VERB
ct-9352	326	22	uterine	uterine	ADJ
ct-9352	326	23	condition	condition	NOUN
ct-9352	326	24	and	and	CCONJ
ct-9352	326	25	fertility	fertility	NOUN
ct-9352	326	26	in	in	ADP
ct-9352	326	27	mares	mare	NOUN
ct-9352	326	28	.	.	PUNCT
ct-9352	327	1	proc	proc	NOUN
ct-9352	327	2	world	world	PROPN
ct-9352	327	3	equine	equine	PROPN
ct-9352	327	4	vet	vet	PROPN
ct-9352	327	5	association	association	PROPN
ct-9352	327	6	2003	2003	NUM
ct-9352	327	7	.	.	PUNCT
ct-9352	328	1	clinical	clinical	ADJ
ct-9352	328	2	theriogenology	theriogenology	NOUN
ct-9352	328	3	2021	2021	NUM
ct-9352	328	4	;	;	PUNCT
ct-9352	328	5	13	13	NUM
ct-9352	328	6	:	:	SYM
ct-9352	328	7	246	246	NUM
ct-9352	328	8	immunomodulator	immunomodulator	NOUN
ct-9352	328	9	use	use	NOUN
ct-9352	328	10	in	in	ADP
ct-9352	328	11	mares	mare	NOUN